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ABSTRACT 
Micah M. Bhatti 
 
FUNCTIONS OF THE UNIQUE N-TERMINUS OF A GCN5 HISTONE  
ACETYLASE IN TOXOPLASMA GONDII 
 
GCN5 is a histone acetyltransferase (HAT) that remodels chromatin by 
acetylating lysine residues of histones.  The GCN5 HAT identified in Toxoplasma 
gondii (TgGCN5) contains a unique N-terminal “extension” that bears no 
similarity to known proteins and is devoid of known protein motifs.  The 
hypothesis of this thesis is the N-terminal extension is critical to the function of 
TgGCN5.  Three possible roles of the N-terminus were investigated: nuclear 
localization, protein-protein interactions, and substrate recognition.  Subcellular 
localization was determined via immunocytochemistry using parasites expressing 
recombinant forms of TgGCN5 fused to a FLAG tag.  Initial studies performed 
with parasites expressing full length FLAGTgGCN5 were positive for nuclear 
localization.  Without the N-terminal extension (FLAGΔNTTgGCN5) the protein 
remains cytoplasmic.  Additional studies mapped a six amino acid motif 
(RKRVKR) as the nuclear localization signal (NLS).  When RKRVKR is fused to a 
cytoplasmic protein, it gains access to the nucleus.  Furthermore, we have 
established the NLS interacts with Toxoplasma importin α, a protein involved in 
nuclear trafficking.  Interaction with importin α provides evidence that the 
TgGCN5 N-terminal extension is involved in mediating protein-protein 
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interactions.  In order to identify additional interacting proteins, FLAG affinity 
purification was performed on parasites expressing full length FLAGTgGCN5 and 
FLAGΔNTTgGCN5.  Upon comparing the results of the two purifications, proteins 
captured with only full length TgGCN5 may be interacting with the N-terminal 
extension.  Full length TgGCN5 affinity purification indicates an interaction with 
histone proteins, two different homologues of Ada2 (adapter protein reported to 
interact with GCN5 homologues), and several heat shock proteins.  With regard 
to substrate recognition, the N-terminal extension of TgGCN5 is dispensable for 
the acetylation of non-nucleosomal histones in vitro.  However, the lysine 
acetylated by TgGCN5 is surprisingly unique.  Other GCN5 homologues 
preferentially acetylate lysine 14 in histone H3, but TgGCN5 exclusively 
acetylates lysine 18 in histone H3 and has no activity on lysine 14.  Taken 
together, these results argue that the N-terminal extension of TgGCN5 is critical 
for mediating protein-protein interactions, including those responsible for 
trafficking the HAT to the parasite nucleus but does not appear to be required for 
the acetylation of non-nucleosomal histones. 
 
William J. Sullivan, Jr., Ph.D. - Chair 
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CHAPTER 1: INTRODUCTION 
 
I. Phylum Apicomplexa and Toxoplasma gondii 
There are over 4,000 members in the phylum Apicomplexa and all are 
parasitic organisms.  Electron microscopy has revealed unique structural 
features which define this phylum (Figure 1).  The defining characteristic of 
apicomplexa is a group of organelles found at the anterior end of the organism 
called the apical complex.  The apical complex includes secretory organelles 
known as micronemes and rhoptries, polar rings composed of microtubules, and 
a conoid which lies within the polar rings (Blackman and Bannister, 2001).  The 
apical organelles play a major role in parasite invasion of the host cell.  Most 
apicomplexan parasites also possess an apicoplast, an essential organelle that 
appears to have been acquired by secondary endosymbiosis of a green alga 
(Waller and McFadden, 2005).  Secondary endosymbiosis theorizes that certain 
organelles such as the mitochondrion and plastids were originally derived from 
an engulfed organism that was incorporated into the cellular structure rather than 
being digested (Marechal and Cesbron-Delauw, 2001).  The 35 kilobase genome 
of the apicoplast encodes its own genes; however most of the proteome of the 
apicoplast is encoded in the parasites nucleus (Foth and McFadden, 2003).   
Several medically important protozoan parasites belong to the phylum 
Apicomplexa.  The most notorious is the Plasmodium spp., the causative agent 
of malaria.  The various species of Plasmodium kill over 3 million people a year; 
one third of which are children (Snow et al., 1999).  The current annual malaria 
death toll equates to approximately 340 deaths every hour.  Cryptosporidium 
parvum is an apicomplexan that causes a self-limiting intestinal illness that can 
be life-threatening in immune compromised individuals.  The largest outbreak of 
C. parvum in the US occurred in Milwaukee, Wisconsin in the spring of 1993.  
Approximately 400,000 people were infected and developed severe diarrhea 
(MacKenzie et al., 1994).  The outbreak is believed to have been caused by 
ineffective filtration and treatment of the local water supply (MacKenzie et al., 
1994).  Of the 400,000 with disease, about 100 deaths occurred; all individuals 
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Figure 1: Transmission electron image of a tachyzoite within a host cell 
Tachyzoites possess organelles present in all eukaryotes (mitochondria, nucleus, 
and Golgi complex).  At the apical end, the micronemes, rhoptries and conoid 
form the apical complex, a group of organelles involved in host cell invasion.  The 
micronemes and rhoptries are secretory organelles and the conoid is a 
cytoskeletal structure connected to the actin-myosin motility of the parasite.  
Although not a part of the apical complex, dense granules are secretory 
organelles that also function in the invasion process.  The parasite is housed 
within a parasitophorous vacuole that is generated during host cell invasion.  
(Binder and Kim, 2004; reprinted with permission from Blackwell Publishing) 
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with immune deficiencies (Anderson, 1998).  Currently, there are no effective 
antimicrobials capable of treating C. parvum infections (Lane et al., 1994). 
Apicomplexans parasites also target non-human hosts causing significant 
economic burden for the livestock industry.  Avian coccidiosis is an intestinal 
disease caused by parasites of the genus Eimeria, and is a constant threat to the 
poultry industry (Allen and Fetterer, 2002).  The annual worldwide cost is 
estimated at about $800 million and about $450 million for the American poultry 
industry alone (Allen and Fetterer, 2002).  These estimates include the costs of 
prophylactic medication and losses due to mortality by Eimeria infection (Allen 
and Fetterer, 2002). 
Toxoplasma gondii, the most widely disseminated parasite in this phylum, 
infects virtually all warm-blooded vertebrates.  It is estimated that between 16-
40% of the United States population is infected and up to 80% of individuals in 
other countries (Hill and Dubey, 2002).  While both the initial and resulting latent 
infection with Toxoplasma are asymptomatic, initial infections in pregnant women 
can result in serious obstetric complications and reactivation of the latent 
infection in immunocompromised patients can cause life-threatening illness 
(Guerina et al., 1994; Wong and Remington, 1993). 
Every year between 400-4000 cases of congenital toxoplasmosis occurs 
in the US alone (Boyer, 1996).  In nations with higher infection rates, the 
frequency of neonatal complications can be as high as 1 in every 1000 births 
(Guerina et al., 1994).  In utero Toxoplasma infections can result in a wide range 
of severity from children born with asymptomatic disease to severe mental 
retardation and disability (Jones et al., 2003). 
Growing numbers of immunocompromised individuals, largely due to the 
AIDS epidemic, has created an increase in toxoplasmosis seen in the health care 
setting.  In the absence of drug therapy, 20-47% of HIV patients with latent 
Toxoplasma infections will develop toxoplasmic encephalitis (Wong and 
Remington, 1993).  Between 1992 and 1998, over 6,000 HIV infected individuals 
died from toxoplasmosis (Jones et al., 2002). 
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Because immune suppression is necessary for organ transplantation, 
these individuals are also at risk for reactivation of latent Toxoplasma.  In 
patients receiving heart transplants, 4-12% will suffer from complications 
stemming from reactivated toxoplasmosis (Hermanns et al., 2001; Wagner et al., 
1994). 
Unfortunately, for individuals threatened by Toxoplasma infections, the 
current therapies (page 14) are limited by serious side-effects (bone marrow 
suppression and hypersensitivity reactions).  Furthermore, these drugs are 
unable to target the latent infection.  Thus, novel therapeutics are seriously 
needed that possess fewer side effects and/or the ability to eradicate the latent 
infection. 
In addition to its own medical significance, Toxoplasma also serves as an 
excellent model to study other apicomplexans (Roos et al., 1999).  Clinically 
important apicomplexans such as the Plasmodium spp. and C. parvum are 
difficult to grow in vitro and are not amenable to genetic manipulation.  
Toxoplasma however, is relatively easy to cultivate in vitro and various molecular 
techniques and resources have been established to study this organism including 
transfection (Soldati and Boothroyd, 1993), gene knockout strategies (Donald 
and Roos, 1994), and an online genomic database (http://toxodb.org/; Kissinger 
et al., 2003).  Thus, for many experimental questions, Toxoplasma remains the 
best model system to study the biology of the Apicomplexa.  Our understanding 
of the mechanisms of drug resistance, the biology of the apicoplast, and the 
process of host cell invasion has been advanced by studies in Toxoplasma (Kim 
and Weiss, 2004).  Heterologous expression of apicomplexan proteins in 
Toxoplasma has frequently facilitated further characterization of proteins that 
could not otherwise be easily studied (Kim and Weiss, 2004).  Although findings 
in Toxoplasma will not always be applicable to other apicomplexan members, it is 
an important model system for understanding apicomplexan biology. 
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A. Life cycle of Toxoplasma gondii 
Toxoplasma was first isolated by Nicolle and Manceaux in 1908, from the 
African rodent Ctenodactylus gondii, which shares the same species designation 
(Petersen and Dubey, 2001).  Under the microscope, the parasite has a distinct 
crescent shape similar to a bow.  The unusual shape of the organism was used 
to derived its genus name from the Greek word toxon, meaning “bow” and 
plasma meaning “the form” (Petersen and Dubey, 2001). 
The life cycle consists of two major phases; an asexual and sexual cycle 
(Figure 2).  While the parasites can grow asexually in almost any warm blooded 
vertebrate, the sexual cycle is restricted to cat intestinal tract (Dubey et al., 
1970).  In feline intestinal epithelium the parasite differentiates into either macro- 
or microgametes that fuse to form diploid oocysts which are subsequently 
excreted in the cat’s feces (Ferguson et al., 1975).  Oocysts have a very thick 
protective wall encasing the organism (Speer, 1998).  Upon exposure to the 
external environment, the diploid organism inside the oocyst sporulate generating 
infectious sporozoites.  The sporulation process (sporogony) consists of two 
meiotic divisions and a single mitotic division, producing eight haploid 
sporozoites.  Sporulated oocysts present in the soil can remain infectious for 
more than a year (Wong and Remington, 1993). 
When oocysts are ingested, the thick protective oocyst wall is degraded by 
host digestive enzymes, releasing the infectious sporozoites.  If a cat consumes 
oocysts, the sexual cycle will take place, resulting in the formation of gametes 
and oocysts which are shed with the cat’s feces.  However, in all mammals 
(including cats) and birds that ingest oocysts, the released sporozoites will 
penetrate the intestinal epithelium and invade intestinal cells.  During this initial 
invasion of host cells, the sporozoites differentiate into tachyzoites that 
disseminate throughout the host upon reaching the blood stream (Wong and 
Remington, 1993). 
Once the parasite differentiates into a tachyzoite, it becomes an obligate 
intracellular parasite and cannot survive for long outside of a host cell.  They are 
purine auxotrophs and require certain amino acids such as glutamine and  
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Figure 2: Life cycle of Toxoplasma gondii  
The diagram depicts the sexual cycle (dotted line), which occurs only in the feline 
intestines, and the asexual cycle (solid line) which takes place in nucleated cells 
of all infected animals.  During the asexual cycle, a small portion of the fast 
growing tachyzoites will differentiate into encysted slow growing bradyzoites.  
These bradyzoite cysts persist throughout the lifespan of the host resulting in a 
permanent latent infection.  Furthermore, the bradyzoites can spontaneously 
recrudesce back to tachyzoites, potentially causing acute illness long after the 
initial infection has resolved. 
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arginine for survival (Sullivan et al., 1999; Fox and et al., 2004).  These 
biomolecules are siphoned from the infected host cell.  Because of its obligate 
intracellular lifestyle, Toxoplasma has developed a highly orchestrated invasion 
process that is quick and involves the use of the apical complex (Carruthers, 
2002). 
During the invasion process, the parasite surrounds itself within a vacuole 
derived largely from the host cell membrane (Leirião et al., 2004).  However, 
many of the host membrane proteins appear to be absent and several parasite 
proteins released during the invasion process are incorporated into the parasite 
vacuolar membrane (Sibley and Krahenbuhl, 1988; Beckers et al., 1994).  
Through an unknown process, the parasite vacuole does not fuse with host cell 
lysosomes, protecting it from normal vacuole acidification (Sibley et al., 1985).  
Inside the vacuole, the parasite undergoes asexual replication by endodyogeny, 
a specialized type of division in which the two daughter cells form within the 
mother cell (Hu et al., 2002).  The parasite continues to replicate inside the host 
cell with a generation time of six to eight hours until the vacuole becomes too 
large for the host cell and the cell ruptures (Black and Boothroyd, 2000).  The 
tachyzoites emerge from the ruptured host cell and repeat the invasion and 
replication processes inside new host cells.  The continuous cycle of invasion, 
replication, and cell lysis by tachyzoites leads to the tissue destruction associated 
with Toxoplasma infection. 
About two weeks post infection, a portion of the invasive tachyzoites will  
differentiate into bradyzoites through a poorly understood process (Lyons et al., 
2002).  Bradyzoites replicate more slowly and are housed inside of a thick, rigid 
cyst-like membrane composed of polysaccharides and chitin (Weiss and Kim, 
2000).  The cysts vary in size (10-100µm) and form inside host cells, rendering 
detection by the immune system difficult and resulting in a permanent latent 
infection. 
When an infected host animal is eaten, the bradyzoite cysts present in the 
host tissues are capable of causing infection in a manner similar to oocysts (Hill 
and Dubey, 2002).  The cyst wall protects the bradyzoites from the digestive 
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enzymes present in the stomach.  After passing through the stomach, the cyst 
wall is eventually degraded and the released bradyzoites infect the intestinal 
mucosa, differentiating back into tachyzoites (Dubey et al., 1970).  The 
tachyzoites disseminate throughout the host animal.  In the case of a feline, 
ingestion of bradyzoite cysts will also result in the formation of gametes 
producing oocysts which will be shed with the feces thus completing the life cycle 
(Dubey et al., 1970). 
 
B. Infection and pathobiology 
Humans can become infected through several routes.  Young children can 
become infected through accidental ingestion by playing in soil contaminated 
with oocysts.  People exposed to cats can acquire infection by handling cat liter 
containing oocysts.  Consumption of improperly cooked meat containing 
bradyzoite cysts can result in infection.  It is estimated that of the 750 deaths 
attributed to toxoplasmosis each year, 375 (50%) are believed to be caused by 
eating contaminated meat, making toxoplasmosis the third leading cause of food 
borne deaths in the United States (Lopez et al., 2000). 
Once ingested, the oocysts or bradyzoite cysts release infective parasites 
that invade the intestinal epithelium and differentiate into tachyzoites.  
Tachyzoites disseminate throughout the body by infected macrophages and as 
extracellular parasites in the blood stream (Wong and Remington, 1993).  The 
initial infection and parasitemia are largely asymptomatic in healthy individuals.  
However, some people may experience “flu-like” symptoms, the most common 
being fever, lymphadenopathy, and headache (Luft and Remington, 1988). 
Due to the intracellular nature of the parasite, protective immunity to 
Toxoplasma is based on a cell-mediated immune response.  A cell-mediated 
immune response relies on CD4+ helper T-cells recognizing antigen presented by 
macrophages and dendritic cells (Germain and Stefanova, 1999).  Infected 
macrophages and dendritic cells are unable to kill internal parasites, but a small 
amount of parasite specific protein is presented as antigen on the surface of 
phagocytic cells.  Antigen presentation and IL-12 secretion by infected 
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macrophages and dendritic cells activates CD4+ helper T-cells resulting in their 
production and release of interferon gamma (IFN-γ; Hunter and Reichmann, 
2001).  The released IFN-γ further activates macrophages and dendritic cells, 
leading to upregulation of inducible nitric oxide synthase (iNOS; Langermans et 
al., 1992).  Macrophages require iNOS to produce reactive nitrogen 
intermediates which inhibit parasite replication (Sibley et al., 1991).  
Nonphagocytic cells are also affected by the release of IFN-γ which activates 
indolamine dioxygenase, starving intracellular parasites of the essential amino 
acid tryptophan (Pfefferkorn, 1984).  The multiple actions of IFN-γ appear to be 
crucial in controlling acute Toxoplasma infections and in driving the infection into 
a quiescent latent stage. 
During the initial infection, the cell-mediated response is accompanied by 
the production of antibodies.  B-cells are stimulated by activated CD4+ helper T-
cells and begin producing low-affinity IgM antibodies.  As the B-cell response 
matures and isotype switching occurs, high levels of high affinity anti-toxoplasma 
IgG antibodies can be detected (Hunter and Reichmann, 2001).  However, 
because Toxoplasma is an intracellular pathogen, the utility of antibodies in 
controlling infection has been questioned.  When the parasites lyse an infected 
cell, the extracellular parasites are susceptible to antibodies.  During this 
intermittent extracellular phase, the antibodies may play a role in killing parasites 
by activating complement or by opsonizing the parasites for phagocytosis and 
killing by macrophages (Hammouda et al., 1995). 
While the immune system is attempting to thwart the initial infection, a 
portion of the invading tachyzoites will differentiate into bradyzoites housed within 
a cyst inside of a host cell (Lyons et al., 2002).  Tachyzoites that do not undergo 
differentiation will be eventually cleared by the immune system.  On the other 
hand, bradyzoites are extremely slow growing and therefore do not provoke an 
inflammatory response (Derouin, 1992).  Thus, an infected individual remains 
infected for life.  Although the bradyzoite cysts can form in any cell in the body, 
they have a preference for skeletal and cardiac muscle and the central nervous 
system (Hill and Dubey, 2002).  Currently, there is no adequate explanation for 
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this tissue preference.  It has been a long standing presumption that the 
bradyzoite cysts present in these tissues does not alter their normal physiological 
function (Yolken et al., 2001).  However, there is preliminary data showing a 
higher rate of Toxoplasma infection in the schizophrenic population suggesting 
that the bradyzoite cysts might alter CNS function and predispose individuals to 
mental illness (Yolken et al., 2001).  At this time, these studies are incomplete as 
they do not take into account several important factors such as age of infection, 
severity of infection, and/or family history of mental illness. 
Even after infected individuals have cleared the initial infection, antibody 
titers remain elevated (Ho-Yen, 1992).  The relatively high antibody titer is best 
explained by a small portion of the bradyzoites cysts spontaneously reverting 
back to tachyzoites, termed recrudescence (Lyons et al., 2002).  In response to 
the reemerging tachyzoites, the immune system is activated through similar 
mechanisms as the initial infection, only much quicker.  Thus, the reemerging 
tachyzoites are efficiently eradicated before they can cause significant tissue 
destruction (Weiss and Kim, 2000).  It is plausible that the constant priming of the 
immune system by recrudescing bradyzoites provides protection against 
reinfection, which is especially important in pregnant women as described in the 
next section. 
 
C. Congenital infection 
Virtually all births suffering complications due to Toxoplasma infection are 
the result of the mother being exposed for the first time during the pregnancy 
(Guerina et al., 1994).  Otherwise healthy, pregnant women who have been 
previously infected with Toxoplasma are able to quickly control reexposure to 
ingested oocysts or bradyzoites before the parasites can spread to the fetus 
(Jones et al., 2003).  The quick ability to control reinfection may be partly due to 
the primed immune system by recrudescing bradyzoites.  Pregnant women who 
are infected for the first time during pregnancy need time to mount an effective 
immune response (Guerina et al., 1994).  During this period, the parasite 
disseminates throughout the body, infecting various tissues including the 
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placenta.  Once the placenta is infected, tachyzoites can cross over and infect 
the developing fetus (Boyer, 1996).  Members of the cell-mediated immune 
system (macrophages and CD4+ helper T-cells) are restricted by placental 
barriers and are unable to protect the fetus from infection.  However, antibodies 
can cross placental barriers and may play a role in helping to control fetal 
infection. 
At birth, the classic triad of signs suggestive of congenital toxoplasmosis 
includes chorioretinitis (infection of the choroid and retina of the eye), 
hydrocephalus, and intracranial calcifications (Hill and Dubey, 2002).  The CNS 
appears to be the system suffering the most damage, resulting in potential 
cognitive and visual disabilities.  Congenital disease is more severe when 
infection is acquired in the first trimester versus the second or third (Guerina et 
al., 1994).  Later in gestation, the fetal immune system is better developed and 
more able to control in the infection.  Interestingly, the risk of transmitting the 
infection to the fetus is higher during the later stages of pregnancy and may be 
related to placental development and increased blood supply during the later 
stages of pregnancy making transmission more likely (Guerina et al., 1994).  In 
general, the overall risk of congenital infection from an initial acute Toxoplasma 
infection during pregnancy ranges from approximately 20 to 50 percent (Jones et 
al., 2003).  When acute Toxoplasma infection is suspected, a diagnosis is made 
on the basis of antibody detection.  Acute infection is confirmed by the presence 
of both IgG and IgM antibodies (Jones et al., 2003).  If a pregnant woman is 
suffering from acute infection with Toxoplasma, the next step is to determine 
whether the fetus is infected, which is usually done via PCR testing of amniotic 
fluid (Jones et al., 2003). 
 
D. Infection in HIV patients 
While recrudescing bradyzoites may help prevent reinfection in healthy 
individuals, they can cause serious problems in immune suppressed individuals 
(Reiter-Owona et al., 2000).  Without the protection of a fully functional immune 
system, reactivated tachyzoites can cause widespread tissue damage, blindness, 
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encephalitis, and even death (Black and Boothroyd, 2000).  In recent decades, 
the population of immune suppressed individuals has become increasingly large 
due to the AIDS epidemic. 
Patients suffering from end-stage AIDS clearly demonstrate the close 
association of T-cell function with resistance to Toxoplasma.  Unfortunately for 
these individuals, the HIV virus attacks and destroys CD4+ T-cells 
(Pattanapanyasat and Thakar, 2005).  As mentioned earlier, CD4+ T-cells are 
essential for controlling Toxoplasma infection and reactivation.  There is strong 
correlation with the clinical presentation of Toxoplasma infection and CD4+ cell 
counts.  At the time they present with clinical toxoplasmosis, AIDS patients 
usually have CD4+ T-cell counts that have fallen from 800-12000/mm3 to less 
than 100/mm3 (Hunter and Reichmann, 2001). 
Toxoplasmic encephalitis (TE) without any other organ involvement is the 
most frequent manifestation of toxoplasmosis in patients with AIDS (Mariuz and 
Steigbigel, 2001).  In one study of 86 HIV patients with TE, the most common 
general signs included fever and headache unresponsive to analgesics (Renold 
et al., 1992).  The diagnosis of TE in HIV patients is usually made by the 
combination of neurological symptoms and findings on computerized 
tomographic (CT) scan or magnetic resonance imaging (MRI).  The neurological 
symptoms can include cranial nerve palsies, confusion, lethargy, and ataxia.  CT 
or MRI scans with contrast dye often reveal the presence of intracranial 
abscesses that can be as large as a tennis ball.  If untreated, toxoplasmic 
encephalitis is uniformly fatal (Luft et al., 1993). 
 
E. Infection in HIV-negative immune suppressed 
 Besides HIV infection, other individuals with suppressed immune systems 
are threatened by Toxoplasma infection or reactivation.  Immune suppression in 
these individuals is the result of advances in the medical field and includes post 
operative organ transplant patients undergoing immunosuppressive therapy to 
prevent organ rejection and patients with neoplastic conditions receiving 
immunosuppressive chemotherapy (Wong and Remington, 1993). 
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The biggest concern in organ transplantation is the potential for the donor 
recipient to become infected via the donated organ.  A report by Speirs et al. 
(1988) stated that 57% of heart and 20% of liver transplant recipients who were 
Toxoplasma negative before transplantation and who received organs from 
Toxoplasma positive donors acquired primary infection (Wreghitt and Joynson, 
2001).  Because the parasite has a tropism for cardiac tissue, heart and heart-
lung recipients are at the greatest risk versus other transplanted tissues (Wreghitt 
et al., 1989).  When a patient becomes infected from a donated organ, it is 
probably due to bradyzoite cysts present in the donated organ recrudescing back 
into tachyzoites in the recipient (Hermanns et al., 2001).  When an uninfected 
recipient receives an infected organ, it is referred to as a “Toxoplasma mismatch” 
(Wreghitt and Joynson, 2001).  “Toxoplasma mismatches” can be avoided by 
measuring antibody titers to determine if the recipient has had previous exposure 
to Toxoplasma.  In cases where “Toxoplasma mismatches” cannot be avoided, 
immediate treatment for toxoplasmosis (page 14) may reduce the severity of 
acute Toxoplasma infection (Wreghitt and Joynson, 2001). 
Another concern in organ transplantation is the post operative immune 
suppression necessary to prevent organ rejection.  In the early years of organ 
transplantation, large amounts of immunosuppressive drugs were used resulting 
in high risk Toxoplasma reactivation (Wreghitt and Joynson, 2001).  Newer, less 
aggressive therapies including low dose cyclosporine A, steroids, and 
azathioprine have significantly reduced toxoplasmosis seen in organ transplant 
patients (Wreghitt and Joynson, 2001).  However, patients are often placed on 
prophylaxis therapy with trimethoprim/sulfamethoxazole to prevent toxoplasmosis 
and other opportunistic diseases (Wreghitt and Joynson, 2001). 
Toxoplasmosis can occur in patients with immune suppression caused by 
certain malignancies, particularly Hodgkin’s lymphoma, with extended doses of 
corticosteroids, or certain chemotherapies.  While such infections are usually 
rare, patients must undergo treatment for toxoplasmosis (page 14) and 
alternations made in the dosage of chemotherapy that can limit the treatment of 
the malignancy (Wreghitt and Joynson, 2001). 
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F. Treatment of toxoplasmosis 
The standard treatment for toxoplasmosis is with pyrimethamine 
(Daraprim) and a sulphonamide, usually sulphadiazine.  Both drugs target two 
different enzymes involved in the folate pathway and therefore work 
synergistically to inhibit replicating tachyzoites.  Toxoplasma cannot uptake 
preformed folic acid and therefore must synthesize its own (Derouin, 2001).  The 
first step in the synthesis is carried out by dihydropteroate synthase (DHPS) 
which converts para-aminobenzoic acid to dihydrofolic acid, which then is 
converted to tetrahydrofolic acid by dihydrofolic acid reductase (DHFR).  
Sulphonamides are competitive inhibitors of DHPS and pyrimethamine inhibits 
DHFR (Tracy and Webster, 1996).  However, both of these drugs have 
potentially serious side effects. 
DHPS is not expressed in mammalian cells and thus there are few serious 
adverse reaction associated with administering sulphonamides (Derouin, 2001).  
Hypersensitivity reactions are the most common and can vary in severity from 
mild dermatitis to sever dermatological reactions and anaphylaxis (McCabe, 
2001).  The development of severe mucocutaneous reactions such as Steven-
Johnson syndrome and toxic epidermal necrosis (TEN) is also a concern when 
administering sulphonamides (Schmidt-Westhausen et al., 1998).  TEN is 
characterized by widespread blisters that involve over 90% of human body.  The 
blisters usually burst and the skin sloughs off causing increased risk of 
dehydration, hypothermia, and infection secondary to substantial skin loss 
(Fritsch and Sidoroff, 2000).  Furthermore, there is evidence that adverse skin 
reactions are higher among patients with AIDS than those without AIDS (Kimura 
et al., 1991).  Because TEN is a severe, potentially fatal skin reaction, 
sulfonamide-containing drugs should be given cautiously to patients with AIDS 
(Kimura et al., 1991) 
Unlike DHPS, DHFR is expressed in mammalian cells.  While 
pyrimethamine possesses a much higher affinity for the Toxoplasma DHFR there 
is still an effect on mammalian cells at therapeutic doses (Derouin, 2001).  In 
particular, the rapidly dividing progenitor blood cells in the bone marrow are 
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suppressed resulting in decreased platelets (thrombocytopenia), macrophages 
(granulocytopenia), and red blood cells (megaloblastic anemia; Winstanley et al., 
1995).  These types of anemia can lead to bleeding problems, further infections, 
and difficulty oxygenating tissues (cyanosis).  The likelihood of bone marrow 
suppression can be reduced with folic acid (Leucovorin) supplements in 
conjunction with pyrimethamine, but it does not prevent suppression (Tracy and 
Webster, 1996).  Folic acid supplementation only benefits mammalian cells 
because parasites cannot import it (Tracy and Webster, 1996). 
AIDS patients and other immune suppressed individuals suffering from 
reactivated toxoplasmosis are usually treated with pyrimethamine and 
sulphadiazine.  Once the acute infection has resolved, these individuals are 
usually placed on prophylaxis treatment to prevent reactivated tachyzoites from 
causing further tissue destruction (Nath and Sinai, 2003).  Because there is no 
drug capable of eradicating the encysted bradyzoites the prophylaxis treatment is 
usually life long (Lane et al., 1994).  Unfortunately, prolonged treatment with 
sulphonamides increases the risk of developing a hypersensitive reaction.  If an 
adverse reaction with sulphadiazine occurs, prophylaxis treatment can be 
maintained with pyrimethamine and a macrolide antibiotic such as clindamycin 
(Lane et al., 1994).  These compounds block protein synthesis in bacteria but 
their target in Toxoplasma is unknown.  It is theorized that the bacterial-like 
ribosomes present in the apicoplast may be inhibited by these antibiotics 
(Fichera et al., 1995). 
Highly active anti-retroviral therapy (HAART) has significantly reduced the 
number of AIDS-related cases of toxoplasmosis (Samuel et al., 2002).  These 
drugs slow the destruction of CD4+ cells by the HIV virus.  If CD4+ cell counts are 
maintained above 100/mm3, AIDS patients can usually be taken off prophylaxis 
treatment (Hunter and Reichmann, 2001).  However, the HIV virus mutates 
rapidly and if the virus develops resistance to current antiretroviral drugs, the 
incidence of AIDS-associated toxoplasmosis will likely rise again (Sacktor, 2002). 
If a fetus is suspected of being infected with toxoplasmosis, treatment 
must begin immediately.  Pyrimethamine is not used in pregnant women because 
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at high doses it has been shown to be teratogenic in animals (McCabe, 2001).  
The preferred treatment is with the macrolide antibiotic spiramycin (Jones et al., 
2003).  The exact mechanism of action of this antibiotic in Toxoplasma is 
unknown, but it is preferred because high concentrations in the placenta are 
achieved and it is extremely safe (Nath and Sinai, 2003).  Spiramycin has no 
known adverse effects on the fetus (McCabe, 2001).  Despite the relative safety 
of spiramycin, it is not readily available in the United States.  The drug can only 
be obtained through direct purchase from the manufacturer which generates 
logistical barriers to fast and effective treatment of pregnant women infected with 
Toxoplasma (Many and Koren, 2006).  If the Toxoplasma infection is thought to 
have occurred before the 16th week of pregnancy, or if the fetus shows evidence 
of hydrocephalus on ultrasound, abortion should be considered because of the 
high likelihood of severe fetal central nervous system damage (McCabe, 2001). 
 
G. Bradyzoite differentiation and transcriptional control 
The bradyzoite cyst is critical to the pathogenesis of Toxoplasma, 
responsible for the permanent latent stage of infection.  Currently, there are no 
therapies capable of targeting and eradicating this form of the parasites.  The 
differentiation process from tachyzoite to bradyzoite and back to tachyzoite is 
poorly understood.  In order for better therapeutics to be designed to target 
bradyzoites conversion, a better understanding of the differentiation process 
must be established. 
Studying bradyzoite differentiation was initially limited by the ability to 
generate in vitro bradyzoites.  In 1986, Jones et al. discovered that addition of 
IFN-γ to in vitro cultures of parasites results in the formation of bradyzoite cysts.  
As previously mentioned, it is theorized that IFN-γ starves the parasites of 
tryptophan.  Other mediators of in vitro differentiation that have since been 
discovered include alkaline treatment (pH 8.1), heat shock (42°C), and chemical 
stress (2μM sodium arsenite) (Soête, 1994).  All of these treatments share a 
common feature: they are all stressors slowing down the growth of the host cell 
16 
and parasite (Soête, 1994).  Thus, it would seem that bradyzoite differentiation is 
a stress mediated event. 
In addition to the development of in vitro differentiation protocols, 
bradyzoite-specific antiserums have been developed.  Western blot and ELISA 
studies using these antiserums have confirmed that tachyzoites and bradyzoites 
have unique as well as shared antigens (Weiss and Kim, 2000).  The first 
bradyzoite specific antigen discovered was BAG1 (bradyzoite antigen; Bohne et 
al., 1995).  Since then there have been 6 other bradyzoite-specific antigens and 
two stage-specific enzymatic paralogues (Singh et al., 2002).  The two enzymatic 
paralogues are lactate dehydrogenase 2 (LDH2) and enolase 1 (ENO1).  The 
respective counterparts to these paralogues, LDH1 and ENO2, are expressed 
only in tachyzoites.  The bradyzoite-specific LDH2 and ENO1 have different 
enzyme kinetics than the tachyzoite-specific counterparts, and it is believed that 
these differences help facilitate the slow metabolic rate of bradyzoites (Yang and 
Parmley, 1997; Dzierszinski et al., 2001, respectively).  Additional studies are 
underway attempting to characterize the promoters of these and other 
bradyzoite-specific genes.  Bradyzoite-specific promoters will aid in the 
identification of additional bradyzoite-specific genes and transcription factors that 
regulate these promoters. 
There are currently no known transcription factors in Toxoplasma that 
control or are involved in the bradyzoite differentiation process.  Additionally, the 
signaling pathways involved in triggering the differentiation process are unknown.  
As bradyzoite differentiation is unique to parasites, there is potential that 
transcription factors and/or signaling proteins involved in mediating differentiation 
are parasite specific and would make excellent drug targets.  Drugs capable of 
targeting proteins involved in controlling differentiation could halt the 
differentiation process and thus prevent the latent stage of infection.  However, 
searches of apicomplexan genome databases suggests there are a relatively 
small number of transcription factors present in Toxoplasma and other 
apicomplexans (Saksouk et al., 2005; Templeton et al., 2004). 
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In addition to transcription factors, other classes of proteins known to be 
involved in regulating gene expression should be investigated in Toxoplasma as 
they may participate in the differentiation process.  Chromatin remodeling 
proteins in other eukaryotic organisms play a profound in role in gene 
expression, some of which are instrumental in mediating stress responses 
(Huisinga and Pugh, 2004).  Analogous chromatin remodeling homologues exist 
in Toxoplasma (Sullivan and Hakimi, 2006) and may also be involved in stress 
responses which, as mentioned above, initiate bradyzoite conversion.  Currently, 
very little is known about chromatin remodeling proteins in apicomplexans.  
Identification and characterization of chromatin remodeling proteins in 
Toxoplasma will facilitate our understanding of gene regulation in this parasite 
and other apicomplexans, and may shed new light on the bradyzoite 
differentiation process. 
 
II. Transcription Control and Chromatin Remodeling Proteins 
A. Chromatin structure and nucleosomes 
Chromatin is defined as a complex of DNA, histones, and non-histone 
proteins from which eukaryotic chromosomes are formed (Alberts et al., 2002).  
The fundamental unit of chromatin is the nucleosome which is composed of a 
core of eight histones (two molecules of H2A, H2B, H3 and H4; Figure 3).  
Around this protein core, 146 base pairs of DNA is wrapped much like thread 
around a spool (Loid, 2001).  The core histones are small proteins with a basic 
charge that share the same basic structure: a globular C-terminal domain critical 
to nucleosome formation and a flexible N-terminal tail that protrudes from the 
nucleosome core (Santos-Rosa and Caldas, 2005).  The flexible N-terminal tails 
are enriched with basic residues which are theorized to interact with the 
negatively charged backbone of DNA (Allfrey et al., 1963). 
In-between each nucleosome is a short stretch of DNA termed linker DNA.  
The nucleosomes and their linker DNA form chains like a long string of beads,  
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Figure 3: Nucleosome structure 
DNA is wrapped around the octameric histone core forming the nucleosome.  
Each nucleosome is tethered together by linker DNA which associates with one 
H1 protein forming the 10nm “bead on string” fiber.  Through interactions 
between the H1 histones the fiber coils into a solenoid structure with a diameter 
of 30nm.  (adapted from Grunstein, 1992; reprinted with permission from author 
and Scientific American) 
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known as the 10-nm chromatin fiber (Loid, 2001).  These fibers are then packed 
into a higher order structure, facilitated by another histone protein, H1.  Histone 
H1 binds to the linker DNA and interacts with neighboring H1 proteins to form a 
spiral, with 6-8 nucleosomes per turn, generating a solenoid or 30nm chromatin 
fiber (Figure 3; Grunstein, 1992).  There are higher orders of structure that 
eventually lead to the formation of the metaphase chromosomes (Grunstein, 
1992).  However, these higher order structures have not been completely 
resolved. 
 
B. Histone acetylation and transcriptional control 
In the early 1960s, two papers by Allfrey and colleagues were the first to 
demonstrate the impact histones had on gene expression.  In 1963, Allfrey and 
colleagues confirmed that DNA-histone complexes (nucleosomes) fail to act as 
primers for RNA synthesis (Allfrey et al., 1963).  The high basic charge of 
histones was theorized to interact strongly with DNA preventing DNA from being 
transcribed by a polymerase.  Allfrey also developed a trypsin treatment that 
selectively depleted nuclear histones from cells.  Treating calf thymus cells with 
his trypsin protocol resulted in a large increase in RNA synthesis.  The increase 
in transcription was caused by increases in existing message and by the 
transcription of new mRNA not present before histone depletion (Allfrey et al., 
1963).  Allfrey deduced that the new transcripts were being generated because 
the digested histones were no longer able to repress transcription. 
Based on observations made by Phillips in 1963 of the substantial 
presence of acetylated histones in the nucleus, Allfrey examined the effect of 
acetylated histones on RNA synthesis (Allfrey et al., 1964).  Unlike unmodified 
histones, DNA-acetylated histone complexes were not inhibitory to RNA 
synthesis (Allfrey et al., 1964).  It was argued that acetylation attenuated the 
highly basic charge of histone proteins preventing them from strongly interacting 
with DNA.  However, the failure to inhibit RNA synthesis was not caused by 
acetylated histones completely dissociating from DNA.  Allfrey demonstrated that 
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acetylated histones were still able to protect DNA from thermal denaturation, 
suggesting an interaction is still present (Allfrey et al., 1964). 
The studies conducted by Allfrey and colleagues clearly demonstrated that 
histones possess the ability to control gene expression.  Furthermore, unmodified 
histones are repressive to RNA synthesis and acetylated histones are correlated 
with active transcription.  Although acetylated histones still interact with DNA, 
they generate a more favorable environment for gene transcription.  Despite this 
interesting discovery, the proteins responsible for acetylation of nuclear histones 
would not be elucidated for several decades. 
 
C. Histone acetyltransferases and GCN5 
Proteins capable of acetylating histones are termed histone acetyl 
transferases or HATs.  HATs covalently modify histones by transferring an acetyl 
group from acetyl-coenzyme A to the ε-amino group of specific lysine side chains 
within the N-terminal tails of histones (Sterner and Berger, 2000). 
GCN5 (General Control of Non-derepressed 5) was the first discovered 
protein capable of acetylating nuclear histones.  GCN5 was initially identified by 
Penn et al. in a yeast mutation screen identifying genes involved in amino acid 
biosynthesis (Penn et al., 1983).  Mutations were induced by UV-light irradiation 
and clones unable to grow in media deficient in preformed amino acids were 
considered to have disruptions in the regulation of their amino acid biosynthesis 
pathways.  The screen lead to the discovery of 5 genes involved in the 
derepression (induction) and expression of proteins involved in the synthesis of 
histidine, arginine, tryptophan, and methionine (Penn et al., 1983).  The genes 
were named GCN1 through GCN5. 
Additional work by Hope and Struhl lead to the discovery that GCN4 was 
the main transcription factor of the five GCN genes responsible for upregulation 
of amino acid biosynthesis genes under starvation conditions (Hope and Struhl, 
1985; Hope and Struhl, 1987).  Increasing the amount of GCN4 protein rescues 
cells suffering from mutations in GCN1, GCN2, and GCN3, suggesting that these 
genes are involved in the upregulation and expression of GCN4 (Hinnebusch, 
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1985).  However, mutations in GCN5 are not rescued by alterations in levels of 
GCN4 (Georgakopoulos and Thireos, 1992).  Using a GCN4 promoter driven 
reporter system, it was determined that GCN5 is required by GCN4 to fully 
activate its target genes (Georgakopoulos and Thireos, 1992).  Thus, GCN5 is 
involved in potentiating GCN4 mediated transcription.  However, the mechanism 
by which GCN5 functioned remained unknown.  Georgakopoulos and Thireos 
cloned the GCN5 gene, which encoded a protein of 439 amino acids.  They 
noted the presence of a putative domain in the C-terminus, between residues 
348 and 422, which shared similarity with a class of transcriptional factors related 
to DNA helicases.  Although GCN5 does not share any similarity to DNA 
helicases, this observation lead Georgakopoulos and Thireos to postulate that 
GCN5 may be involved in regulating chromatin structure (Georgakopoulos and 
Thireos, 1992). 
While the true function of GCN5 was attempting to be ascertained, others 
were working on trying to identify proteins responsible for acetylating histones.  
Although many attempts had been made trying to purify HATs from eukaryotic 
cells, all were unsuccessful due to low level of endogenous expression.  In 1995, 
success in identifying a HAT was finally achieved by Brownell and Allis using an 
“in gel” assay system (Brownell and Allis, 1995).  Core histones were 
incorporated into standard polyacrylamide gels during acrylamide polymerization.  
Nuclear extracts from Tetrahymena (a ciliated freshwater protozoan) were 
resolved on the histone-SDS gels under native conditions.  Following 
electrophoresis, the gels were incubated in a buffer containing tritiated acetyl-
CoA.  Upon exposure to film, a single band at 55 kilodaltons was detected 
suggesting the presence of a single HAT of this size termed p55 (Brownell and 
Allis, 1995).  Peptide sequencing of p55 was performed following several 
fractionation techniques on large amounts of Tetrahymena nuclear extracts.  
Using the peptide sequence data, they were able to clone the p55 gene 
(Brownell et al., 1996).  The full-length p55 gene encoded a protein of 421 amino 
acids and possessed unequivocal homology to yeast GCN5 (Brownell et al., 
1996).  This observation established a clear biochemical function for yeast GCN5 
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as a HAT and provided a mechanistic link between histone acetylation and gene 
activation (Brownell et al., 1996). 
Since its initial discovery, GCN5 proteins have been identified and 
characterized in many eukaryotic organisms including humans, mouse, 
Drosophila, and Arabidopsis (Candau et al., 1996; Driessen et al., 1997; Smith et 
al., 1998a; Stockinger et al., 2001; respectively).  Figure 4 contains diagrams 
depicting the different GCN5 homologues in these organisms and the conserved 
domains. 
All the GCN5 homologues known to date possess three conserved 
domains.  The catalytic domain is responsible for acetyltransferase activity.  
Initial enzymatic studies demonstrated that yeast GCN5 selectively acetylates 
histone H3 in nucleosomal substrates in vivo (Ruiz-Garcia et al., 1997).  
Additional studies with recombinant yeast GCN5 indicated that acetylation 
occurred on lysines in the N-termini of histones H3 and H4 (Kuo et al., 1996).  
Although the N-termini of H3 and H4 contain several conserved lysine residues 
that can be acetylated, recombinant yeast GCN5 preferentially acetylates lysine 
14 of H3 and to a lesser degree, lysine 8 and lysine 16 of H4 in vitro (Kuo et al., 
1996). 
The two other domains, the Ada2 binding domain and the bromodomain, 
are downstream of the catalytic domain.  The Ada2 binding domain is the region 
where the Ada2 protein binds to GCN5.  Ada2 belongs to the Ada 
(alteration/deficiency in activation) group of proteins that complex with GCN5 in 
vivo (Berger et al., 1992).  Proteins that interact with GCN5 including Ada 
proteins are discussed further in a Section II-E (page 29). 
The bromodomain is a conserved motif present in many transcription and 
chromatin regulators and is the same domain first noted in the C-terminus of 
yeast GCN5 by Georgakopoulos and Thireos in 1992.  Further analysis of the 
bromodomain has revealed it binds to specific acetylated lysines in histones H4 
and H3 (Dhalluin et al., 1999).  Thus, the bromodomain appears to be involved in 
recognizing modified histones and may serve to direct the function of GCN5 to 
areas of chromatin containing modified histones (Marmorstein, 2001).  The 
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Figure 4: GCN5 homologues and domains 
Schematic diagrams comparing homologues of GCN5.  All GCN5 proteins 
contain three conserved domains: the catalytic domain responsible for 
acetylating histones, the Ada2 binding domain (ADA2) where the Ada2 protein 
interacts with GCN5, and the bromodomain (br) which has been shown to 
interact with acetylated histones (Dhalluin et al., 1999).  Upstream of the catalytic 
domain is referred to as the N-terminal extension.  The N-terminus is highly 
conserved between metazoans but not between metazoans, plants, yeast or 
protozoa. 
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potential link between the bromodomain and the enzymatic activity of GCN5 will 
be addressed in Section II-G (page 36). 
The sequence upstream of the HAT catalytic domain varies in size and is 
sometimes referred to as an N-terminal extension.  Early branching eukaryotes 
generally possess a short sequence of less than 100 residues upstream of the 
HAT catalytic domain (Brownell et al., 1996).  The N-terminal extension in plant 
homologues are of moderate length, between 150 and 250 amino acids (Bhat et 
al., 2003).  The N-terminal extensions in plants and lower eukaryotes have little 
homology to each other or other HAT proteins.  The GCN5 homologues present 
in metazoans contain rather long N-terminal extensions, approximately 500 
residues in length.  The relatively long N-terminal extensions present in mouse 
and human GCN5 have been shown to be important in substrate recognition.  
When the N-terminal extension is removed from human and mouse GCN5, they 
are no longer able to recognize and acetylate nucleosomal histones in vitro (Xu 
et al., 1998).  The ability to acetylate free histones in solution is unaffected by 
removal of the N-terminal extension.  Another role for the N-terminal extension 
might be nuclear localization.  The maize homologue of GCN5 (ZmGCN5) has an 
N-terminal extension of about 160 residues and appears to be involved in 
targeting the HAT to the nucleus (Bhat et al., 2003).  Without the N-terminal 
extension, ZmGCN5 remains cytoplasmic.  Furthermore, when the first 175 
amino acids of ZmGCN5 are fused to GFP, the fusion protein accumulates in the 
nucleus (Bhat et al., 2003).  The involvement of the N-terminal extension in the 
nuclear localization of other GCN5 homologues has not been investigated. 
In addition to amino acid starvation, GCN5 is also important in the 
activating response elements during the stress of phosphate starvation.  The 
GCN5 knock-out (Δgcn5) generated in yeast has shown GCN5 to be important 
for remodeling chromatin at the inducible PHO5 and PHO8 promoters under 
phosphate starvation (Gregory et al., 1998; Gregory et al., 1999).  Unlike wild-
type yeast, the PHO5 and PHO8 promoters in Δgcn5 are resistant to DNase 
digestion, suggesting the promoters are condensed and not properly opened 
during starvation conditions (Gregory et al., 1998; Gregory et al., 1999). 
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In addition to stress remediation pathways, several studies on GCN5 in 
various organisms have implicated this HAT in more essential and global 
processes.  In yeast, Δgcn5 cells accumulate in G2/M cell cycle checkpoint 
indicating that GCN5 is important for normal cell-cycle progression (Zhang et al., 
1998).  GCN5-null mouse embryos die 10.5 days post conception.  The embryos 
failed to form mesodermal-derived structures (precursors to muscles and bones) 
and rarely formed a recognizable neural tube implicating a critical role for GCN5 
in mammalian development (Xu et al., 2000).  In Arabidopsis, GCN5-null 
seedlings fail to form a proper root structure and have shorter stature, suggesting 
that GCN5 is critical in plant development and growth (Vlachonasios et al., 2003). 
Another HAT with striking homology to GCN5 termed PCAF (p300/CBP 
Associating Factor) has been identified and characterized.  PCAF was originally 
identified from a human cDNA database on the basis of its homology to GCN5 
(Sterner and Berger, 2000).  There is an 86% homology between the C-terminal 
portion of PCAF (containing the HAT domain, Ada2 binding domain, and 
bromodomain) and the C-terminal end of GCN5 (Yang et al.,1996).  To date, 
PCAF has only been found in vertebrates and has overlapping and separate 
roles from GCN5 (Sterner and Berger, 2000). 
PCAF also possess an N-terminal extension that is 66% homologous to 
the N-terminal extension found in human and mouse GCN5 proteins (Xu et al., 
1998).  Just as in GCN5, the N-terminal extension in mouse and human PCAF is 
required for the recognition of nucleosomal substrates in vitro (Xu et al., 1998).  
PCAF possess the ability to acetylate its own N-terminus which augments its 
enzymatic activity (Herrera et al., 1997).  The acetylation of the N-terminus 
occurs by transacetylation; acetylation by second PCAF protein (Santos-Rosa et 
al., 2003).  There are five lysines in the PCAF N-terminus that are acetylated; 
lysines 416, 428, 430, 441, and 442.  Human GCN5 does not appear to acetylate 
its N-terminus (Herrera et al., 1997).  Only two of the five lysines that are 
acetylated in human PCAF are conserved in human GCN5 (lysines 428 and 
441).  Lysines 428, 430, 441, and 442 in human PCAF also appear to be 
involved in nuclear localization (Santos-Rosa et al., 2003).  When these four 
26 
lysines are mutated to arginine, PCAF is no longer targeted to the nucleus 
(Santos-Rosa et al., 2003).  These results suggest that transacetylation of PCAF 
may play a role in targeting it to the nucleus. 
As its name implies, PCAF interacts in vivo with another transcriptional 
regulator p300/CBP (CREB binding protein), which is another HAT.  The histone 
acetylation properties of p300/CBP will be addressed in the next section (page 
28).  Interestingly, PCAF binds to the same site on p300/CBP as does the 
oncogenic viral protein E1A (Yang et al., 1996).  In fact, the mitogenic actions of 
E1A occur by disrupting the interaction between PCAF and p300/CBP, 
suggesting a role for PCAF in cell cycle regulation through its interaction with 
p300/CBP (Yang et al., 1996). 
Recombinant PCAF, like GCN5, acetylates histones, preferring lysine 14 
of histone H3, and more weakly lysine 8 of histone H4 (Schiltz et al., 1999).  
Multiple studies have shown PCAF to be important in several cellular processes 
including myogenesis and nuclear receptor-mediated activation (Sterner and 
Berger, 2000). 
In addition to acetylating histones, PCAF also acetylates several non-
histone proteins involved in transcriptional regulation, a processes referred to 
factor acetyltransferase (FAT) activity.  The non-histone factors targeted by 
PCAF acetylation include the cell cycle regulator p53 (Liu et al., 1999), the 
general transcription factors TFIIE and TFIIF (Imhof et al., 1997), and the 
chromatin associating protein HMG17 (Herrera et al., 1999).  The acetylation of 
p53 by PCAF increases the ability of p53 to bind DNA, and the acetylation of p53 
increases in response to DNA-damaging agents (Liu et al., 1999).  Thus, PCAF 
appears to be involved in stress remediation pathways through its FAT activity. 
Unlike GCN5, mice lacking PCAF are developmentally normal without a 
distinct phenotype (Yamauchi et al., 2000).  In PCAF null homozygous mice, 
protein levels of GCN5 are drastically elevated, suggesting that GCN5 can 
functionally compensate for the loss of PCAF (Yamauchi et al., 2000).  However, 
PCAF is unable to compensate for the loss GCN5, as mice lacking GCN5 are not 
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viable.  Therefore, PCAF and GCN5 may have overlapping functions but are not 
functionally equivalent, especially in embryogenesis. 
 
D. Other HATs and HAT families 
In addition to GCN5 and PCAF, there are two other groups of HATs: the 
p300/CBP family and the MYST family.  The p300/CBP family is named after the 
two proteins p300 and CBP [CREB (cAMP responsive element binding protein) 
binding protein].  Currently, these are the only two proteins in this family.  Due to 
the considerable structural and functional homology between the two proteins, 
they are often referred to as a single entity, p300/CBP (Roth et al., 2000).  
Several studies have also determined that the two proteins have many 
overlapping functions (Goodman and Smolik, 2000).  The two proteins are found 
only in multi-cellular animals (from worms up to humans) and are highly 
conserved across these organisms (Marmorstein, 2001).  CBP and p300 have 
been implicated in many cellular processes including cell cycle control, 
differentiation, and apoptosis.  Mutations in CBP are associated with various 
types of cancer, further demonstrating their regulatory importance in cell cycle 
(Timmermann et al., 2001).  As mentioned in the previous section, p300/CBP 
binds to the HAT PCAF, an interaction that is interrupted by the adenoviral 
oncoprotein E1A (page 27). 
p300/CBP is a large protein of about 300kD and is capable of acetylating 
all four core histones.  In vitro enzymatic assays revealed it acetylates all lysines 
on the four core histones known to be acetylated in vivo.  However, it shows the 
strongest activity on lysines 14 and 18 of histone H3 and lysines 5 and 8 of 
histone H4 (Schiltz et al., 1999).  The actions of p300/CBP are not always linked 
to histone acetylation.  p300/CBP can also function as a FAT acetylating non-
histone proteins such as p53.  Acetylation of p53 by p300 increases the binding 
affinity of p53 to DNA (Gu and Roeder, 1997).  The global acetylation capabilities 
of p300/CBP versus other HATs is congruent with its multiple regulatory 
functions. 
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The MYST family of HATs is named for its founding members: MOZ 
(monocytic leukemia zinc finger protein; Borrow et al., 1996), Ybf2/Sas3 
(something about silencing 3; Reifsnyder et al., 1996), Sas2 (something about 
silencing 2; Reifsnyder et al., 1996), Tip60 (Tat-interactive protein, 60kD; Kamine 
et al., 1996).  The MYST members share a highly conserved catalytic domain 
and although similar to the GCN5 catalytic domain, it is structurally divergent and 
may explain the differing acetylation patterns between GCN5 and MYST HATs 
(Utley and Cote, 2003).  MYST members do not share the exact same 
acetylation specificities, but in general, they preferentially acetylate histone H4.  
Some MYST HATs can also acetylate H3 and H2A to a lesser degree (Utley and 
Cote, 2003).  The divergence in acetylation patterns may explain the differing 
regulatory functions in which the various MYST members are involved. 
The first MYST family member to be linked to histone acetylation was the 
Drosophila protein MOF (male absent on first; Hilfiker et al., 1997).  MOF is 
involved in dosage compensation of the “X” sex chromosome in male flies.  
Dosage compensation refers to a regulatory mechanism that ensures the 
equalization of X-linked gene products in males and females (Lucchesi et al., 
2005).  In addition to MOF, other MYST HATs have been implicated in other 
regulatory processes.  Saccharomyces cerevisiae Esa1 (essential SAS2-related 
acetyltransferase) is a MYST member shown to be important for cell cycle 
progression.  Deletion of Esa1 resulted in strains that grew 40 times slower and 
eventually died (Smith et al., 1998b).  MOZ was identified to cause acute myeloid 
leukemia when fused to CBP due to a chromosomal translocation (Timmerman 
et al., 2001).  It is believed that the resulting fusion protein is unable to be 
properly regulated and disrupts the cell cycle through aberrant histone 
acetylation (Borrow et al., 1996). 
 
E. HAT complexes 
Although histone acetylases have been studied extensively in vitro, these 
proteins do not function as single entities in vivo but as members of large multi-
subunit complexes (Roth et al., 2001).  The two best characterized HAT 
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complexes are SAGA (Spt-Ada-GCN5 acetyltransferase) and ADA (Ada 
containing complex).  Both complexes were initially discovered in yeast but 
homologous complexes have also been isolated in other eukaryotic organisms 
such as humans, mouse, and Drosophila (Sterner and Berger, 2000).  The 
catalytic core of both SAGA and ADA is GCN5 (Grant et al., 1997).  In 
metazoans, it is theorized that PCAF can also serve as the catalytic core in 
GCN5 containing complexes (Roth et al., 2001). 
The ADA complex was discovered first and is much smaller than SAGA, 
approximately 800kD (Eberharter et al., 1999).  The complex is comprised of 
several Ada (alteration/deficiency in activation) proteins (Berger et al., 1992).  
The Ada proteins were discovered using a mutational screen looking for yeast 
resistant to the growth suppressive effects of VP16 (herpes simplex viral protein 
16).  VP16 causes growth arrest by sequestering multiple general transcription 
factors, preventing them from properly regulating gene expression (Berger et al., 
1992).  The ability of VP16 to bind multiple transcriptional regulators is facilitated 
by a group of endogenous adapter proteins.  Using a chemical mutagenesis 
screen, 5 adapter proteins were isolated and determined to be involved in the 
sequestering effects of VP16 (Berger et al., 1992).  When any one of these five 
proteins is mutated, yeast cells become resistant to the growth suppressive effect 
of the VP16 (Berger et al., 1992).  These proteins were termed Ada1-5.  Upon 
further analysis, it was discovered that the Ada4 isolated in the mutagenesis 
screen was identical to GCN5, providing a link between GCN5 and the Ada 
proteins (Berger et al., 1992). 
Only Ada2 and Ada3 are found in the ADA complex (Pina et al., 1993).  In 
fact, there is a conserved domain in the C-terminus of all known GCN5 proteins 
where Ada2 interacts with GCN5, termed the Ada2 domain.  Ada3 interacts only 
with Ada2 within the complex and not with GCN5 (Pina et al., 1993).  In addition 
to the two Ada proteins, the complex also contains the protein Ahc1 (Ada HAT 
complex component 1; Eberharter et al., 1999).  Although the Ada proteins are 
present in other HAT complexes, the Ahc1 protein is not, indicating that the ADA 
complex is a unique GCN5-containing acetylation complex (Eberharter et al., 
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1999).  In vitro acetylation assays using purified yeast ADA complex revealed it 
can acetylate histone H3 at lysines 14 and 18 (Grant et al., 1999).  When the 
Ahc1 protein is knocked out, the ADA complex can no longer be purified from 
yeast, indicating the complex is not present.  The Ahc1 knockout does not have a 
readily observable phenotype indicating the ADA complex is not essential in 
yeast (Eberharter et al., 1999).  A physiological function of the ADA complex 
remains to be elucidated.  There is difficulty teasing apart its potential function 
from the much larger SAGA complex. 
SAGA is a 1.8 MDa HAT complex and 15 different subunits have been 
characterized, but it is expected that at least several more remain to be identified 
(Figure 5; Sterner and Berger, 2000).  In addition to GCN5, the complex contains 
The four remaining Ada proteins (Ada1-3 and Ada5), several Spt proteins 
(suppression of Ty insertions; Spt 1, Spt 7, Spt 8, and Spt 20), a subset of TAFIIs 
[TBP (TATA binding protein) associated factors], and Tra1 (transplantability 
associated gene 1) (Sterner and Berger, 2001). 
The Spt proteins were discovered in a mutagenesis screen isolating 
proteins capable of suppressing the effects of Ty (translocatable yeast element) 
insertions (Silverman and Fink, 1984).  Knockout studies targeting specific Spt 
family members have revealed these proteins function as important general 
transcription regulators.  Strains harboring Spt3, Spt7, Spt8, or Spt15 mutations 
showed reduced viability and had multiple transcriptional defects (Marcus et al., 
1996).  Upon further analysis, it was discovered that many of the Spt proteins 
were TBP associating factors (Dudley et al., 1999).  In fact, Spt15 is identical to 
TBP, TATA binding protein (Schroeder and Weil, 1998).  Interestingly, Ada5 is 
identical to Spt20 and is the only Ada protein to date to display a Spt phenotype 
providing a link between Spt and Ada proteins (Marcus et al., 1996). 
To date, several TAFII proteins have been isolated from SAGA including 
TAFII20/17, TAFII25/23, TAFII60, TAFII68/61, and TAFII90 (Eberharter et al.,
1999).  Not only are those proteins integral components of the SAGA complex, 
but the TAF
 
IIs found in SAGA resemble histones H3 (TAFII20/17), H4  
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Figure 5: Yeast SAGA Complex 
Above is a schematic diagram of known subunits of the yeast SAGA complex.  
The yeast SAGA complex contains Gcn5 as its HAT catalytic subunit.  SAGA has 
been shown to interact with acidic activation domains mediated by its adaptor 
components (Ada2, Ada3, Ada5, and Gcn5/Ada4).  Another subset of SAGA 
proteins (Ada1, Spt7, and Spt20/Ada5) are required for structural integrity.  The 
Spt3 and Spt8 subunits have been implicated in interaction with TBP.  The TAFII 
(Taf) group of subunits share structural homology to the four core histones.  
(adapted from Sterner and Berger, 2000; reprinted with permission from 
Microbiology and Molecular Biology Reviews) 
32 
(TAFII25/23), and H2B (TAFII68/61) (Roth et al., 2001).  The significance of the 
homology to histones is unknown.  Further analysis of TAFII68 revealed it was 
required for both SAGA-dependent nucleosomal HAT activity and transcriptional 
activation from chromatin templates in vitro (Grant et al., 1998).  These results 
illustrate a role for certain TAFII proteins in the regulation of gene expression 
through their association with the SAGA complex (Grant et al., 1998). 
TRA1 (transplantability associated gene 1) is an essential yeast gene 
which encodes a 3744-amino acid protein that belongs to a group of proteins 
possessing carboxy-terminal regions related to phosphatidylinositol 3-kinases 
(Saleh et al., 1998).  Despite possessing a kinase-like domain, no kinase activity 
has ever been elicited from Tra1 or its homologues (Saleh et al., 1998).  The 
human homologue of Tra1, TRRAP (transformation/transcription domain–
associated protein), has been shown to be essential for c-Myc and E2F-mediated 
oncogenic transformation in human cells (McMahon et al., 1998).  The 
identification of TRRAP as an essential cofactor for oncogenic transcription factor 
pathways implies that the recruitment of TRRAP by DNA-binding activators 
directly regulates gene expression (Grant et al., 1998).  Given the relatively large 
size of TRRAP, it is likely a central molecule in the formation and stability of the 
SAGA complex (Saleh et al., 1998). 
A relatively new collection of proteins that interact with the SAGA complex 
are SGF (SAGA associated factor) proteins (Powell et al., 2004).  They do not 
possess a common element except that are believed to function as part of the 
SAGA complex.  SGF11 (11-kD SAGA associated factor) was the first SGF 
protein to be identified and it does not appear to play a role in SAGA-mediated 
histone acetylation (Powell et al., 2004).  SAGA purified from an SGF11 deletion 
strain has reduced amounts of the deubiquitylation protein Ubp8p (Powell et al., 
2004).  Histone H2B ubiquitylation and Ubp8-mediated deubiquitylation are both 
required for transcriptional activation (Ingvarsdottir et al., 2006).  Therefore, it has 
been suggested that Ubp8 and SGF11 represent a new function for the SAGA 
complex that involves gene regulation through H2B deubiquitylation (Ingvarsdottir 
et al., 2006).  Another SGF protein recently identified is SGF73, a protein with 
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unknown molecular function (Titz et al., 2006).  The human homologue of SGF73 
is ataxin-7 which is defective in the neurodegenerative disorder spinocerebellar 
ataxia type 7 (Helmlinger et al., 2004).  Ataxin-7 is a subunit of the human SAGA-
like complex, TFTC (TATA-binding protein-free TAF-containing complex; 
Helmlinger et al., 2004).  However, the role of SGF73 or ataxin-7 within their 
respective complexes is unknown. 
Unlike the ADA complex, loss of the SAGA complex results in severe 
phenotypic changes demonstrating that the SAGA complex is an essential gene 
regulator (Roth et al., 2001).  The SAGA complex has a more expanded 
acetylation pattern than the ADA complex.  In vitro HAT assays using purified 
complexes, revealed both SAGA and ADA can acetylate at lysines 14 and 18 on 
histone H3 (Grant et al., 1999).  However, SAGA can also acetylate histone H3 
at lysines 9 and 23, which ADA cannot (Grant et al., 1999). 
Given the diversity of the subunits comprising the SAGA complex, it is 
highly likely that this complex is designed to act as a co-activator.  It bridges 
basal transcription factors such TBP and TAFIIs with transcriptional activators 
such as GCN5 and the Ada proteins (Roth et al., 2001).  The transcriptional 
activators are designed to augment basal transcription factors and help facilitate 
regulation of gene expression.  With regard to GCN5, it is theorized that HAT 
complexes guide the HAT activity to certain promoters during cellular events 
(Sterner and Berger, 2000).  HAT complexes provide a connection to histone 
acetylation from signal transduction cascades initiated by a cellular stimulus.  For 
example, the SAGA complex has been shown to be required for the proper 
remodeling and activation of the inducible yeast phosphate gene PHO8 (Gregory 
et al., 1999).  Without the SAGA complex, the PHO8 promoter is not properly 
opened and there is minimal transcription even at maximal induction.  Members 
of the SAGA complex interface with stress remediation pathways activated 
during phosphate starvation resulting in the activation of the PHO8 gene 
(Gregory et al., 1999).  How SAGA is regulated and how it interacts with various 
signaling events is still largely unknown. 
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There are complexes containing other HATs besides GCN5.  PCAF also 
functions in a complex that is very similar to SAGA.  In fact, many of the same 
proteins are found in both complexes including Ada2, Ada3, Spt3, and Tra1 and 
also some of the same TAFII proteins (Kotani et al., 1998).  As the deletion of 
PCAF does not cause a different phenotype from wild-type, it is plausible that 
SAGA can compensate for the loss of PCAF-containing complexes (Yamauchi et 
al., 2000).  However, studies to fully answer this question have not been 
conducted. 
There are three known MYST containing complexes: NuA3 (nucleosome 
acetyltransferase of histone H3; Utley and Cote, 2003), NuA4 (nucleosome 
acetyltransferase of histone H4; Utley and Cote, 2003), and MSL (male-specific 
lethal; Hilfiker at el., 1994).  The NuA3 and NuA4 are yeast complexes and MSL 
was isolated from Drosophila (Utley and Cote, 2003).  Currently, the MYST 
complexes are not as well defined as SAGA or ADA.  However, there are some 
similar proteins found between the NuA3, NuA4 and SAGA complexes.  All three 
complexes contain Spt and TAFII proteins and NuA4 contains Tra1 (Sterner and 
Berger, 2000).  NuA4 acetylates histones H4 and H2A, and NuA3 acetylates 
predominantly histone H3 (Eberharter et al., 1998).  The MSL complex contains 
MOF as its catalytic core and is integral to the dosage compensation of the X-
chromosome in male fruit flies (Taipale and Akhtar, 2005).  The MSL complex 
does not appear to possess subunits found in other HAT complexes, but rather 
contains proteins specific to interacting with the X-chromosome (Taipale and 
Akhtar, 2005). 
 
F. Histone deacetylases 
Histone acetylation is a reversible modification.  In order to reestablish the 
nucleosome structure, histone deacetylases (HDACs) are recruited to 
deacetylate the histones (Kurdistani and Grunstein, 2003).  HDACs are divided 
into three main classes.  The enzymatic domains between class I and II HDACs 
are highly conserved (Ekwall, 2005).  The class III enzymes differ in that they 
require nicotinamide adenine dinucleotide (NAD; Blander and Guarente, 2004).  
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Just like HATs, HDACs also function as subunits of large complexes, often 
referred to as repressor complexes (de Ruijter et al., 2003). 
In addition to deacetylating histones, HDACs can also deacetylate 
transcription factors.  The mammalian histone deacetylase, HDAC-1 is capable 
of deacetylating p53 acetylation by p300/CBP and thus down regulating its 
activity (Juan et al., 2000). 
Ultimately, in order for a cell to achieve a proper functioning state, there 
must be an appropriate balance between HDACs and HATs (Kurdistani and 
Grunstein, 2003).  When this balance is lost, it often leads to cancer, 
developmental disorders, or other detrimental cellular states resulting in cell 
death (Timmermann et al., 2001).  As mention above, dysregulation of CBP 
through a translocation has been implicated in leukemia and the disruption of the 
interaction between PCAF and p300/CBP by E1A results in oncogenesis.  
Dysfunction of all three classes of HDACs has been implicated in loss of cell 
cycle control and tumorgenesis (Ekwall, 2005).  In fact, treatment of colon cancer 
cells with HDAC inhibitors results in an upregulation of p21 expression and 
subsequent growth arrest (Timmerman et al., 2001). 
 
G. The histone code 
The discovery that histone acetylation facilitated gene transcription led to 
the immediate hypothesis that acetylation of lysine residues neutralized the 
positive charge of histones attenuating their interaction of DNA.  However, Allfrey 
and colleagues demonstrated that acetylated histones are still able to protect 
DNA from thermal denaturation (Allfrey et al., 1964).  Therefore, it would appear 
that acetylated histones maintain an interaction with DNA. 
In addition to acetylation, histones can also be methylated, 
phosphorylated, ubiquitinated, ADP-ribosylated, and sumolated (Strahl and Allis, 
2000).  The large number of post-translation modifications that can be made to 
histones led to the development of the histone code hypothesis.  The histone 
code hypothesis suggests that these modifications serve as a code which is 
“read” by various transcription factors and chromatin associating proteins (Strahl 
36 
and Allis, 2000).  For example, a particular pattern of acetylation, methylation, 
and/or phosphorylation may lead to the recruitment of specific transcription 
factors that regulate gene expression. 
There are two major lines of support for this hypothesis.  First is the 
discovery of protein domains capable of binding to post-translationally modified 
histones.  For examples, bromodomains bind acetylated lysine residues and 
chromodomains recognize methylated histone residues (Bottomley, 2004).  The 
bromodomain was the first domain discovered to bind modified histones.  It is 
found in several classes of transcription factors including the HATs GCN5, 
PCAF, and p300/CBP.  The SAGA complex is able to bind and anchor to 
nucleosomal arrays by interacting with acetylated H3 via the bromodomain of 
GCN5.  If the GCN5 bromodomain is deleted, the SAGA complex is still 
enzymatically active but cannot anchor itself to the nucleosomal array (Hassan et 
al., 2002).  In addition, a crystal structure for the GCN5 bromodomain binding 
histone H4 acetylated at lysine 16 has been resolved indicating a stable 
interaction (Owen et al., 2000).  Acetylation of H4 at lysine 16 is one of the major 
targets of the MYST family of HATs.  The ability of GCN5 to recognize MYST 
modifications suggests that histone modifications made by MYST HATs may 
direct the enzymatic activity of GCN5-containing complexes through the GCN5 
bromodomain.  The bromodomain has been shown to interact with acetylated 
non-histone proteins as well.  Acetylated p53 has been shown to be involved in 
recruiting p300/CBP and PCAF to promoters through interactions with their 
bromodomains (Barlev et al., 2001). 
The second major support for the histone code hypothesis is the discovery 
that certain modifications take place in predictable and reproducible patterns.  
However, deciphering the histone code is still in its beginning stages.  
Phosphorylation of histone H3 at serine-10 (H3S10) occurs at high frequency 
resulting in chromatin condensation as cells enter and pass through mitosis 
(Bottomley, 2004).  However, H3S10 is also phosphorylated in response to 
growth factors causing chromatin to unfold and allowing for increased 
transcription (Bottomley, 2004).  The same modification may thus cause two 
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completly different effects.  Upon further analysis, it was discovered that after 
H3S10 is phosphorylated in response to growth factors, H3 is heavily acetylated 
(Bottomley, 2004).  The presence of hyperacetylation allows for the upregulation 
of gene transcription. 
It has also been recognized that newly synthesized DNA incorporates 
histone H4 acetylated at lysines 5 and 12 (Turner, 2000).  However, the 
importance of such modifications is unknown.  Mutagenesis of these two 
residues does not adversely affect DNA synthesis.  Another example is the 
activation of the pS2 promoter by estrogen.  Within 15 minutes of estrogen 
stimulation, CBP is recruited to the promoter and acetylates histone H3 at lysine 
18 (H3K18) followed by acetylation of lysine 23 (H3K23) and recruitment of the 
arginine histone methyltransferase CARM1 (cofactor-associated arginine [R] 
methyltransferase 1) that methylates histone 3 at arginine 17 (Daujat et al., 
2002).  The combination of these modifications leads to the upregulation of 
estrogen sensitive promoters (Daujat et al., 2002). 
 
H. Histone variants 
Histone variants are expressed in eukaryotic cells, adding another level of 
complexity to the histone code hypothesis (Henikoff et al., 2004).  The four 
canonical core histones that comprise the nucleosome can be replaced by 
slightly different histones termed histone variants (Henikoff et al., 2004).  Histone 
variants exist for histones H2A, H2B, and H3; to date no variant exists for histone 
H4 (Kamakaka and Biggins, 2005).  Histone variants differ from core histones in 
several aspects.  There are usually multiple copies of genes encoding the core 
histone, but only a single copy of each gene encoding a histone variant 
(Kamakaka and Biggins, 2005).  The mRNA for variant histones contains introns, 
is polyadenylated, and is constitutively expressed (Pusarla and Bhargava, 2005).  
Canonical core histone mRNA is intronless, is not polyadenylated, and is only 
expressed during S-phase for incorporation into newly synthesized DNA 
(Kamakaka and Biggins, 2005).  How histone variants are regulated and the 
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mechanisms involved in directing their incorporation into the genome are poorly 
understood (Pusarla and Bhargava, 2005). 
CenH3 and H3.3 are two well known variants of H3 (Pusarla and 
Bhargava, 2005).  CenH3 is a conserved essential protein that binds to 
centromeres, the DNA locus that directs formation of the kinetochore protein 
structure that mediates chromosome segregation in eukaryotes (Kamakaka and 
Biggins, 2005).  H3.3 is the least divergent variant, containing only four amino 
acid differences compared to core histone H3 in Drosophila.  However, unlike the 
core H3 histone, H3.3 is expressed throughout the cell cycle and often localizes 
to transcriptionally active regions of the chromosome (Ahmad and Henikoff, 
2002). 
Of the core histones, H2A has the largest number of variants in higher 
eukaryotes.  The two major variants are H2A.Z and H2A.X.  H2A.X and H2A.Z 
are constitutively expressed and localize throughout the genome (Pusarla and 
Bhargava, 2005).  Interestingly, the core H2A protein in Saccharomyces 
cerevisiae is more similar to the mammalian H2A.X variant than to the 
mammalian core H2A (Malik and Henikoff, 2003). 
Histone H2B has only a few variants and they appear to have very 
specialized functions in chromatin compaction and transcription repression 
during gametogenesis (Lewis et al., 2003).  Despite extensive searching, there 
are no known variants for histone H4 (Henikoff et al., 2004). 
 
III. Histone Modification and Apicomplexan Parasites 
Although there are drugs capable of treating acute Toxoplasma infection 
and reactivation, the current therapies are limited by adverse toxicities.  
Furthermore, no currently approved therapy is capable of eradicating the latent 
bradyzoite cysts.  Therefore, research continues looking for novel therapeutics 
capable of targeting bradyzoites and/or with less severe side effects.  In the 
search for better therapeutics to treat apicomplexan diseases, Darkin-Rattray et 
al. (1996) discovered a novel antiprotozoal agent, termed apicidin.  Apicidin is a 
cyclic tetrapeptide isolated from a Costa Rican fungus (Fusarium spp.; Darkin-
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Rattray et al., 1996).  In vitro studies showed that apicidin was a broad spectrum 
antiprotozoal inhibiting the growth of drug-resistant human malaria, C. parvum, 
and Toxoplasma (Darkin-Rattray et al., 1996).  The mechanism of action of 
apicidin is the non-competitive inhibition of a histone deacetylase (Singh et al., 
2002).  Unfortunately, apicidin also inhibits human HDACs, causing an anti-
proliferative effect which is detrimental to human cells, and thus limits its clinical 
potential.  However, the potent broad spectrum antiprotozoal effect of apicidin 
illustrates that chromatin remodeling enzymes may provide urgently needed 
targets for drug research (Darkin-Rattray et al., 1996). 
 
A. GCN5 homologue in Toxoplasma 
Before the discovery of apicidin, chromatin remodeling proteins had not 
been investigated in Toxoplasma.  In 1999, Hettman and Soldati described a 
homologue of GCN5 in Toxoplasma termed TgGCN5.  They reported a cDNA of 
2.3kb, which encoded a 474 amino acid protein.  TgGCN5 possesses a high 
degree of homology to the GCN5 present in yeast and fellow Alveolate 
Tetrahymena, with a short N-terminal extension of 141 residues. 
However, in 2000 Smith and Sullivan published their cloning results of 
GCN5 in Toxoplasma, which indicated that the actual transcript was considerably 
larger.  The new sequence contained a longer, unique N-terminal extension 
encoded by a single exon in the genomic locus (Sullivan and Smith, 2000).  A 
Northern blot containing mRNA purified from Toxoplasma tachyzoites was 
probed with 2.6kb of sequence capable of hybridizing to both the long form and 
the previously reported short form of TgGCN5.  The Northern results showed 
hybridization to only one band consistent with the larger version of TgGCN5 
(Bhatti and Sullivan, 2005).  Furthermore, Hettman and Soldati reported that the 
truncated form of TgGCN5 does not localize to the nucleus when over-expressed 
in Toxoplasma tachyzoites (Hettman and Soldati, 1999).  In contrast, the full-
length protein with the longer N-terminal extension does localize to the parasite 
nucleus when fused to green fluorescent protein (Sullivan, unpublished data).  
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Collectively, the above data argues that Toxoplasma expresses only the form of 
TgGCN5 consistent with the size reported by Sullivan and Smith. 
 
B. The N-terminal extension of TgGCN5 
Figure 6 shows a comparison of TgGCN5 with other GCN5 homologues 
present in other organisms.  The conserved Ada2 and bromodomains are 
present in TgGCN5.  However, there is a striking difference in the N-terminal 
sequence between TgGCN5 and other GCN5 homologues.  As depicted in 
Figure 6, the large N-terminal extension of TgGCN5 goes against the general 
trend that GCN5 proteins from lower eukaryotes have shorter N-termini.  The 
entire TgGCN5 N-terminal extension is comprised of 820 amino acids which is 
larger than the extensions found in metazoan GCN5 homologues (approximately 
500 residues).  The closely related Tetrahymena possesses a small N-terminal 
extension.  Furthermore, unlike the large N-terminal extensions present in 
metazoan GCN5 and PCAF, the lengthy N-terminal extension present in 
TgGCN5 bears no similarity to any known protein and is devoid of known protein 
motifs. 
The presence of a parasite-specific domain in a highly conserved protein 
generates many questions regarding its function(s).  Given what is known about 
other GCN5 proteins, the N-terminus may interact with other proteins to form 
HAT complexes not present in other eukaryotes.  The unique N-terminal 
extension may play a role in regulating the acetylation activity of TgGCN5.  
Perhaps TgGCN5 has a unique histone acetylation pattern directed by the N-
terminal extension.  The N-terminus may also be involved in substrate 
recognition and facilitate the acetylation of non-histone proteins in the parasite.  
There are many theoretical functions of the unique N-terminus of TgGCN5.  
However, from the two initial reports of TgGCN5, it can be deduced that at least 
one known function of the N-terminus is involvement in nuclear localization.  As 
mentioned, the N-terminal extension present in the maize homologue of GCN5 is 
also required for nuclear targeting, but the exact sequence and mechanism  
41 
 
 
 
 
 
 
 
Figure 6: TgGCN5 and other GCN5 homologues 
Above are schematic diagrams comparing known homologues of GCN5 to 
TgGCN5.  Compared to other species, TgGCN5 possess a lengthy unique N-
terminal extension.  The N-terminal extensions present in human, mouse, and 
Drosophila are highly homologous to the N-terminal extension found in PCAF.  
The N-terminal extension in TgGCN5 shares no homology to any known protein.  
TgGCN5 also possesses the conserved catalytic domain, responsible for 
acetylating histones, an Ada2 binding domain (Ada2), and a bromodomain (br). 
 
42 
responsible for transporting the protein to the nucleus was not determined (Bhat 
et al., 2003). 
 
IV. Nuclear Import 
The histone acetylase and gene regulatory functions of GCN5 have been 
rigorously studied.  However, little attention has been directed at determining 
how the HAT gets into the cell nucleus.  Clearly the unique N-terminal extension 
of TgGCN5 is involved in nuclear targeting making it an excellent tool to resolve 
how this protein is target to the parasite nucleus.  Understanding how TgGCN5 
and other transcription factors enter the parasite nucleus may lead to the 
discovery of novel elements present in nuclear trafficking pathways in 
Toxoplasma and other apicomplexans.  Novel elements not present in higher 
eukaryotes may be exploited in the design of more selective therapeutic agents.  
Blockade of parasite nuclear trafficking could subvert parasite differentiation and 
other processes essential for parasite survival.  Additionally, the study of these 
pathways in protozoa provides a unique perspective on how these systems 
evolved in early eukaryotic cells. 
 
A. Nuclear localization signals 
In all eukaryotic organisms, the nucleus is separated from the cytoplasm 
by the nuclear envelope.  The nuclear envelope is perforated by many pores 
through which water-soluble molecules enter and leave the nucleus.  Each pore 
is an elaborate multi-protein structure termed the nuclear pore complex (NPC), 
which regulates the movement of macromolecules across the nuclear envelope 
(Pante and Kann, 2002).  The nuclear pore complex is immense, approximately 
12.5 million Daltons (Weis, 2003).  Ions, small metabolites and globular proteins 
less than 40kD can diffuse through the nuclear pore complex (Pante and Kann, 
2002).  However, large proteins and complexes cannot diffuse in and out of the 
nucleus.  Therefore, they must be actively transported through the nuclear pore 
complex.  Many proteins actively imported through the nuclear pore contain a 
nuclear localization signal (NLS; Quimby and Corbett, 2001). 
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The first NLS was discovered during mutational analysis of the large T-
antigen, an early viral protein of the simian virus SV40 (Kalderon et al., 1984a).  
In infected cells, large T-antigen normally accumulates in the nucleus.  Mutations 
within a short sequence of basic residues KKKRK (K=lysine, R=arginine) 
prevented large T-antigen from entering the nucleus (Kalderon et al., 1984a).  
Therefore the basic pentapeptide defined a region of the protein involved in 
nuclear localization.  When the basic penta-peptide was fused to two very large 
cytosolic proteins, beta-galactosidase and pyruvate kinase, both were targeted to 
the cell nucleus instead of remaining in the cytosol (Kalderon et al., 1984b). 
Since the initial discovery in large T-antigen, NLSs have been isolated in 
numerous other proteins imported into the nucleus (Quimby and Corbett, 2001).  
They are similar to the SV40 large T-antigen NLS in that they contain 
consecutive basic amino acids.  A large study looking at different NLSs by 
Boulikas reported nine distinct forms of strongly basic hexapeptides 
characteristic of nuclear proteins among all eukaryotic species (Boulikas, 1994).  
The hexapeptides contained at least four arginines and/or lysines and one or two 
non-polar residues.  The four most common NLS motifs were θθθθ, θθxθθ, 
θθθxθ, and θθxθxθ, where θ equals a basic residue (arginine or lysine) and “x” 
represents a non-polar residue.  Boulikas suggested that these streches of basic 
residues are different versions of a core NLS (Boulikas, 1994). 
Targeting proteins to the nucleus utilizing clusters of basic residues is a 
highly conserved eukaryotic phenomenon that occurred early in eukaryote 
evolution.  Using phylogenetic analysis with 16s rRNA sequence, Giardia lamblia 
represents the earliest diverging lineage in the eukaryotic line of descent (Sogin 
et al., 1989).  When GFP is expressed in Giardia lamblia, is localizes throughout 
the cytoplasm, but if the SV40 large T-antigen NLS is fused to GFP, it is targeted 
to the Giardia lamblia nuclei (Elmendorf et al., 2000).  Therefore, this early 
branching eukaryote contains machinery capable of recognizing and transporting 
proteins to the nucleus through recognition of an NLS composed of basic 
residues. 
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B. Importin alpha 
Additional experiments studying nuclear localization revealed two proteins 
involved in nuclear import through interaction with NLSs composed of basic 
residues: importin α and importin β (Gorlich et al., 1995).  Importin α (IMPα) and 
importin β (IMPβ) are also referred to as karyopherin α and karyopherin β (Chook 
and Blobel, 2001). 
The function of importin α is to recognize and bind to NLSs comprised of 
basic residues (Gorlich et al., 1994).  Importin α is a highly conserved protein 
present in virtually all eukaryotic organisms (Chook and Blobel, 2001).  A text 
search of the annotated proteins in the Giardia genomic database 
(www.mbl.edu/Giardia) revealed the presence of an importin α homologue 
present in this primitive eukaryote.  From its early origins, the importin α gene 
family has undergone considerable expansion during the course of eukaryotic 
evolution.  Whereas the yeast Saccharomyces cerevisiae genome encodes a 
single importin α, the human genome encodes six different genes (Chook and 
Blobel, 2001).  Phylogenetic analyses indicate that a single ancestral animal 
importin α gave rise to the additional paralogues in higher eukaryotes (Goldfarb 
et al., 2004).  The presence of multiple importin α genes in metazoans suggests 
they appeared during the evolution of multicellular animals and presumably 
perform cell and tissue specific roles (Goldfarb et al., 2004). 
Crystallographic analysis revealed that importin α has a rather unique 
structure that facilitates its ability to bind to an NLS (Kobe, 1999).  The structure 
of importin α can be divided into two parts.  The first part is a short N-terminal 
domain of about 60 residues in length called the importin β binding (IBB) domain 
(Goldfarb et al., 2004).  As the name implies, the IBB domain is the region of the 
protein that interacts with importin β.  The remainder of the ~60kD protein is 
comprised of repeating armadillo (ARM) motifs (Teh et al., 1999).  Each ARM 
motif is composed of three α-helices and the repeating ARM motifs associate 
together to form a superhelical tunnel-like structure.  The superhelical structure 
exposes highly conserved acidic residues on its surface which interact with the 
basic residues present in the NLS of nuclear proteins (Teh et al., 1999). 
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Although importin-α is capable of recognizing and binding an NLS, it is 
unable to translocate a protein into the nucleus.  In order to transport a protein 
into the nucleus importin α must complex with importin β through its IBB domain 
(Gorlich et al., 1995).  Importin α must also be bound by importin β before it can 
effectively bind an NLS (Goldfarb et al., 2004).  Further analysis of the crystal 
structure of importin α indicates that the IBB domain is autoinhibitory (Kobe, 
1999).  When not bound to an NLS, the IBB domain folds over and interacts with 
the ARM repeats (Kobe, 1999).  The IBB contains an NLS-like motif, KKR.  Thus, 
it appears that importin α is autoinhibited by an internal NLS.  Once importin α is 
bound by importin β, the autoinhibition is negated allowing an NLS to be bound 
(Kobe, 1999).  Once the NLS is bound by importin α, importin β facilitates 
translocation into the nucleus through interaction with components of the nuclear 
pore complex (Chook and Blobel, 2001). 
Several other proteins that interact with importin α and importin β have 
been discovered, eventually leading to the development of a model for the import 
of cytosolic proteins containing a basic NLS (Figure 7).  Once the trimeric 
complex consisting of importin β, importin α, and the nuclear protein are 
translocated through the NPC, importin β is bound by Ran-GTP causing the 
complex to dissociate (Quimby and Corbett, 2001).  Ran (ras-related nuclear 
protein) is a small GTPase that is involved in recycling importin β and importin α 
back to the cytoplasm (Bischoff and Ponsting, 1991; Chook and Blobel, 2001).  
When importin β is bound by Ran-GTP, it is transported out of the nucleus back 
into the cytoplasm where Ran-GTP interacts with RanGAP (Weis, 2003).  
RanGAP (Ran GTPase activating factor) facilitates the GTPase activity of Ran, 
causing it to hydrolyze GTP to GDP (Stewart and Rhodes, 1999).  The hydrolysis 
of GTP causes Ran to release importin β.  Ran-GDP is then translocated back 
into the nucleus where it is acted upon by RCC1 (regulator of chromosome 
condensation; Bischoff and Ponsting, 1991).  RCC1 (or RanGEF; Ran guanine 
nucleotide exchange factor), catalyzes the release of GDP from Ran and the 
regeneration of Ran-GTP (Quimby and Corbett, 2001). 
46 
 
 
Figure 7: Importin α and β nuclear import pathway 
A diagram of the proposed mechanism for the transport of proteins 
containing a basic NLS into the nucleus.  Importin α, Importin β, and the nuclear 
protein form a trimeric complex, that is transported through the NPC into the 
nucleoplasm.  Ran-GTP and importin β are transported back to the cytoplasm.  
Importin α is also recycled back to the cytoplasm through interactions with CAS 
and Ran-GTP.  In the cytoplasm, RanGAP stimulates conversion of Ran-GTP to 
Ran-GDP resulting in Ran to dissociate from Import β and CAS.  The released 
Importin β and α can now interact with another nuclear protein bearing a basic 
NLS.  Ran-GDP is transported back to the nucleus, where RCC1 causes it to 
release GDP and bind GTP.  (modified from Lodish et al., 2000; reprinted with 
permission from H. Freeman & Company) 
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Importin α is recycled in a similar manner, but involves a nuclear export  
protein, CAS (cellular apoptosis susceptibility gene; Stewart and Rhodes, 1999).  
CAS binds to importin α, and then CAS is bound by Ran-GTP.  The trimeric 
complex is exported out the nucleus where Ran-GTP interacts with RanGAP 
causing GTP hydrolysis and dissociation of the complex.  CAS and Ran-GDP are 
subsequently transported back into the nucleus.  The majority of Ran-GTP in the 
nucleus and Ran-GDP in the cytoplasm establishes a gradient that drives the 
recycling of importin α and β facilitating continuous nuclear import (Weis, 2003). 
 
C. Nuclear import in Apicomplexans 
Nuclear trafficking is virtually an untapped area of research in 
apicomplexans.  Homologues of importin β and importin α have been identified 
and characterized in Plasmodium (Mohmmed et al., 2003).  Plasmodium also 
possesses Ran and RCC1 (Ji et al., 1998).  However, no functional studies have 
been performed on any of these nuclear trafficking proteins.  There have been no 
reports on the identification of any proteins involved in nuclear transport in 
Toxoplasma.  The N-terminal extension of TgGCN5 may provide an excellent 
tool to begin studying the nuclear trafficking pathways in apicomplexans. 
 
D. Nuclear trafficking of GCN5 
To date, very little is known about how GCN5 is targeted to the nucleus in 
any organism.  The maize GCN5 homologue (ZmGCN5) is the only GCN5 
protein for which an NLS has been proposed.  When the entire 175 amino acid 
N-terminal extension of ZmGCN5 is fused to GFP, GFP is targeted to the maize 
nucleus (Bhat et al., 2003).  Near the beginning of the N-terminal extension of 
ZmGCN5 there is a motif comprised of four basic residues, RKRK, that has been 
proposed to be the NLS for ZmGCN5 (Bhat et al., 2003).  However, no additional 
studies have been performed to confirm that RKRK is indeed the NLS for 
ZmGCN5.  The 118 amino acid yeast GCN5 N-terminal extension reveals no 
stretches of 3 or more consecutive basic residues.  How yeast GCN5 is targeted 
to the nucleus is unknown, but it is doubtful to involve the N-terminal extension.  
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A study investigating the ability of a human importin α paralogue to target nuclear 
proteins to the nucleus used the GCN5 related HAT, PCAF as one of many bait 
proteins (Kohler et al., 1999).  The study demonstrated that importin α is required 
for PCAF to be transported to the nucleus.  However, the binding site (NLS) of 
PCAF was not identified in the study.  TgGCN5 contains several clusters of basic 
residues in its N-terminal extension that may be functioning as an NLS capable 
of associating with a putative Toxoplasma homologue of importin α and targeting 
it the parasite nucleus. 
 
V. Thesis Goals 
Bradyzoite differentiation can be replicated in vitro using physiological and 
chemical stressors such as heat, sodium arsenite, basic pH, and IFNγ.  GCN5 in 
yeast is involved in mediating stress responses, particularly amino acid and 
phosphate starvation.  Thus, it is quite possible that TgGCN5 may be involved in 
mediating stress responses in Toxoplasma and therefore involved in the 
bradyzoite differentiation process.  Characterization of TgGCN5 will facilitate our 
understanding of chromatin remodeling in apicomplexans and may bring us 
closer to understanding the differentiation process in Toxoplasma. 
TgGCN5 contains a unique N-terminal extension upstream of the catalytic 
domain that shares no homology to analogous domains found in other GCN5 
proteins, nor is it similar to any sequence in protein databases.  The goal of this 
thesis is to better understand the purpose of the unique N-terminus.  Our 
hypothesis is that this unique N-terminal extension is critical to the 
function of TgGCN5.  Three possible roles of the N-terminal domain will be 
investigated in the following aims: 
 
A. AIM 1: Determine how the N-terminal domain mediates nuclear localization 
It is clear that the N-terminal extension is involved in mediating the nuclear 
localization of TgGCN5.  Therefore, TgGCN5 makes an excellent model to study 
how a GCN5 protein is translocated into the nucleus.  Previous studies 
performed in the laboratory have narrowed the region involved in nuclear 
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localization to be between amino acids 58 and 260.  Between residues 58 and 
260 there is a single stretch of basic residues that may be function as an NLS.  
Truncations will be made in the N-terminal extension to isolate this stretch of 
basic residues to determine if it is functioning as the NLS.  Localization of the 
truncation mutants will be determined using immunocytochemistry via a fused 
FLAG tag.  If this stretch of basic residues is indeed the NLS, it will be 
determined if it is sufficient to target a cytoplasmic protein to the parasite 
nucleus.  To date, an NLS has never been mapped for any Toxoplasma protein.  
Therefore, the NLS elucidated in TgGCN5 will be the first NLS described in 
Toxoplasma.  In addition, it will be the first NLS described in a GCN5 homologue. 
 
B. AIM 2: Assess the involvement of the N-terminal extension in protein-protein 
interactions 
There are two different groups of proteins that may interact with the N-
terminus of TgGCN5.  First group of proteins would be those involved in 
mediating the translocation of GCN5 into the parasite nucleus.  Once the NLS 
has been elucidated in AIM 1, it will be used to guide our search for potential 
nuclear trafficking proteins.  If the NLS is indeed comprised of basic residues, we 
will search the Toxoplasma genomic database for a homologue of importin α.  If 
present, the homologue will be cloned and protein expressed.  Using an in vitro 
pull down assay, it will determined if the importin α homologue interacts with 
TgGCN5 and if the interaction occurs at the NLS elucidated in AIM 1.  To date, 
no one has determined if nuclear trafficking proteins exist in Toxoplasma. 
The second group proteins that may interact with TgGCN5 are those 
involved in forming HAT complexes analogous to the SAGA and ADA complexes 
found in yeast.  To identify proteins interacting with N-terminus, co-
immunoprecipitation experiments using anti-FLAG affinity resin will be performed 
on transgenic parasites that over-express recombinant full length TgGCN5 fused 
to FLAG tag  (FLAGTgGCN5) and TgGCN5 lacking the N-terminal extension also 
fused to a FLAG tag (FLAGΔNTTgGCN5).  Proteins isolated in pull down assays 
from FLAGTgGCN5 and that are not present in pull down assays from 
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FLAGΔNTTgGCN5 will be deemed to be interacting with the N-terminal extension 
of TgGCN5. 
 
C. AIM 3: Determine if the N-terminal extension modulates enzymatic (HAT) 
function 
The long extensions present in metazoan homologues of GCN5 are 
involved in substrate recognition.  Even though the N-terminal extensions are not 
homologous, the unusual N-terminal domain of TgGCN5 may have a role in 
regulating substrate specificity and/or acetylase function.  In vitro HAT assays will 
be performed using full length recombinant TgGCN5 and TgGCN5 lacking the N-
terminal extension on free histone substrates.  Antibodies to specific acetylated 
lysine residues will be used to determine the substrate specificity of TgGCN5 
with and without the N-terminal extension. 
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CHAPTER 2: MATERIALS AND METHODS 
 
I. Culture and Parasite Techniques 
Below is an explanation of these well established techniques, which are 
described in greater detail in Roos et al., 1994. 
 
A. Cell and parasite culture 
The RH Toxoplasma strain obtained from the AIDS Research and 
Reference Reagent Program (Division of AIDS, NIAID, National Institutes of 
Health; http://www.aidsreagent.org) was used for all experiments in this thesis.  
Tachyzoites were cultivated using confluent monolayers of human foreskin 
fibroblast (HFF) cells in T-25cm2 flasks (Fisher #10-126-30).  HFF cells 
(American Tissue Culture Company; #CRL-2522) were grown to confluency in 
host cell (HC) media.  HC media consists of Dulbecco’s Modified Eagle Medium 
(DMEM; Invitrogen #11965-126) supplemented with 10% heat-inactivated fetal 
bovine serum (Invitrogen #16000-044) and 25μg/L gentamicin (Invitrogen 
#15710-064).  After combining the components of HC media, it is filter sterilized 
using a 0.2µm filtering device (Fisher #09-740-25A).  HFF cells were grown at 
37°C in a humidified 5% CO2 environment.  All tissue culture work was 
performed under sterile conditions inside a laminar flood hood. 
Additional HFF flasks were generated using trypsin digestion.  The HC 
media from a T-150cm2 flask (Fisher #10-126-32) containing confluent HFF cells 
was aspirated.  The monolayer was washed with 3.0ml of 37°C sterile PBS which 
was subsequently aspirated.  Following the wash, 3.0ml of trypsin (Invitrogen 
#25200-056) was added to the flask.  The flask was rocked several times to allow 
the trypsin to adequately coat the monolayer and then approximately two-thirds 
of the trypsin was aspirated.  The flask was placed at 37°C for one minute.  The 
monolayer was disrupted by banging the corner of the flask against the palm of 
the hand several times.  The trypsinization was squelched by pipetting 25ml of 
fresh 37°C HC media into the flask.  The wall of the flask containing the 
monolayer was pipetted against several times to completely suspend all of the 
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trypsinized cells.  The trypsinized cells were diluted up to 400ml using fresh 37°C 
HC media.  For making additional T-25cm2 flasks, 10ml of the trypsinized cells 
were added to each new T-25cm2 flasks and for making additional T-150cm2 
flasks, 50ml of the resuspended trypsinized cells were added to new T-150cm2 
flasks.  New flasks containing resuspended trypsinized cells were placed at 37°C 
in a humidified 5% CO2 environment.  The caps on the flasks were left slightly 
loose to allow for gas exchange.  Cell growth of the new monolayers was 
monitored daily using a Leica DM IL inverted microscope at 250X and 400X 
magnification with a phase filter.  Once the monolayers were confluent, the flask 
lids were closed tightly. 
Because HFF cells are not an immortalized cell line, they cannot be 
passed an infinite number of times.  Therefore, the number of times HFF cells 
were trypsinized was recorded on each flask.  HFF cells usually senesced and 
would no longer grow to confluency after 20 rounds of trypsin digestion.  When 
this occurred, lower passage HFF cells were thawed from liquid nitrogen stocks 
as outline below (page 56).  HFF cells are routinely chosen for parasite 
cultivation because they exhibit strong contact inhibition and can be stored in 
incubators for up to 4 weeks without losing their ability to support parasites. 
For immunofluorescence assays, 12 well plates containing coverslips 
were required.  Tissue culture grade 12 well plates (Fisher #07-200-81) and 
coverslips (Fisher #12-545-83) were used.  The coverslips were sterilized by 
autoclaving prior to use in cell culture.  Using sterile flat tweezers (Fisher #09-
753-50), a single cover slip was placed in each well of the 12 well plate.  Host 
cells from a T-150cm2 flask were trypsinized as outline on the previous page.  
After squelching the trypsinization with 25ml of fresh 37°C HC media, 1.0ml of 
the trypsinized cells were diluted into 25ml of 37°C HC media in a sterile 50ml 
conical tube (Fisher #14-959-49A).  The diluted cells were mixed gently by 
inversion.  Two milliliters of the diluted cells were added to each well and the 
plate was placed at 37°C in a humidified 5% CO2 environment.  Cell growth 
within each well was monitored daily using a Leica DM IL inverted microscope at 
250X and 400X magnification with a phase filter. 
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For cloning by limiting dilution assays, 96 well plates were required.  
Tissue culture grade 96 well plates (Fisher #07-200-89) were used.  Host cells 
from a T-150cm2 flask were trypsinized as outline above (page 52).  After 
squelching the trypsinization with 25ml of fresh 37°C HC media, 5.0ml of the 
trypsinzed cells were diluted into 100ml of 37°C HC media in a sterile T-75cm2 
(Fisher #10-126-31).  The diluted cells were mixed gently by inversion.  20ml of 
the diluted cells were poured into a sterile trough (Fisher #13-681-101) and using 
a Brinkmann EasyPet automatic pipetter (Fisher #13-688-177), 200µl of diluted 
cells were added to each well generating a total of 5, 96 well plates.  The plates 
were placed at 37°C in a humidified 5% CO2 environment.  Cell growth of the 
monolayers within each well was monitored daily using a Leica DM IL inverted 
microscope at 250X magnification without a phase filter. 
Due to the obligate intracellular nature of the tachyzoite, they must 
constantly be provided with new host cells in order to sustain themselves.  Once 
a monolayer in a T-25cm2 flask has been infected with tachyzoites, the 
monolayer will be destroyed or lysed in a matter of days depending on the size of 
the inoculum.  If the parasites are not provided with a new monolayer, the 
parasites will die.  Prior to parasite inoculation, the old HC media in the flasks 
was aspirated and replaced with 9ml of parasite media (PA) which consists of 
DMEM, 1% heat-inactivated fetal bovine serum, and 25μg/L gentamicin, filter 
sterilized using a 0.2µm filtering device (Fisher #09-740-25A).  The reduction in 
fetal bovine serum is thought to minimize the exposure of parasites to serum 
antibodies and does not have detrimental effect on confluent host cells. 
The flask containing the infected monolayer is scrapped with a sterile 
spatula (Fisher #08-773-2) to completely rupture any remaining parasite 
vacuoles and to suspend the parasites into the media.  For routine parasite 
upkeep, 1.0ml of media containing the parasites from an infected flask was 
transferred to a T-25cm2 flask containing a new confluent HFF monolayer.  
Infection and subsequent destruction of the new monolayer would typically occur 
within 2-3 days yielding approximately 1X107 to 5X107 parasites.  Once the HFF 
monolayer is destroyed parasites must be transferred to a new flask containing a 
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confluent HFF monolayer.  Parasites which remain extracellular for longer than 
ten to twelve hours begin to die.  When large numbers of parasites were required 
(e.g. for immunoprecipitation) a T-150cm2 flask of HFF cells was inoculated with 
3-4ml of parasites yielding at least 1X108 parasites.  All flasks containing infected 
monolayers were grown at 37°C in a humidified 5% CO2 incubator.  The lids on 
the flasks were left loose overnight (approximately twelve to eighteen hours) to 
allow media to equilibrate with the 5% CO2 environment inside the incubator.  
The following day, the lids were tightened to minimize the risk of spillage and 
culture contamination.  Parasite infection of new host cells was monitored daily 
using a Leica DM IL inverted microscope at 400X magnification with a phase 
filter. 
 
B. Purification and quantification of parasites 
Before genetic manipulation or biochemical experiments were performed 
using parasites, tachyzoites had to be purified away from host cell debris.  Flasks 
containing infected monolayers were scrapped with a sterile spatula to 
completely rupture any remaining parasite vacuoles and to suspend the parasites 
into the media.  The suspended parasites were transferred into the barrel of a 
60ml plastic syringe (Fisher #14-841-36).  The syringe was attached to a filter 
cartridge (Fisher #NC9671597) containing a 3μm pore-size polycarbonate filter 
disk (Fisher #NC9655197).  The parasites were passed through the filter 
cartridge removing most of the host cell debris.  If the filtered parasites were to 
be maintained in tissue culture an unopened sterile syringe and autoclaved 
sterile filter cartridge were used.  The filtrate containing parasites was centrifuged 
at 800 x g for ten minutes.  The supernatant was aspirated off and the parasite 
pellet was resuspended in PBS (pH 7.0).  When necessary, tachyzoites were 
quantitated using an improved Neubauer phase hemocytometer (Fisher #02-671-
54) viewed with a Leica DM IL inverted microscope  at 400X magnification with a 
phase filter.  Following quantitation, the parasite were centrifuged again 800 x g 
for ten minutes.  The PBS was aspirated off and the parasite pellet was 
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resuspended in an appropriate buffer dictated by the intended experimental 
design. 
 
C. Freezing and thawing cells and parasites 
For long-term storage, tachyzoites were frozen in liquid nitrogen using 
DMSO (Sigma #D4540) as a cryoprotectant.  Because tachyzoites do not survive 
very long out side of a host cell, parasites were frozen before completely 
destroying the host cell monolayer.  An infected monolayer in T-150cm2 flask was 
scraped at about 70-80% destruction with a sterile spatula (Fisher #08-773-2).  
The suspended infected cells were transferred to a 15ml conical (Fisher #14-959-
70C) and centrifuged for ten minutes at 800 x g at 4°C and the pellet was 
resuspended in 1.5ml of ice cold PA media (page 54).  An equal volume of 
freezing media (FZ; DMEM with 20% heat-inactivated fetal bovine serum and 
20% DMSO) was added.  The culture was aliquoted into round-bottom, cryovials 
(Fisher #09-761-72) and placed in a pre-chilled styrofoam freezer box at -80°C.  
Frozen aliquots were moved to liquid nitrogen storage the following day. 
HFF cells were frozen in a similar manner from a confluent T-150cm2 
flask.  Trypsinized cells were resuspended in 1.5ml of ice cold HC media and 
1.5ml of FZ media.  The culture was divided into 0.5ml aliquots in round-bottom, 
cryotubes (Fisher #09-761-72) and placed in a pre-chilled styrofoam freezer box 
at -80°C.  Frozen aliquots were moved to liquid nitrogen storage the following 
day. 
When necessary, parasites and HFF cells were thawed quickly to ensure 
adequate viability.  Frozen aliquots were removed from liquid nitrogen and 
immediately placed into 37°C water.  Close to complete thawing, the tube was 
doused with 70% ethanol and dried (to minimized contamination).  Thawed HFF 
cells were quickly transferred to a T-75cm2 flask (Fisher #10-126-31) containing 
30ml of host cell media.  Thawed parasites were inoculated into a T-25cm2 of 
confluent HFF cells with 9.5ml PA media.  Freshly thawed HFF cells took up to a 
week to become confluent.  Thawed parasites could also take up to a week to 
destroy a monolayer.  After the thawed parasites had lysed the initial monolayer 
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1.0ml of parasites was transferred to a fresh HFF monolayer and the parsites 
were maintained in culture as outlined above in Section-A (page 54). 
 
D. Parasite transfection 
For the purposes of generating transgenic parasites, the RH parasite in 
which the HXGPRT (hypoxanthine-xanthine-guanine phosphoribosyltransferase) 
enzyme had been deleted was used (RHΔHX; Donald et al., 1996).  The RHΔHX 
parasite line can be selected for by the addition of the prodrug 6-thioxanthine (6-
TX; 320μg/ml Sigma #S448524 in 0.5M KOH) to PA media (Pfefferkorn et al., 
2001).  Parasites are transfected with a plasmid containing a copy of the 
HXGPRT gene and are selected for using mycophenolic acid [MPA; 25mg/ml 
Sigma #M3536 in 100% EtOH (ethyl alcohol)] supplemented with xanthine 
(50mg/ml Sigma #X4002 in 0.5M KOH).  Under MPA selection, RHΔHX parasites 
that did not incorporate the plasmid, no longer possess a mechanism to generate 
guanine nucleotides and die (Donald et al., 1996).  Transformed parasites can 
utilize their restored HXGPRT salvage pathway to generate guanine nucleotides 
from the supplemented xanthine. 
RHΔHX parasites for transfection were harvested from a freshly lysed T-
25cm2 flask and filter purified from host cells as described above.  Parasites were 
washed in 5.0ml of filter sterilized cytomix electroporation buffer (Soldati et al., 
1993).  After centrifugation, the pellet was resuspended in 300µl of cytomix 
supplemented with fresh 2mM ATP (Sigma #A6419) and 5mM glutathione 
(Sigma #G6013).  Between 30-50µg of sterile DNA was resuspended in 100µl of 
cytomix supplemented with 2mM ATP and 5mM glutathione and was added to 
the 300µl of parasites.  The parasites and DNA were mixed thoroughly and 
transferred to a 2.0mm gap cuvette (Fisher #BTX620) and electroporated using a 
single 1500V pulse with a resistance setting of 25Ω on a BTX model 630 Electro 
Cell Manipulator.  Electroporated parasites were allowed to recover for fifteen 
minutes at room temperature.  The transfected parasites were split between two 
T-25cm2 flasks containing a confluent monolayer of HFF cells.  After complete 
destruction of the monolayer, 2.0ml of parasites were passed onto a fresh 
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monolayer.  Following the destruction of the second monolayer, 2.0ml of 
parasites were passed onto a fresh monolayer adding 10µl of MPA (25mg/ml 
Sigma #M3536 in 100% EtOH) supplemented with 25μl xanthine (50mg/ml 
Sigma #X4002 in 0.5M KOH) for selection of parasites possessing the 
transfected plasmid. 
 
E. Clonal dilution 
Despite the use of MPA to select for parasites possessing the transfected 
plasmid, the population of transfected parasites is never homogenous.  In order 
to obtain a homogenous population of transfected parasites a process termed 
clonal dilution was employed to generate a parasite population originally derived 
from a single parasite. 
Following at least two rounds of MPA selection, parasite were harvested 
and filtered under sterile conditions to remove host cell debris.  The parasites 
were resuspended in PM media containing MPA and xanthine.  The 
concentration of the parasites was determined using an improved Neubauer 
phase hemocytometer (Fisher #02-671-54) viewed with a Leica DM IL inverted 
microscope at 400X magnification with a phase filter.  Ten microliters of the 
suspended parasites was added to the hemocytometer.  The hemocytometer 
contains a 5 X 5 grid generating 25 boxes when viewed on the microscope.  The 
number of parasites within 5 boxes is counted and averaged.  The counting is 
repeated with a total of 4 ten-microliter samples.  The average number of 
parasite from each round of counting is then averaged.  The purpose of multiple 
rounds of counting is to reduce the amount of error.  The final average from four 
rounds of counting is multiplied by 25 because there are 25 boxes on the grid.  
The resulting product is multiplied by 1000 because the volume of the grid in the 
hemocytometer is approximately 1 microliter.  The final number is concentration 
of parasite per milliliter in the flask.  The concentration is usually around 1X106 to 
5X106 parasites per milliliter. 
A 1:1000 dilution must be performed to bring the concentration of the 
parasites down to a useable concentration.  Ten microliters of the parasites is 
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added to 10ml of PM buffer containing MPA supplemented with xanthine.  The 
parasite concentration in the flask is divided by 1000 giving the concentration of 
the diluted parasites (usually about 1-5X103 parasites per milliliter).  The 
concentration of diluted parasites can be rewritten as parasites per microliter 
(usually about 1 to 5 parasites per microliter).  In order to separate out the 
parasite individually, 96 well plates are generated with a confluent monolayer of 
HFF cells at the bottom of each well as outlined above (page 54).  The goal is to 
get one parasite into each well.  For simplicity, the 96 wells in a single plate are 
rounded up to 100 wells which means 100 parasites are needed.  Therefore, the 
number of parasites (100) is divided by the concentration of the parasites (100 
wells / 1 to 5 parasites/μL = 20 to 100μL) giving the volume of the 1:1000 dilution 
that contains 100 parasites.  Because of the high amount of error associated with 
parasite counting, the calculated volume containing 100 parasites is usually 
multiply by 2 to ensure enough parasites are used to seed the well plate (~40 to 
200µl).  The final volume, which contains about approximately 100 parasites is 
added to 20ml of PA media containing MPA supplemented with xanthine (20ml is 
the volume of media necessary to fill one 96 well plate).  The 20ml containing 
approximately 100 parasites is then divided evenly over one 96 well plate by 
placing 200µl into each well.  The plates are allowed to grow for about seven 
days without being disturbed.  The goal will be to look for individual wells that 
contain a single plaque of destroyed host cells caused be a single parasite.  
Multiple plaques in a well indicate more than one parasite was placed in the well 
and does not represent a population derived from a single parasite.  If the plates 
are moved excessively it will suspend the parasites in the wells causing the 
appearance of multiple plaques making it difficulty to tell which wells contain 
populations derived from a single parasite and which one do not. 
Several wells, usually between 4 to 7, were picked and the parasites 
present in the well were transferred to a T-25cm2 flask containing a fresh 
monolayer of host cells with PA media containing MPA supplemented with 
xanthine.  Because of the small inoculum, it took between 7 to 14 days for the 
parasites to destroy the monolayer.  The parasites are passed through at least 
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two more T-25cm2 flasks to ensure the parasites numbers were sufficient and 
then the clonal parasites were assessed for the presence of the transfected 
plasmid.  For the purposes of this thesis, immunofluorescent assays were 
performed to assess the presence and expression of the transfected plasmid.  
Clonal dilution was used to obtain clonal parasite lines expressing full length 
TgGCN5 and TgGCN5 lacking the N-terminal extension (ΔNTTgGCN5). 
 
II. Vector Construction 
A. General PCR protocol 
All primers were ordered from Invitrogen and were resuspended at 
~100pm/µl in double-distilled deionized 18 milliohm water.  All of the reaction 
components except for the template DNA were assembled on ice in a designated 
PCR only area using barrier tips to minimize contamination.  The 50µl reactions 
were assembled in thin walled 500µL PCR tubes (Fisher #E0030 124 600).  For 
all reactions approximately ~100ng of primer was used.  All PCRs were 
conducted with 1.0µL of the proofreading DNA polymerase PfuUltra™ 
(Stratagene #600380), 5.0µl of the accompanying 10X reaction buffer, 0.5µl of 
100µM dNTP mixture, and 1.5µl of DMSO.  The ice bucket was moved out of the 
designated clean area and ~50ng of template was added to the reaction.  The 
PCR was mixed by gently flicking the tube and was spun down in a microfuge 
and placed in the thermalcycler. 
 
The general thermal-cycling protocol for all PCR is as follows: 
1. 95°C for two minutes 
2. 95°C for thirty seconds 
3. Tm for thirty seconds [Tm calculated using Cybergene Primer design 
utility software (http://www.cybergene.se/primer.html)] 
4. 72°C for one minute per kilobase of amplicon 
5. Repeat steps 2-4 for a total of 25 cycles 
6. 72°C for ten minutes 
7. 4°C indefinitely 
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PCR reactions were separated by agarose gel electrophoresis using a 
0.8% agarose gel impregnated with 0.5 µg/ml ethidium bromide run at 110V for 
approximately twenty-five mintues.  Agarose gels were place on plate glass and 
visualzed by transluminating UV light at 312nm wavelength through the glass.  
Appropriate bands were excised using a clean razor blade and purified using a 
gel extraction kit (Marligen Bioscience #11456-019).  Purified PCR products were 
subsequently TOPO® ligated into the pCR®-Blunt II-TOPO® (Invitrogen #K2800-
20) vector. 
 
B. Tranformation into E. coli 
After the TOPO® ligation, One Shot® TOP10 chemically competent E. coli 
(Invitrogen #C4040-03) were transformed with the pCR®-Blunt II-TOPO® vector 
containing the PCR product using the heat shock method outline in the product 
literature.  Following transformation, the bacteria were plated out on LB agar 
plates containing 50 µg/ml kanamycin and incubated inverted overnight in a dry 
37°C incubator.  Eight colonies were picked using sterile loops to inoculate 2ml 
LB culture media with 50 µg/ml kanamycin.  Liquid cultures were incubated for 
eight to twelve hours at 37°C in a shaking incubator.  1.5ml of each culture was 
pipetted into a 2.0ml microfuge tube and spun down at 13,000g for ten minutes.  
The remaining 0.5ml of each culture was placed at 4°C.  After centrifugation, the 
liquid media was aspirated off and plasmids from the bacterial pellet were 
isolated using the Qiagen Miniprep Kit (Qiagen #27144) according to the 
manufacture’s instructions.  Ten microliters of each purified plasmid was 
analyzed using restriction digest mapping based on restriction sites incorporated 
into the primers.  The restriction digests were incubated at overnight at 37°C.  
Digest reactions were separated by agarose gel electrophoresis using a 0.8% 
agarose gel impregnated with 0.5 µg/ml ethidium bromide run at 110V for 
approximately twenty-five mintues.  Agarose gels were place on plate glass and 
visualized by transilluminating UV light at 312nm wavelength through the glass.  
One of the plasmids that produced the predicted fragments was sequenced 
verified at the Biochemistry Biotechnology Facility (Indiana University School of 
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Medicine, IN) using the M13 primer sites present in the pCR®-Blunt II-TOPO® 
plasmid.  In addition, the remaining 0.5ml of culture at 4°C containing the plasmid 
sent for sequencing was used to generate a glycerol stock by transferring 100µl 
to a 1.5ml microfuge tube and adding 10µl of sterile glycerol.  The tube was 
mixed by through shaking and inversion and stored at -80°C. 
Once sequencing of the PCR product was verified as correct, the 
remaining pCR®-Blunt II-TOPO® vector containing the PCR product was digested 
with restriction enzymes based on the restriction sites incorporated into the 
primers to cleave the PCR product from the pCR®-Blunt II-TOPO® vector.  In 
parallel, the destination vector was also digested with the same restriction 
enzymes.  Both digests were incubated overnight at 37°C.  Digest reactions were 
separated by agarose gel electrophoresis using a 0.8% agarose gel impregnated 
with 0.5 µg/ml ethidium bromide run at 110V for approximately twenty-five 
minutes.  Agarose gels were place on plate glass and visualized by 
transilluminating UV light at 312nm wavelength through the glass.  Bands 
corresponding to the liberated PCR product and the cut destination vector were 
excised using a clean razor blade and purified using a gel extraction kit (Marligen 
Bioscience #11456-019).  One microliter of the purified PCR product and 
destination vector were analyzed by agarose gel electrophoresis using a 0.8% 
agarose gel impregnated with 0.5 µg/ml ethidium bromide run at 110V for 
approximately twenty-five mintues to establish proper ratios for the ligation 
reaction.  Agarose gels were place on plate glass and visualzed by 
transluminating UV light at 312nm wavelength through the glass.  Typically a 1:3 
or 1:5 ratio of vector to PCR product was used.  Ligation reactions were 
completed using using T4 DNA Ligase (Promega #M179A) as outline in the 
product literature and were incubated at 15°C overnight.  Two microliters of each 
ligation reaction were transformed into One Shot® TOP10 chemically competent 
E. coli (Invitrogen #C4040-03) using the heat shock method outline in the product 
literature (Invitrogen).  Following transformation the transformed cells were plated 
out on LB agar plates containing the appropriate antibiotic selection and 
incubated at 37°C overnight.  Liquid cultures from 8 different colonies present on 
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the agar plates were grown the following day and plasmids were isolated using 
the Qiagen Miniprep Kit (#27144).  Each purified plasmid was analyzed using 
restriction digest mapping as outlined above.  A plasmid displaying the 
appropriate predicted bands was sent for sequencing and a glycerol stock was 
made as outline above. 
For large amounts of plasmid (e.g. transfection), the glycerol stock was 
thawed on ice and used to inoculate a 100 to 250ml liquid culture.  The liquid 
culture was incubated for twelve to sixteen hours at 37°C in a shaking incubator 
at 250rpm.  Plasmid was purified using the Qiagen Hi-Speed MIDI-Prep Kit 
(Qiagen #12643) as outlined in the product literature. 
For the purposes of bacterial expression the expression vector was made 
as outline above.  Once sequencing analysis confirmed the correct sequence 
had been ligated into the destination vector, BL21-CodonPlus® (DE3) cells were 
transformed with the expression vector obtained from a Qiagen Hi-Speed MIDI-
Prep plasmid purification.  Depending on the base pair composition of the gene 
to be expressed, either BL21-CodonPlus® (DE3)-RIL (Novagen #230245) or 
BL21-CodonPlus® (DE3)-RP (Novagen #230255) competent cells were used for 
the transformation.  The transformation was performed as outlined in the product 
literature (Novagen). 
 
C. Constructs mapping the TgGCN5 NLS 
Constructs for immunolocalization of TgGCN5 and NLS mutants were 
based on a Toxoplasma expression vector built into pminiHXGPRT (AIDS 
Research and Reference Reagent Program, Division of AIDS, NIAID, National 
Institutes of Health; http://www.aidsreagent.org).  The Toxoplasma TUB1 
promoter was amplified from ptubP30-GFP/sagCAT (Striepen et al., 1998) using 
primers 1 and 2 (listed in Table I).  These primers incorporate a BamHI site on 
the 5’ end of the PCR product and a polylinker region at the 3’ end containing 
sites for BglII, NdeI, EcoRV, and AvrII.  The 3’UTR of Toxoplasma DHFR was 
amplified using primers 3 and 4.  The resulting PCR product contained AvrII and 
NotI sites that were digested for a 3-piece ligation with the TUB1 amplicon above  
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 Table I: Primers used in PCRs detailed in Vector Construction 
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[cut with BamHI (New England Biolabs #R0136S) and AvrII (New England 
Biolabs #R0174S)] and the pminiHXGPRT vector [cut with BamHI (New England 
Biolabs #R0136S) and NotI (New England Biolabs #R0189S)].  We have 
designated this expression construct as ptubXFLAG::HX, the first “X” represents 
where the gene of interest is to be installed (Figure 8).  The “HX” refers to the 
hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT) gene 
expressed by the vector, which is used as a selection marker following 
transfection.  It is important to note that while a C-terminal FLAG tag option is 
available in this vector, it was used only for the βgal constructs below.  An N-
terminal FLAG tag was incorporated into the primers generating TgGCN5 
sequences to be tested for localization (primers 5-8 in Table I) 
The sense primers 5 through 8 with the antisense primer 9 from Table I 
were used to amplify the different form of TgGCN5 using the pHAT vector 
(Sullivan and Smith, 2000) as template DNA.  PCRs were performed as outlined 
above (page 60).  All of the TgGCN5 derived inserts were cut from the pCR®-
Blunt II-TOPO® vector by digestion with NdeI (New England Biolabs #R0111S) 
and AvrII (New England Biolabs #R0174S) and were ligated into the 
ptubXFLAG::HX vector at the same restriction sites.  Prior to electroporation, 
~50μg of plasmid DNA was linearized by digestion with NotI (New England 
Biolabs #R0189S) overnight at 37°C.  Following digestion, the cut DNA was 
ethanol precipitated using 2.5 volumes of 100% ice cold ethanol and 0.1 volumes 
of sodium acetate (3M, pH 5.2).  The microfuge tube was mixed by inverting 15-
20 times resulting in a visible clump of DNA precipitating out of solution.  The 
microfuge tube was placed at -20°C for at least thirty minutes.  The precipitated 
DNA was spun down using a microfuge in a 4°C cold room at maximum speed 
(~13,000 X g) for ten minutes.  The supernatant was carefully poured off and the 
DNA pellet was washed with 500µl of 70% ethanol.  The DNA was spun down 
again using a microfuge in a 4°C cold room at maximum speed (~13,000 X g) for 
five minutes.  In the tissue culture hood, supernatant was carefully poured off 
onto paper towels.  A kemwipe twised to a point is used to remove large droplets  
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Figure 8: Schematic diagram of the Toxoplasma expression vector 
ptubXFLAG::HX 
Vector was built into the pBluescript KS+ (pKS+; Stratagene #212205) containing 
an ampicillin selection marker for plasmid propagation in E. coli.  Striped boxes 
refer to the untranslated regions of the Toxoplasma DHFR-TS gene (dihydrofolic 
acid reductase-thymidylate synthase; Donald and Roos, 1993).  TUB1 = 
Toxoplasma tubulin promoter (Striepen et al., 1998); HXGPRT = hypoxanthine-
xanthine-guanine phosphoribosyltransferase 
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of ethanol present on the sides of the microfuge tube.  The pellet is dried in 
tissue culture hood for several hours or overnight.  The microfuge tube was 
capped while in hood and transferred to -20 for temporary storage until parasites 
were ready for electroporation. 
To create the beta galactosidase (βgal) constructs verifying the NLS, two 
PCRs were performed with the sense primers 10 and 11 in conjunction with 
antisense primer 12 from Table 1 utilizing the pTUB-βgal vector (Seeber and 
Boothroyd, 1996) as template DNA.  The βgal derived inserts were cut from the 
pCR®-Blunt II-TOPO® vector by digestion with BglII (New England Biolabs 
#R0144S) and AvrII (New England Biolabs #R0174S) enzymes.  The cut PCR 
products were ligated into the ptubXFLAG::HX vector at the same two restriction 
sites.  Unlike the TgGCN5 derived inserts, the βgal inserts do not contain a 3’ 
stop codon and therefore utilized the C-terminal FLAG tag incorporated into the 
ptubXFLAG::HX vector.  Prior to electroporation, ~50μg of plasmid DNA was 
linearized by digestion with NotI (New England Biolabs #R0189S), ethanol 
precipitated, and dried under sterile conditions as outlined in the previous 
paragraph. 
 
D. pGBK-TgGCN5 and pGAD-TgIMPα vectors 
For the production of in vitro translated protein, the pGADT7 (Clontech 
#630442) and pGBKT7 (Clontech #630443) vectors were used.  PCR was 
performed with sense primers 13 and 14 and the antisense primer 15 from Table 
I (page 64) using tubFTgGCN5:HX as template to amplify inserts encoding full-
length TgGCN5 and TgGCN5 lacking the first 99 amino acids (Δ99TgGCN5), 
respectively.  The inserts were cut from the pCR®-Blunt II-TOPO® vector using 
NdeI and XmaI sites incorporated in the primers.  Full-length TgGCN5 and 
Δ99TgGCN5 were ligated into the pGBKT7 vector using the NdeI and XmaI sites. 
ΔNLS-TgGCN5 was generated by a ligation of three DNA fragments: two PCR 
products and the destination vector, pGBKT7.  The first PCR product encodes TgGCN5 
amino acids 1-93 and was amplified using the primer 13 (contains a NdeI site) and 16 
(contains a NheI site) from Table I (page 64) with tubFTgGCN5:HX as template.  The 
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first PCR product was cut from the pCR®-Blunt II-TOPO® vector by digestion with NdeI 
(New England Biolabs #R0111S) and NheI (New England Biolabs #R0131S).  The 
second PCR fragment encodes amino acids 100-1169 and was generated with primer 
17 (contains a NheI site) and primer 15 (contains an XmaI site) from Table I (page 64).  
pGBKT7 was digested with NdeI (New England Biolabs #R0111S) and XmaI (New 
England Biolabs #R0180S).  The ligation of the two PCR products and the pGBKT7 
vector resulted in a plasmid encoding a form of TgGCN5 in which RKRVKR was 
replaced by an alanine-serine dipeptide (encoded by the NheI site). 
TgIMPα insert was generated by single tube RT-PCR using primers 18 and 19 
from Table I (page 64) with Toxoplasma mRNA purified from RH tachyzoites.  The 
mRNA was purified from RH tachyzoites using the Ambion Poly(A)PureTM Kit (Fisher 
#NC9343859).  The reverse transcription step was carried out using the Omniscript 
Reverse Transcriptase (Qiagen #205110) following the single tube PCR protocol as 
outlined in the product literature (Qiagen).  The TgIMPα insert was cut from pCR®-Blunt 
II-TOPO® by digesion with NdeI (New England Biolabs #R0111S) and XmaI (New 
England Biolabs #R0180S).  The insert was ligated into the pGADT7 vector in frame 
with an N-terminal hemagglutinin (HA) tag using the same two restriction sites. 
 
E. pET28-ScGCN5 Vector 
Sacchromyces cerevisiae GCN5 (ScGCN5) was amplified from a previously 
made yeast cDNA library by PCR using the sense primer: 5’-
ATCGAgctagcGTCACAAAACATCAGATTGAAGAGG-3’ and the antisense primer: 5’-
ATCGActcgagTAATCAATAAGGTGAGAATATTCAGG-3’.  The sense primer encodes a 
NheI restriction site (lower case) and the antisense primer encodes an XhoI site (lower 
case).  The two restriction sites were used to digest the pCR®-Blunt II-TOPO® vector to 
liberate the PCR product.  The same two restriction sites (NdeI and XhoI) were also 
used as the insertion sites for ligation into the pET28 bacterial expression vector 
(Novagen #69865-3) in frame with an N-terminal poly-histidine tag. 
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F. pET28-TgGCN5 vector 
Toxoplasma gondii (TgGCN5) was amplified from the ptubXFLAG::HX vector 
containing full length TgGCN5 (ptubFLAGTgGCN5::HX) by PCR using the sense primer: 
5’-ATCGAcatatgGAGACTGTCAAGGTGCCTGCATTCC-3’ and the antisense primer: 5’-
ATCGAgcggccgcTCAGAAACTCCCGAGAGCCTCGACC-3’.  The sense primer 
encodes an NdeI restriction site (lower case) and the antisense primer encodes a NotI 
site (lower case).  The two restriction sites were used to cut the PCR product out of the 
pCR®-Blunt II-TOPO® vector and were also use as the insertion sites for ligation into the 
pET28 bacterial expression vector (Novagen #69865-3) in frame with an N-terminal 
poly-histidine tag. 
 
III. Bioinformatics 
Sequencing alignments and phylogeny trees of importin α homologues 
were generated using AlignX, a component of the Vector NTI Advance 9.0 
(Informax) program.  Other protein sequencing alignments were performed using 
the ClustalW program (http://www.ch.embnet.org/software/ClustalW.html) where 
indicated.  Protein motif searches were performed using the Pfam database (ver. 
14.0; http://pfam.wustl.edu/) and/or PROSITE database (ver. 18.35; 
http://us.expasy.org/prosite/). 
 
IV. Biochemical Techniques 
A. Immunofluorescence assay 
For immunofluorescence assays (IFA), 12 well plates containing 
coverslips were made as outlined above (Section I-A, page 53).  Prior to 
infection, the lid of the well plate(s) were labeled with the parasite line to be 
infected into each well.  The old HC (host cell) media in the wells was aspirated 
and replaced with 1.0ml of PA media (parasite media) which consists of DMEM, 
1% heat-inactivated fetal bovine serum, and 25μg/L gentamicin).  The T-25cm2 
flask containing the infected monolayer was scrapped with a sterile spatula 
(Fisher #08-773-2) to completely rupture any remaining parasite vacuoles and to 
suspend the parasites into the media.  Each well was inoculated with 200µl of 
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parasites from the T-25cm2 flask.  To maintain the parasites in culture, 1.0ml of 
parasites from the scraped flask was also is transferred to a T-25cm2 flask 
containing a new confluent HFF monolayer as mentioned above (Section I-A, 
page 54). 
The infected 12 well plates were incubated at 37°C in a humidified 5% 
CO2 environment for eighteen to twenty-four hours.  Parasite infection of the well 
plate was monitored using a Leica DM IL inverted microscope at 400X 
magnification with a phase filter.  Once the infection had progressed to the point 
where each parasite vacuole contained an average of 4-8 parasites per vacuole, 
the well plate(s) were removed from the tissue culture incubator and processed 
for IFA. 
The PA media from each well was aspirated and each well was washed 
with 1.0ml of PBS three times.  Cultures were fixed by adding 1.0ml of ice-cold 
methanol to each well and incubating the well plate at -20°C for ten minutes.  The 
methanol was aspirated and each well was washed with 1.0ml PBS three times.  
Cells were blocked with 0.5ml of PBS containing 3% Fraction-V BSA (Sigma 
#A3059), 5% goat serum (Invitrogen #10000C), and 1% fish gelatin (Sigma 
#G7765) for one hour at 25°C or overnight at 4°C.  After aspirating the blocking 
buffer, 0.5ml of polyclonal anti-FLAG (Sigma #F7425) at 1:1000 in 3% BSA 
(Sigma #A3059) in PBS was added to each well and incubated for one hour at 
25°C.  After 3 washes with 1.0ml PBS, 0.5ml of goat anti-rabbit Alexa 488 
(Molecular Probes #A11034) was added to each well at 1:3000 in 3% BSA 
(Sigma #A3059) in PBS.  Immediately after adding the Alexa conjugated 
antibody, the well plate was wrapped in aluminum foil and incubated for one hour 
in the dark at 25°C.  Each well plate was washed with 1.0ml PBS and then 0.5ml 
of 0.3µM DAPI (Invitrogen #D1306) was added to each well and incubated, 
wrapped in foil for five minutes at 25°C.  Each well was washed three times with 
1.0ml of PBS.  The last 1.0ml of PBS was left in each well to aid in removing the 
coverslips from the wells. 
A single drop of mounting reagent (~10µl) containing 50% glycerol with 
Mowiol 4-88 (Calbiochem #81381) and DABCO (Sigma #10981) to retard 
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photobleaching was placed on a microscope slide.  The next paragraph contains 
the protocol for making the mounting reagent.  The coverslips were removed 
from each well using non-sterile flat tweezers (Fisher #09-753-50) and placed 
inverted on top of the drop of mounting agent on the microscope slide.  Slides 
were air dried in the dark for approximately thirty minutes.  Slides were viewed 
with a Leica DMLB scope with a 100X HCX Plan Apo oil immersion objective.  
Images were captured using a monochrome SPOT-RTSE (Model 12) Camera 
and Spot Diagnostic Software 4.0.9 and pseudocolored using Adobe Photoshop 
7.0. 
The mounting reagent was made by dissolving 2.4 grams of Mowiol 4-88 
(Calbiochem #81381) in to 12ml of 50% glycerol in a 50ml conical (Fisher #14-
959-49A).  The solution was mixed well by vigorous vortexing.  After the Mowiol 
4-88 has dissolved, 0.5 grams of DABCO (Sigma #10981) was added.  The 
conical was taped down on the plate form of a shaking incubator.  The solution 
was shaken for two hours at room temperature to dissolve the Mowiol 4-88 and 
DABCO.  The conical was removed from the shaker and 12ml of 200mM Tris-
HCl (pH 8.5) was added to the conical.  The solution was incubated at 50°C with 
accasional mixing to until the Mowiol 4-88 was completely dissolved 
(approximately three hours).  The solution was transferred to a Beckman tube 
and spun at 5000 x g for fifteen minutes at room temperature.  The mounting 
reagent was aliquoted out into 1.5ml microfuge tubes and stored at -20°C.  Prior 
to use, the solution was thawed by hand warming an aliquot. 
 
B. Production of TgGCN5 antiserum 
The pET19-TgGCN3000 vector had been previously generated in Sullivan lab 
and had been transformed into BL21(DE3) E. coli cells.  The pET19-TgGCN3000 vector 
contains a fragment encoding 30kD of the C-terminal end of TgGCN5 (amino acids 976-
1169) in-frame with an N-terminal polyhistidine tag. 
A glycerol stock was used to inoculate 100ml of LB media which was 
grown at 37°C shaking at 250rpm until the OD600 reading was apprimately 0.5 
(usually around two to three hours).  Bacterial protein expression in the 100ml 
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culture was induced by adding 100mM IPTG stock solution to a final 
concentration of 0.5mM.  The culture was placed back at 37°C for three hours 
shaking at 250rpm.  At the end of induction, the 100ml induction was spun down 
in large Beckman centrifuge at 4°C at 10,000rpm for ten minutes to pellet the 
bacteria.  After centrifugation, the media was poured off and the pellet was 
resuspended into 10ml of cold PBS and transferred to a 25ml Beckman tube.  
The reususpended pellet was spun down at 4°C at 10,000Xg for ten minutes.  
Following spin, the PBS was poured off and the pellets were stored at -20°C.  
The histidine fustion protein was purified as outlined below (Section D, page 75).  
The purified protein was lyophilized and sent to Pocono Rabbit Farms & 
Laboratories (Canadensis, PA).  The purified protein was used as antigen to 
produce polyclonal antisera in rabbits. 
Upon receiving the antiserum from Pocono Rabbit Farms & Laboratories, 
it was tested against recombinant antigen in a western blot (Figure 9).  
Approxmiately 0.02µg and 0.2µg of antigen were resolved on a NuPAGE gel 
(Invitrogen #NP0335BOX) and transferred to a PVDF membrane (Invitrogen 
#LC2005).  The membrane was blocked overnight at 4°C in TBST (20mM Tris, 
150mM NaCl, 0.1% v/v Tween-20) containing 5% milk.  The membrane was cut 
in half and one half was incubated with TgGCN5 antiserum at 1:10,000 in TBST 
containing 5% milk for one hour and the other half was incubated for one hour in 
pre-immune rabbit serum obtained prior to antibody production also diluted 
1:10,000 in TBST containing 5% milk.  Both blots were washed 3 times, 5 
minutes each with TBST.  The secondary antibody, goat derived anti-rabbit 
conjugated to HRP (horseradish peroxidase; Amersham #NA934), was incubated 
with both membranes at 1:2500 dilution in 5% Milk-TBST for one hour, washed 3 
times, five minutes each with TBST. 
The blots were treated with 1.5ml of Amersham’s ECL™ detection reagent 
(#RPN2209).  Excess reagent was removed by gently shaking the blot over 
paper towels.  The blot was then wrapped in cellophane and taped down in a 
metal film tray.  In a photography dark room, the blot was exposed to High 
Senstive Blue photographic film (RPS Imaging #33-0810).  Following exposure, 
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Figure 9: Evalulation of TgGCN5 antisera 
Western blot shows 1:10,000 dilution of antiserum (RAB 1) reacts specifically to 
0.02 and 0.2μg of TgGCN5 antigen (Ag; ~30kD). Pre-immune (PRE) serum was 
tested as a control.  Secondary antibody (goat derived anti-rabbit, Amersham 
#NA934) was used at 1:2500.  Detection was performed using Amersham ECL 
reagent (#RPN2209) with High Sensitive Blue photographic film (RPS Imaging 
#33-0810).  kD = kilodaltons 
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the film was removed and run through an automated developer.  As shown in 
Figure 9, the TgGCN5 antiserum recognizes <0.1μg of recombinant antigen at a 
dilution of 1:10,000, while pre-bleed sera is non-reactive. 
 
C. In vitro translation and co-immunoprecipitation 
In vitro translated proteins representing full-length TgGCN5, Δ99TgGCN5, 
ΔNLS-TgGCN5, and Toxoplasma importin α (TgIMPα) were generated using the 
TNT® T7 Coupled Reticulocyte Lysate System (Promega #L4610) in the 
presence of Redivue™ L-[35S]methionine (Amersham Pharmacia #AG1094) and 
RNase Out (Invitrogen #10777-019).  Translation reaction mixtures with a total 
volume of 50μl were assembled and incubated as described by manufacturer 
(Promega).  Co-immunoprecipitations (CoIP) were performed by combining 20μl 
of the TgGCN5 in vitro translation reaction with 20μl of the TgIMPα in vitro 
translation reaction in a fresh microfuge tube.  The mixture was mixed by gently 
tapping the side of the tube and subsequently incubated at 25°C for one hour.  
Initially, CoIPs were performed by adding 10μl of a polyclonal HA antibody 
(Santa Cruz #SC-7392) and 10μl of monoclonal cMyc antibody (Santa Cruz #SC-
40).  When these antibodies failed to provide positive results, subsequent CoIPs 
were performed by adding 1.0μl of TgGCN5 polyclonal antiserum (page 71) to 
each mixtures, mixing by tapping the tube, and incubating at 25°C for one hour.  
EZ-View Protein A agarose (Sigma #P6486) was washed two times with PBS 
and 10μl washed agarose slurry was added to all CoIPs, mixed by tapping tube, 
and incubated at 25°C for one hour. 
A similar protocol was followed for immunoprecipitation of single proteins 
using 10μl of completed translation reaction and 1μl of TgGCN5 polyclonal 
antisera for TgGCN5 proteins and 10μl of a polyclonal HA antibody (Santa Cruz 
#SC-7392) for TgIMPα.  EZ-View Protein A agarose (Sigma #P6486) was 
washed twice with PBS and 10μl of washed agarose was added to 
immunoprecipitations, mixed by tapping tube, and incubated at 25°C for one hour 
For both co-immunoprecipitations and immunoprecipitations, the protein-A 
agarose was washed 5 times with 200μl of CoIP Buffer 1 [10mM HEPES (pH 
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7.7), 500mM KCl, 0.1mM CaCl2, 1mM MgCl2, 50mM Sucrose, 0.5% Nonidet P-
40 (nonionic detergent)] and twice with 300μl of CoIP Buffer 2 (10mM HEPES 
(pH 7.7), 100mM KCl, 0.1mM CaCl2 , 1mM MgCl2, and 50mM Sucrose).  Bound 
proteins were eluted by boiling the protiein A agarose in NuPAGE loading dye 
(Invitrogen #NP0007) containing 5.0% β-mercaptoethanol (Sigma #M7154) and 
resolved on 4-12% NuPAGE Bis-Tris SDS gels (Invitrogen #NP0335BOX).  Ten 
microliters of SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) was run on 
the gel and was used to estimate protein molecular weight after gel 
electrophoresis.  Gels were fixed in an aqueous solution of 5% isopropanol and 
5% glacial acetic acid overnight and rinsed in running distilled water for one hour.  
Gels were incubated in Autoflour (National Diagnostics #LS-315) for two hours, 
wrapped in gel wrap(The Gel Company #EJA331-050), and air dried overnight.  
The excess gel wrap was trimmed away and the gel was taped down in a metal 
film tray.  In a photography dark room, a piece of High Sensitive Blue 
photographic film (RPS Imaging #33-0810) was placed over the gel and the film 
tray was closed and locked.  The film tray was placed at -80°C for twenty-four 
hours.  Following exposure, the film tray was removed and allowed to warm to 
room temperature.  In a photography dark room, the film was removed and run 
through an automated developer. 
 
D. Bacterial expression and purification of ScGCN5 and TgGCN5 
The glycerol stocks of the BL21-CodonPlus® (DE3)-RIL E. coli cells 
containing the pET28-ScGCN5 vector and BL21-CodonPlus® (DE3)-RP E. coli 
cells containing the pET28-TgGCN5 generated following transformation were 
thawed on ice and 10µl of each was used in inoculate 4ml of LB with 50µg/ml 
chloramphenicol (selection for proprietary plasmid coding for extra tRNAs) and 
35µg/ml kanamycin (pET28 vector selection).   
For both ScGCN5 and TgGCN5, The liquid culture was incubated 
overnight at 37°C shaking at 250rpm.  A 250ml flask containing 100ml of LB 
media with 35µg/ml kanamycin was inoculated with 1.0ml of the overnight 
culture.  The 100ml culture was grown at 37°C shaking at 250rpm until the OD600 
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reading was approximately 0.5 (usually around two to three hours).  Before 
inducing protein expression, a 1.0ml sample of the 100ml culture was obtained 
and placed into 1.5ml microtube.  The 1.0ml sample was centrifuged at maximum 
speed for a few minutes to pellet the bacteria.  The LB media was aspirated off, 
and the record OD600 reading of culture was written on the side of tube, and the 
bacterial pellet was stored at -20°C. 
Bacterial protein expression in the 100ml culture was induced by adding 
100mM IPTG stock solution to a final concentration of 0.5mM.  The bacteria 
culture of cells expressing ScGCN5 was placed back at 37°C for three hours 
shaking at 250rpm.  The bacteria culture of cells expressing TgGCN5 was 
incubated at 15°C for sixteen hours shaking at 250rpm.  At end of induction, two 
1.0 samples of the induced culture were obtained into 2 separate 1.5ml 
microtubes.  One of the samples was centrifuged at maximum speed for a few 
minutes to pellet the bacteria.  The media was aspirated off and stored at -20°C 
for subsequent analysis.  The second tube was used to determine the OD600 of 
the induced culture.  The sample was too turbid to perform a direct reading.  
Therefore, it was diluted 1:10 by pipeting 100µl of the culture into the cuvette and 
adding 900µl of H2O.  The dilution was mixed by inversion and OD600 reading 
was obtained and recorded. 
The remaining 100ml induction was spun down in large Beckman 
centrifuge at 4°C at 10,000rpm for ten minutes to pellet the bacteria.  After 
centrifugation, the media was poured off and the pellet was resuspended into 
10ml of cold PBS and transferred to a 25ml Beckman tube.  The resuspended 
pellet was spun down at 4°C at 10,000Xg for ten minutes.  Following spin, the 
PBS was poured off and the pellets were stored at -20°C. 
The two 1.0ml pellets were used to verify successful induction before 
attempting to purify the protein from the bacteria.  The two 1.0ml samples were 
thawed one ice for five minutes and were resuspended each in 100µl of COLD 
PBS.  The bacterial pellets were sonicated using a  microprobe 3 times for 15 
seconds with a 30 second recovery on ice between each pulse.  The sonicated 
samples were spun down using a microfuge in the 4°C cold room at maximum 
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speed (~13,000 X g) for ten minutes.  The supernatant (~100µl) was transferred 
into pre-chilled microfuge tubes and labeled as the soluble fraction. 
For SDS-PAGE analysis, 21.0µl of the soluble fraction sample was mixed 
with 7.5µl of NuPAGE Loading Dye (Invitrogen #NP0007) and 1.5µl of beta-
mercaptoethanol (β-Me; Sigma #M7154).  The samples were heated at 70°C for 
ten minutes and the entire sample was loaded onto a NuPAGE gel (Invitrogen 
#NP0335BOX).  The insoluble fraction (pellet) was resuspended in 25.0µl of 
NuPAGE Loading Dye (Invitrogen #NP0007), 5.0µl of β-Me (Sigma #M7154) and 
70.0µl of ddH2O.  If the sample was very viscous, it was sonicated 3 times for 15 
seconds with a 30 second recovery on ice between each pulse.  Each sample 
was incubated at 70°C for ten minuntes and 30µl was loaded onto the NuPAGE 
gel (Invitrogen #NP0335BOX).  The NuPAGE gel was run using MOPS buffer 
(Invitrogen #NP0001) according to manufacture’s (Invitrogen) directions.  Ten 
microliters of SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) was run on 
the gel and was used to estimate protein molecular weight after gel 
electrophoresis. 
Following gel electrophoresis, the gel was removed from the gel mold and 
was washed in deionized water three times, for ten minutes each.  To visualize 
protein in the gel, the gel was stained overnight with SimplyBlue™ (Invitrogen 
#LC6060).  The gel was destained by washing in deionized water three times, for 
ten minutes each.  If analysis of the 1.0ml samples indicated that induction was 
successful in producing protein, the large bacterial pellet was processed for 
protein purification by virtue of the polyhistidine fusion tag using nickel resin. 
The frozen bacterial pellet from the 100ml culture was thawed on ice for 
fifteen minutes.  The pellet resuspended in 4ml of lysis buffer (50mM NaH2PO4 
(pH 8.0), 300mM NaCl, 10mM of imidazole) with 4mg lysozyme (Sigma #L6876) 
and 80µl of His-Tag Protease Inhibitor Cocktail (Sigma #P8849).  The lystate was 
incubated on ice for thirty minutes with occasional mixing every five to seven 
minutes.  The lysate was transferred to a 15ml conical tube (Fisher #14-959-70C) 
and sonicated 6 times at 15 second bursts with a 30 second recovery on ice 
between each burst.  Following sonication, lysate was transferred into centrifuge 
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tube and spun at 4°C and 10,000 X g for thirty minutes.  The supernatant was 
poured into a 15ml conical tube and placed on ice.  An additional 40µl of His-Tag 
Protease Inhibitor Cocktail (Sigma #P8849) was added to the lysate in the 
conical and mix thoroughly.  Approxmiately 1.0ml of Ni-NTA agarose slurry 
(Qiagen #30210) was added to the conical and mixed by inversion.  The conical 
was taped to the platform of shaking incubator in a 4°C cold room and was 
incubated at 15°C one hour, shaking at 200rpm. 
During the shaking incubation, a column was prepared by packing a small 
wad of glass wool into the bottom of a 5ml syringe.  The syringe was clamped to 
a ring stand in the cold room.  After incubation, the contents of the conical was 
poured slowly into the syringe column and the column was pack by gravity.  
Once the supernatant flowed through the column, the column was washed twice 
with 4.0ml of wash buffer (50mM NaH2PO4 (pH 8.0), 300mM NaCl, 50mM of 
imidazole).  After the washes, protein was eluted off the column using the 
following buffers: 
Buffer A: 50mM NaH2PO4 (pH 8.0), 300mM NaCl, 100mM imidazole 
Buffer B: 50mM NaH2PO4 (pH 8.0), 300mM NaCl, 200mM imidazole 
Buffer C: 50mM NaH2PO4 (pH 8.0), 300mM NaCl, 300mM imidazole 
Protein was eluted with two treatments of 500µl of buffer A and B and 
three treatments of buffer C.  Each elution was captured in 1.5ml microfuge 
tubes.  An additional 5µl of protease inhibitors (Sigma #P8849) was added to the 
all elutions.  Each elutions was analyzed by SDS-PAGE using NuPAGE gels 
(Invitrogen #NP0335BOX).  For PAGE analysis, 21.0µl of each elution was mixed 
with 7.5µl of NuPAGE Loading Dye (Invitrogen #NP0007) and 1.5µl of beta-
mercaptoethanol (β-Me) and incubated at 70°C for ten minutes.  The NuPAGE 
gel was run using MOPS buffer (Invitrogen #NP0001) according to 
manufacturer’s (Invitrogen) directions.  Ten microliters of SeeBlue® Plus2 
Protein Standard (Invitrogen #LC5925) was run on the gel and was used to 
estimate protein molecular weight after gel electrophoresis. 
Following gel electrophoresis, the gel was removed from mold and was 
washed in deionized water three time for ten minutes each.  To visualize protein 
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in the gel, the gel was stained with SimplyBlue™ (Invitrogen #LC6060) overnight.  
The gel was destained by washing in deionized water three times for ten minutes 
each.  The elutions containing recombinant protein were pooled and 
concentrated using an Amicon Ultra-4 Centrifugal Filter Device (Fisher 
#UFC801008) as outlined in the product literature.  The concentrated elutions 
were transferred to a Slide-A-Lyzer® dialysis cassette (Pierce #PI66380) for 
dialysis to remove the imidazole.  The dialysis cassettes was placed in 1.0L of 
50mM Tris·HCl (pH 8.0) at 4°C for fifteen minutes with gentle stirring using a 
magnetic stir plate.  The cassette was transferred to another 1.0L of 50mM 
Tris·HCl (pH 8.0) at 4°C for forty-five minutes with gentle stirring using a 
magnetic stir plate.  The sample was removed from the dialysis cassette and 
quantitated using a standard Bradford assay (Fisher #PI23225). 
After protein concentration has been determined, approximately two 
samples of 1.0µg of ScGCN5 were resolved on a NuPAGe gel.  The gel was cut 
and one sample was stained with SimplyBlue™ (Invitrogen #LC6060) and the 
other gel was transferred to a PVDF membrane (Invitrogen #LC2005) for western 
blot detection.  After the transfer was complete, the blot was blocked overnight at 
4°C in TBST (20mM Tris, 150mM NaCl, 0.1% v/v Tween-20) containing 5% milk.  
The following day, the membrane was incubated with monoclonal anti-histidine 
antibody (Clontech #PT3359-2) at a dilution of 1:5000 in TBST containing 5% 
milk for one hour then washed 3 times, five minutes each with TBST.  The 
secondary antibody, goat derived anti-mouse conjugated to HRP (horseradish 
peroxidase; Amersham #NA931), was incubated with membrane at a 1:5000 
dilution in 5% Milk-TBST for one hour, washed 3 times, five minutes each with 
TBST. 
In the case of TgGCN5, two samples of 500ng of protein were resolved on 
a NuPAGE gel.  The gel was cut and one sample was stained with SimplyBlue™ 
(Invitrogen #LC6060) and the other gel was transferred to a PVDF membrane 
(Invitrogen #LC2005) for western blot detection.  After the transfer was complete, 
the blot was blocked overnight at 4°C in TBST containing 5% milk.  The following 
day, the membrane was incubated with TgGCN5 antiserum at 1:10,000 in TBST 
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containing 5% milk for one hour then washed 3 times, five minutes each with 
TBST.  The secondary antibody, goat derived anti-rabbit conjugated to HRP 
(Amersham #NA934), was incubated with membrane at 1:2500 dilution in 5% 
Milk-TBST for one hour, washed 3 times, five minutes each with TBST. 
The ScGCN5 and TgGCN5 blots were treated with 1.5ml of Amersham’s 
ECL™ detection reagent (#RPN2209).  Excess reagent was removed by gently 
shaking the blot over paper towels.  The blot was then wrapped in cellophane 
and taped down in a metal film tray.  In a photography dark room, the blot was 
exposed to a High Sensitive Blue photographic film (RPS Imaging #33-0810).  
Following exposure, the film was removed and run through an automated 
developer.  SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) transferred 
to the membrane were used to estimate protein molecular weight after gel 
electrophoresis. 
 
E. FLAG affinity purification of FLAGTgGCN5 and FLAGΔNTTgGCN5 from parasites 
Parasites overexpressing FLAG tagged TgGCN5 (FLAGTgGCN5) and/or 
TgGCN5 lacking the N-terminal extension (FLAGΔNTTgGCN5) were harvested 
from infected T-150cm2 flasks by scraping the monolayer with a sterile spatula 
(Fisher #08-773-2) to completely rupture any remaining parasite vacuoles and to 
suspend the parasites into the media.  The suspended parasites were filtered 
under non-sterile conditions and washed with PBS as previously outlined 
(Section I-B, page 55).  Following PBS washing, the parasite pellet was 
resuspended in 1.0ml of lysis buffer [50mM Tris-HCl (pH 7.4) 150mM NaCl, 1mM 
EDTA, 1% Triton X-100, and 20μl of mammalian protease inhibitors (Sigma 
#P8340)].  Lysate was sonicated 3 times for 15 seconds with 30 second recovery 
on ice between each pulse.  The lysate was placed on rocker at 4°C for thirty 
minutes.  Lysates were spun at maximum speed (~13,000 X g) at 4°C for ten 
minutes.  The supernatant was transferred to a new microtube and 60μl of 
EZviewTM Red Protein A Affinity Gel (Sigma #P6486) was added to the 
supernatant.  The mixture was placed at 4°C on a rocker for thirty minutes.  The 
purposes of this step was to pre-clear the lysate by removing “sticky” proteins 
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that non-specifically interact with affinity resins.  The lysate was spun at 8200 X g 
for one minute and the supernatant was transferred to a new tube with 60μl of 
EZviewTM Red ANTI-FLAG® M2 Affinity Gel (Sigma #F2426) and placed on 
rocker overnight at 4°C. 
The next day, affinity gel was washed 3 times with 750μl of wash buffer 
[50mM Tris-HCl (pH 7.4), 300mM NaCl, and 1mM EDTA) plus 10μl/ml of fresh 
mammalian protease inhibitors (Sigma #P8340), and then washed twice with 
750μl of HAT assay buffer (50mM Tris-HCl (pH 8.0), 50mM KCl, 0.1mM EDTA, 
1.0mM DTT, and 10% glycerol).  During the second wash with 750μl of HAT 
assay buffer, 250μl (~10μl packed resin) was transferred into a separate tube for 
western blot analysis to insure that immunoprecipitation was successful.  The 
remaining 500μl (~20μl packed resin) was used in a HAT assay (see next 
section).  Samples were spun down at 8200 X g for one minute and the HAT 
buffer was aspirated. 
Twenty microliters of 2X NuPAGE Loading Dye (Invitrogen #NP0007) 
containing 2.5μl β-mercaptoethanol (β-Me; Sigma #M7154) was added to the 
10μl of packed resin for western blot analysis.  Samples were incubated at 70°C 
for ten minutes and then loaded on a  4-12% NuPAGE Bis-Tris (Invitrogen 
#NP0335BOX) gel and run in MOPS buffer according to the manufacture’s 
(Invitrogen) directions.  SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) 
was used to estimate protein molecular weight after gel electrophoresis. 
Samples were then transferred to a PVDF membrane (Invitrogen 
#LC2005) and blocked overnight at 4°C in TBST (20mM Tris, 150mM NaCl, 0.1% 
v/v Tween-20) containing 5% milk.  The following day, the membrane was 
incubated with polyclonal anti-FLAG (Sigma #F7425) at 1:1000 in TBST 
containing 5% milk for one hour then washed 3 times, five minutes each with 
TBST.  The secondary antibody, goat derived anti-rabbit conjugated to HRP 
(horseradish peroxidase; Amersham #NA934) was incubated with membrane at 
1:2500 dilution in 5% Milk-TBST for one hour, washed 3 times, five minutes each 
with TBST. 
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The blot was treated with 1.5ml of Amersham’s ECL™ detection reagent 
(#RPN2209).  Excess reagent was removed by gently shaking the blot over 
paper towels.  The blot was then wrapped in cellophane and taped down in a 
metal film tray.  In a photography dark room, the blot was exposed to a High 
Sensitive Blue photographic film (RPS Imaging #33-0810).  Following exposure, 
the film was removed and run through an automated developer.  SeeBlue® Plus2 
Protein Standard (Invitrogen #LC5925) transferred to the membrane were used 
to estimate protein molecular weight after gel electrophoresis. 
 
F. Radioactive histone acetylase assays 
The in vitro HAT assays used in the thesis were based on those originally 
reported by Browell et al. (1996).  All radioactive HAT assays were 50µl reactions 
containing 2μl of 3H-Acetyl-CoA (Amersham #TRK688) and 4μl of chicken 
erythrocyte core histones (1μg/μl in H2O; Upstate #13-107).  The amount of 5X 
HAT assay buffer (250mM Tris-HCl (pH 8.0), 250mM KCl, 0.5mM EDTA, 5.0mM 
DTT, and 50% glycerol; modified from Fan et al., 2004b), and deionized water 
depended on the protein source. 
HAT assays performed with recombinant ScGCN5 contained ~1.0μg of 
protein, 10μl of 5X HAT assay buffer, and water sufficient to 50μl.  HAT assays 
performed with recombinant TgGCN5 generated in bacteria contained ~500ng of 
protein, 10μl of 5X HAT assay buffer, and water sufficient to 50μl.  Assays to 
assess the activity of FLAG tagged proteins immunoprecipitated from parasites 
contained ~20μl of packed resin from a FLAG affinity purification mixed with 6μl 
of 5X HAT assay buffer, and 18μl of deionized water.  A negative control reaction 
was made with 10μl of 5X HAT assay buffer and 34μl of water. 
All of the reactions were mixed thoroughly and incubated at 30°C for sixty 
minutes.  Reactions were remixed by gently tapping the sides of the tubes every 
ten minutes.  Reactions were stopped by adding 15μl of 2X NuPAGE loading dye 
(Invitrogen #NP0007) containing 2.5μl of β-Me (Sigma #M7154) and incubated at 
70°C for ten minutes before resolving on a NuPAGE 10% Bis-Tris gel (Invitrogen 
#NP0315BOX) using MES buffer according to the manufacture’s (Invitrogen) 
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directions.  Ten microliters of SeeBlue® Plus2 Protein Standard (Invitrogen 
#LC5925) was run on the gel and was used to estimate protein molecular weight 
after gel electrophoresis. 
The gel was removed from the mold and was washed in deionized water 3 
times, five minutes per wash.  Gels were fixed in an aqueous solution of 5% 
isopropanol and 5% glacial acetic acid overnight and rinsed in running distilled 
water for one hour.  Gels were incubated in Autoflour (National Diagnostics #LS-
315) for two hours.  A piece of Whatman paper, slighter larger than the gel, was 
added to tray with Autoflour and gently agitated for an additional five minutes.  
The gel was placed on top of the soaked Whatman paper and sandwiched 
between two pieces of gel wrap (The Gel Company #EJA331-050) and air dried 
overnight.  The excess gel wrap was trimmed away and the gel was taped down 
in a metal film tray.  In a photography dark room, a piece of High Sensitive Blue 
photographic film (RPS Imaging #33-0810) was placed over the gel and the film 
tray was closed and locked.  The film tray was placed at -80°C for twenty-four 
hours to one week.  Following exposure, the film tray was removed and allowed 
to warm to room temperature.  In a photography dark room, the film was 
removed and run through an automated developer. 
 
G. Non-Radioactive histone acetylase assays 
Non-radioactive HAT assays were performed the same as the radioactive 
assays outlined in the previous section, with the following differences: 1μl of 1mM 
acetyl CoA and 1μl of recombinant histone H3 (1μg/μl in water) were used in 
place of tritiated acetyl CoA and core histones.  The 1mM acetyl CoA was 
generated by dissolving acetyl CoA sodium salt (Sigma #A2056) in 10mM 
sodium acetate (pH 4.5) to a final concentration of 1mM.  The recombinant 
histone H3 (Upstate #14-411) is Xenopus laevis Histone H3 generated in E. coli.  
The total volume of each reaction remained 50μl and the amount of water added 
to each reaction was adjusted accordingly. 
The same positive and negative controls were used in the non-radioactive 
assay but with histone H3 substrate instead of core histones.  Reactions were 
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resolved via NuPAGE 10% Bis-Tris gel (Invitrogen #NP0315BOX) using MES 
buffer according to the manufacture’s (Invitrogen) directions.  Ten microliters of 
SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) was run on the gel and 
was used to estimate protein molecular weight after gel electrophoresis. 
Following electrophoresis, the proteins were transferred to a PVDF 
membrane (Invitrogen #LC2005) using an XCell II™ Blot Module (Invitrogen 
#EI9051) with 1X NuPAGE® Transfer Buffer (Invitrogen #NP0006-1) at 25V for 
two hours.  After transfer, the membrane was blocked overnight at 4°C in TBST 
(20mM Tris, 150mM NaCl, 0.1% v/v Tween-20) containing 5% non-fat dry milk. 
The following day, the membrane was incubated with a polyclonal 
antibody against acetylation at lysine 14 of histone H3  Polyclonal [α-AcH3(K14), 
Upstate #07-353] at 1:1000 in TBST containing 5% milk for one hour then 
washed 3 times, five minutes each with TBST.  The secondary antibody, goat 
derived anti-rabbit conjugated to HRP (horseradish peroxidase; Amersham 
#NA934) was incubated with membrane at 1:2500 dilution in 5% Milk-TBST for 
one hour, washed 3 times, five minutes each with TBST.  The blot was treated 
with 1.5ml of Amersham’s ECL™ detection reagent (#RPN2209).  Excess 
reagent was removed by gently shaking the blot over paper towels.  The blot was 
then wrapped in cellophane and taped down in a metal film tray.  In a 
photography dark room, the blot was exposed to a High Sensitive Blue 
photographic film (RPS Imaging #33-0810).  Following exposure, the film was 
removed and run through an automated developer.  SeeBlue® Plus2 Protein 
Standard (Invitrogen #LC5925) transferred to the membrane were used to 
estimate protein molecular weight after gel electrophoresis. 
Following western blot detection, the blot was removed from the 
cellophane and placed in tray with ~25ml of TBST (enough to cover the blot well).  
The blot was washed twice, five minutes each, with TBST for at room 
temperature.  The blot was covered with stripping solution and incubated at 50 to 
55°C for thirty minutes with gentle rocking.  The stripping buffer was made 
immediately prior to using it by combining stripping buffer pre-mix (67.5mM Tris 
(pH 6.7) and 2% SDS) with β-Me to a final concentration of 100mM.  
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Commercially available β-Me is 14.3M (Sigma #M7154).  Therefore, to make 
50ml of strip solution, 350µl of stock β-Me was added to 50ml of the strip solution 
pre-mix.  After incubation, the strip solution was poured down the drain with lots 
of water.  The blot was washed twice with TBST for five minutes each at room 
temperature.  The blot was blocked with 5% non-fat dry milk dissolved in TBST 
for one hour at room temp or overnight at 4°C.  Blots were stripped no more than 
two times.  Stripping a blot more than twice removed too much protein from the 
blot to provide adequate detection by subsequent staining with additional 
antibodies. 
After blocking the membrane, it was incubated with either a polyclonal 
antibody against acetylation at lysine 9 of histone H3  [α-AcH3(K9), Upstate #07-
352] or polyclonal antibody recognizing acetylation at lysine 9 and 18 of histone 
H3 [α-AcH3(K9/K18), Upstate #07-593].  Both antibodies were used at a dilution 
of 1:1000 in TBST containing 5% milk for one hour then washed 3 times, five 
minutes each with TBST.  The secondary antibody, goat derived anti-rabbit 
conjugated to HRP (horseradish peroxidase; Amersham #NA934) was incubated 
with membrane at 1:2500 dilution in 5% Milk-TBST for one hour, washed 3 times, 
five minutes each with TBST.  The blot was treated with 1.5ml of Amersham’s 
ECL™ detection reagent (#RPN2209).  Excess reagent was removed by gently 
shaking the blot over paper towels.  The blot was then wrapped in cellophane 
and taped down in a metal film tray.  In a photography dark room, the blot was 
exposed to a High Sensitive Blue photographic film (RPS Imaging #33-0810).  
Following exposure, the film was removed and run through an automated 
developer.  SeeBlue® Plus2 Protein Standard (Invitrogen #LC5925) transferred 
to the membrane were used to estimate protein molecular weight after gel 
electrophoresis. 
 
H. FLAG co-immunoprecipitations on FLAGTgGCN5 and FLAGΔNTTgGCN5 
transgenic parasites 
Figure 10 shows the general scheme used by Dr. Mohamed-Ali Hakimi’s 
laboratory at the French National Centre for Scientific Research in Grenoble,  
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Figure 10: Purification scheme of proteins interacting with FLAGTgGCN5 or 
FLAGΔNTTgGCN5. 
Scheme was developed by Dr. Mohamed-Ali Hakimi’s laboratory at the 
French National Centre for Scientific Research in Grenoble, France.  Nuclear cell 
extract (NCE) or whole cell extract (WCE) from filter-purified transgenic 
tachyzoites expressing FLAGTgGCN5 or FLAGΔNTTgGCN5 was fractionated by 
chromatography as outlined above.  The 0.35M potassium chloride (KCl) elution 
of DEAE-Sephacel column was purified using an anti-FLAG M2 affinity resin.  
The bound proteins were further separated by fractionation on a Superose 6 gel 
filtration column.  The horizontal lines indicate stepwise elution.  Concentrations 
are given in molars (M).  P11 = Whatman phosphocellulose; FT = flow through; 
TCA = trichloroacetic acid; LC-MS/MS = nanocapillary liquid chromatography 
coupled with tandem mass spectrometry  
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France for purifying protein complexes (Saksouk et al., 2005).  The same method 
was employed to identify proteins that may be interacting with full length FLAG 
tagged TgGCN5 (FLAGTgGCN5) and/or TgGCN5 lacking the N-terminal extension 
(FLAGΔNTTgGCN5) stably expressed in Toxoplasma.  Co-immunoprecipitations 
were performed using nuclear cell extract (NCE) from parasites expressing 
FLAGTgGCN5 and using whole cell (WCE) from parasites expressing 
FLAGΔNTTgGCN5. 
The appropriate lysate from freshly harvested and filtered transgenic 
extracellular tachyzoites was loaded onto a 250ml column of phosphocellulose 
(P11, Whatman) and fractionated stepwise by the indicated potassium chloride 
(KCl) concentrations (Figure 10) in buffer A [20mM Tris.HCl (pH 7.9), 0.2mM 
EDTA, 10mM β-Me, 10% glycerol, 0.2mM PMSF (phenylmethanesulfonyl 
fluoride)].  The P11 0.5M KCl fraction was loaded on a 45ml DEAE-Sephacel 
column (diethylaminoethyl; Pharmacia) and eluted with 0.35M KCl.  The 0.35M 
KCl elution was incubated with 1ml of anti-FLAG M2 affinity gel (Sigma #A2220) 
for two hours at 4°C.  Beads were washed with 50ml of BC500 buffer (20mM Tris 
(pH 8.0), 0.5M KCl, 10% glycerol, 1mM EDTA, 1mM DTT, 0.1% NP40, 0.5mM 
PMSF, and 1μg/ml aprotinin, 1μg/ml leupeptide, and 1μg/ml pepstatin).  Beads 
were subsequently washed once with 10ml BC100 buffer (20mM Tris (pH 8.0), 
0.1M KCl, 10% glycerol, 1mM EDTA, 1mM DTT, 0.1% NP40, and 1μg/ml 
aprotinin, 1μg/ml leupeptide, and 1μg/ml pepstatin).  Protein bound to the anti-
FLAG M2 affinity gel proteins were eluted stepwise with 350μg/ml of 3X FLAG 
peptide (Sigma #F4799) diluted in BC100 buffer.  Elutions enriched in 
FLAGTgGCN5 or FLAGΔNTTgGCN5 were fractionated on a Superose 6 HR 10/30 
(Pharmacia) and equilibrated in 0.5M KCl in buffer A containing 0.1% NP-40, 
1μg/ml aprotinin, 1μg/ml leupeptin, and 1μg/ml pepstatin.  Proteins were TCA 
precipitated and resolved using SDS-PAGE and stained with SimplyBlue™ 
(Invitrogen #LC6060). 
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I. Mass spectrometry peptide sequencing 
Dr. Mohamed-Ali Hakimi’s laboratory at the French National Centre for 
Scientific Research in Grenoble, France excised protein bands from 
SimplyBlue™ (Invitrogen #LC6060) stained gels.  The exised gel pieces were 
treated with 7% H2O2 and subjected to in-gel tryptic digestion as described in the 
literature (Ferro et al., 2003).  Extracted proteins were analyzed by nanocapillary 
liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS).  
Tandem mass spectra were searched against a compiled Toxoplasma database 
with their in-house software, Mascot (Matrix Sciences, London). 
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CHAPTER 3: RESULTS 
 
I. Elucidating How TgGCN5 is Targeted to the Parasite Nucleus 
This section reports the mapping of the first NLS to be identified and 
validated for any apicomplexan protein and in the process defined a function of 
the long N-terminal extension of TgGCN5.  Furthermore, the NLS elucidated in 
TgGCN5 is the first completely mapped NLS to be defined for any GCN5 protein.  
The mechanism involved in targeting GCN5 proteins to the nucleus is poorly 
understood.  Understanding how TgGCN5 is targeted to the nucleus may be 
applicable to other GCN5 proteins. 
In addition, we searched the Toxoplasma and related apicomplexan 
databases for proteins containing similar NLS motifs.  The goal of the search was 
two-fold.  If results of the search found other known or predicted nuclear proteins 
that contained a similar NLS-like sequence it would provide further evidence that 
this is a true NLS.  Secondly, the NLS may assist in the annotation of predicted 
proteins in apicomplexan databases with no homology or known function as well 
as the continued characterization of known proteins. 
 
A. Mapping the NLS of TgGCN5 
Figure 11 is the result of immunocytochemistry on transgenic parasites 
expressing the full length TgGCN5 and TgGCN5 lacking the N-terminal extension 
(residues 1-697; ΔNTTgGCN5) both fused to a FLAG tag.  To determine the 
localization of the recombinant proteins, immunocytochemistry was performed 
using a polyclonal antibody against the FLAG tag (Sigma #F-7425) followed by 
an anti-rabbit antibody conjugated to the fluorochrome Alexa-488 (Molecular 
Probes #A-11034).  As a reference, parasite nuclei were visualized with the 
fluorescent nuclear stain, 4’,6’-diamino-2-phenylindole (DAPI; Molecular Probes 
#D-1306).  Recombinant protein that co-localizes with the DAPI stain is in the 
parasite nucleus.  As shown in Figure 11, full length TgGCN5 co-localizes with 
the DAPI stain, indicating it is targeted to the nucleus.  ΔNTTgGCN5 does not co-
localize  
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Figure 11: The N-terminal extension of TgGCN5 is required for nuclear 
localization 
Recombinant protein in transgenic parasites expressing either full-length 
FTgGCN5 or TgGCN5 lacking the N-terminal extension (FΔNTTgGCN5) was 
detected by immunofluorescence assay using anti-FLAG antibodies followed by 
staining with anti-rabbit Alexa 488 (green).  4’,6’-Diamino-2-phenylindole (DAPI) 
was used as a nuclear co-stain (red).  Images were obtained at 1000X 
magnification using a Leica DMLB scope with a 100X HCX Plan Apo oil 
immersion objective.  Images were captured using a monochrome SPOT-RTSE 
(Model 12) Camera and Spot Diagnostic Software 4.0.9 and pseudocolored 
using Adobe Photoshop 7.0.  hN = host cell nucleus =  TgN, parasite nucleus, F 
= FLAG 
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with DAPI and is restricted to the parasite cytoplasm.  These results confirm the 
extension’s involvement in nuclear localization as indicated in previous studies. 
The 697 amino acid sequence for the N-terminal extension of TgGCN5 
known to be involved in nuclear localization is shown in Figure 12.  Motif 
searches of the N-terminal extension suggested an NLS between residues 488 
and 504 (Sullivan and Smith, 2000).  However, removal of this 18-amino acid 
motif from full-length TgGCN5 fused to a C-terminal green fluorescent protein tag 
did not subvert nuclear localization (Sullivan and Striepen, unpublished 
observations).  As shown in Figure 12, the N-terminal extension contains several 
clusters of basic residues that may be functioning as an NLS.  Previous studies 
performed in our laboratory have narrowed the location of the NLS to be between 
amino acids 58 and 260.  Within this region, there is only one stretch of basic 
residues, the sequence RKRVKR.  The RKRVKR sequence fits one of the nine 
groups of NLS hexapeptide motifs devised by Boulikas, θθθxθθ where θ equals a 
basic residue (arginine or lysine) and x represents a non-basic residue (Boulikas, 
1994).  However, the NLS motif, θθθxθθ, was found to be a rare motif not 
commonly used by nuclear proteins identified in yeast or multicellular organisms 
(Boulikas, 1994). 
In order to determine if the RKRVKR sequence contributed to the nuclear 
localization of TgGCN5, two truncated mutants of TgGCN5 were expressed in 
tachyzoites.  An N-terminal FLAG tag was fused to both recombinant proteins.  
The first truncation was at residue 99, just downstream of the RKRVKR 
sequence (FLAGΔ99TgGCN5).  The second truncation removed the first 93 
residues which includes all amino acids upstream of the RKRVKR sequence 
(FLAGΔ93TgGCN5).  If RKRVKR is the NLS of TgGCN5, FLAGΔ93TgGCN5 should 
localize to the nucleus and FLAGΔ99TgGCN5 should not.  To determine the 
localization of the truncated mutants, immunocytochemistry was performed using 
the same antibodies as in Figure 11 (page 91).  As shown in Figure 13, 
FLAGΔ93TgGCN5 co-localizes with the DAPI stain, indicating it is in the nucleus, 
but FLAGΔ99TgGCN5 does not co-localize with DAPI and cannot enter the 
parasite nucleus. 
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METVEVPAFLEAANSAEAPRPASPARELDVQLTVPCPRDGADAGEAVGTRKRSRGPADRAEEASG 65 
RTHSAAEEPRAKEGGLSPASRDGDSGQSRKRVKREWASGGRLEQRGPLGVAAHAVEWRRASAEAR 130 
GDARQTPDAARGSSSRVDRFAGEDGVLDEGDLFSPSPFWPFFSACDPVALAPAPTVCPDTPSVSV 195 
VSACSRLLRAPPRDLASEATLDSLAGNVHVEESLWRGCESPNILEILRDILVVFAKDPSTQLSKM 260 
FHTASLLAPYQAASCHAASDAERDKKGDEADSARRRDHHEKERNHGGGPLAVGESADSEGRHPGA 325 
TEHAAGEAAGEAADGVRTADGDACQERRAEGAGAANGVAPLGMPEPAHAVGDRERENGSLEVKKA 390 
EREDAERLENGGGGQTAGEDRDDVNDDPPDTEREPGPQQAGRRCLEANGVRGVKQEQENAGTDEE 455 
RVLYLQLKEVVLSVAAALEIQQLEPPRKRKDPKKKPHSSSASSACRRGRGNAVSSSVSCFSASAN 520 
CTSEDGERSGGDAAGARANGEIKAASDETYSDRRVPGGLHEESEKNEAAREKTREESGQTRTPAS 585 
ESGSNAFVGFAQQSESRANSGVSSRPAEERGNEETFPDKEEEGAPAQREKHVAWAETTGAETARN 650 
SDESEARRDPRLETCPLCDCQEDDAAWTRHGILPYDILYEKWKAFLM 697 
 
Figure 12: Putative NLSs in the N-terminal extension of TgGCN5 
The 697 amino acids comprising the N-terminal extension of TgGCN5 required 
for nuclear localization.  Consecutive stretches of three or more basic residues 
are highlighted in gray.  Previous work performed in the laboratory narrowed the 
region involved in mediating nuclear localization to be between residues 58 and 
260 (denoted by the underlined sequence).  The box outlines the NLS predicted 
by motif search analysis reported by Smith and Sullivan in 2000, which was later 
demonstrated to be uninvolved in nuclear localization (Sullivan and Striepen, 
unpublished observations). 
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Figure 13: The hexapeptide RKRVKR (amino acids 94-99) is necessary for 
nuclear localization of TgGCN5 
Parasites were transfected with FLAG-tagged forms of TgGCN5 lacking the first 
93 (FΔ93TgGCN5) or 99 (FΔ99TgGCN5) amino acid residues.  
Immunofluorescence assay was carried out as described in the legend to Figure 
11 (page 91).  F = FLAG 
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These results demonstrate that the hexapeptide RKRVKR is required for 
the nuclear localization of TgGCN5.  To verify whether the hexapeptide is a 
complete and sufficient NLS, RKRVKR was fused to a large cytoplasmic protein.  
The confirmation studies of the NLS from the SV40 large T antigen were 
performed fusing the basic NLS pentapeptide to beta-galactosidase, a large 
cytoplasmic protein (Kalderon et al., 1984b).  Therefore, the TgGCN5 NLS was 
fused to the N-terminus of E. coli beta-galactosidase (βgal) and expressed in 
Toxoplasma.  As shown in Figure 14, when βgal is expressed in parasites 
(βgalFLAG), it does not co-localize with DAPI.  However, when βgal is fused to the 
RKRVKR sequence (NLS-βgalFLAG), it co-localizes with DAPI indicating it can 
now access the parasite nucleus.  Interestingly, NLS-βgalFLAG is not found only in 
the nucleus, but in both the nucleus and the cytoplasm. 
There are several explanations for why NLS-βgalFLAG is present in both 
the nucleus and cytoplasm.  Beta-galactosidase might be interacting with oth
proteins in Toxoplasma.  During these interactions, the NLS may not be properly 
exposed for binding by nuclear trafficking proteins, but when β-galactosidase is 
not involved in any interactions it is transported into the nucleus.  Another 
explanation may be that beta-galactosidase contains a nuclear export signal and 
the NLS fusion protein is being shuttled back and forth between the nucleus and 
the cytoplasm.  A different possibility may be due to the high overexpression of 
NLS-βgal
er 
FLAG which is driven by the Toxoplasma beta-tubulin promoter, an 
extremely potent promoter (Striepen et al., 1998).  Overexpression of NLS-
βgalFLAG may be saturating the nuclear trafficking pathways causing the protein 
to accumulate in the cytoplasm.  However, saturation of nuclear trafficking 
pathways by a heterologous protein would mean that endogenous nuclear 
proteins would be unable to be effectively transported into the parasite nucleus.  
In other eukaryotic cell, a global disruption in nuclear trafficking is usually 
detrimental to cell survival (Zaidi et al., 2004).  There did not appear to be a 
gross defect in the growth of parasites expressing NLS-βgalFLAG indicating no 
such global defects in nuclear localization were occurring.  Nonetheless, forcing  
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Figure 14: The TgGCN5 NLS is sufficient to translocate a heterologous 
cytoplasmic protein to the parasite nucleus 
Parasites transfected with E. coli βgal fused to FLAG with or without the TgGCN5 
NLS (βgalF and NLS-βgalF, respectively) were examined by immunofluorescence 
assay as described in the legend to Figure 11 (page 91).  F = FLAG 
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the nuclear localization of a highly expressed heterologous protein could create 
perturbations in parasite nuclear trafficking resulting in the homogenous staining 
seen in Figure 14.  Regardless of the explanation, there is clearly a difference in 
the nuclear localization between βgalFLAG and NLS-βgalFLAG; βgalFLAG is 
restricted from the parasite nucleus while NLS-βgalFLAG is capable of being 
targeted to the parasite nucleus. 
It should be noted that the FLAG epitope tag in the βgal constructs was 
moved to the C-terminal end of the protein.  The FLAG epitope tag was moved 
for two reasons.  In the truncated mutant FLAGΔ93TgGCN5, the FLAG tag was 
placed directly upstream of the RKRVKR sequence.  The FLAG tag sequence, 
DYKDDDDK, (D = aspartate, Y = tyrosine, K = lysine) contains several basic and 
acidic resides that might generate artifactual localization.  Therefore, in the NLS-
βgal constructs, the FLAG tag was moved to the opposite end of the protein to 
show that the FLAG tag is not causing artifactual localization.  Secondly, placing 
the FLAG tag and the NLS sequence at opposite ends prevents the 
misinterpretation of localization data due to the cleavage of the NLS-βgal fusion 
protein.  It is possible that protein degradation of NLS-βgal in Toxoplasma could 
result in the cleaving off of the RKRVKR sequence.  If the FLAG tag was present 
on the N-terminus upstream of the NLS, the small cleaved product could freely 
diffuse into the nucleus.  As mentioned in the Chapter 1 Section IV, small 
globular proteins less than 40kD can freely diffuse into the nucleus (page 43).  
The antibodies utilized in immunocytochemistry would bind to the FLAG tag 
present in the cleavage products located in the parasite nucleus, and it would 
erroneously appear as if the NLS-βgal fusion protein was nuclear.  With the 
FLAG tag and NLS motifs on opposite ends, it insures that the difference in 
localization patterns between βgalFLAG and NLS-βgalFLAG is being generated by 
intact protein, not cleavage by-products. 
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B. Searches of apicomplexan databases for proteins containing the TgGCN5 
NLS 
To facilitate apicomplexan research, online genomic databases have been 
established for Toxoplasma (ToxoDB, http://toxodb.org; Kissinger et al., 2003), 
Plasmodium spp. (PlasmoDB, http://plasmodb.org/; Bahl et al., 2003), and 
Cryptosporidium parvum (CryptoDB, http://cryptodb.org; Puiu et al., 2004).  
These databases contain the results of extensive genomic sequencing efforts in 
these parasites and searchable EST libraries.  Each database also contains 
information about known genes and predicted and known proteins.  Predicted 
proteins are generated using gene prediction algorithms to generate proteins 
theorized to exist in the parasite.  These proteins are only theorized to exist in the 
parasite; they have not been confirmed in vivo. 
The NLS mapped in TgGCN5 is the first NLS to be elucidated for any 
apicomplexan protein.  As this is a new motif identified in apicomplexans, it would 
be important to search the databases looking for proteins that contain an 
identical motif.  Proteins that contain the sequence RKRVKR present in 
Toxoplasma and other apicomplexans should also contain other domains 
indicating a nuclear function.  Predicted nuclear parasite proteins containing the 
sequence RKRVKR would provide additional evidence that RKRVKR is indeed a 
nuclear localization signal. 
In additional to verifying RKRVKR as an NLS, searches of apicomplexan 
databases for identical or similar motifs may assist in the characterization of 
novel parasite-specific proteins.  Despite the active research into apicomplexans, 
the protein databases contain large numbers of proteins with no known function.  
Of the estimated 10,585 genes in Toxoplasma, 74% are considered to be unique 
parasite-specific proteins with no homology to known proteins and are devoid of 
any discernable protein motifs (Li et al., 2003).  In Plasmodium and Eimeria, it is 
estimated that over 50% of the genes present in both of these apicomplexan 
organisms have no clear predictable function (Li et al., 2003).  These proteins 
may be the most worthwhile to study as they might be involved in parasite-
specific functions such as virulence and differentiation.  As new functional motifs 
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are elucidated, the databases should be searched for other predicted proteins 
that contain similar domains.  Parasite-specific proteins without any recognizable 
function that contain the sequence RKRVKR would indicate a function within the 
parasite nucleus, thus aiding in the characterization of novel proteins. 
Unfortunately, searches of the ToxoDB using the TgGCN5 NLS against 
known and predicted proteins revealed no exact matches, save TgGCN5 itself.  
No known or predicted proteins present in the PlasmoDB or in CryptoDB 
possessed the motif RKRVKR, either. 
The fact that no proteins contain the exact same motif is not all together 
surprising.  The particular NLS motif θθθxθθ (“θ” representing arginine or lysine 
and the “x” representing any amino acid) is not a commonly utilized NLS motif by 
nuclear proteins (Boulikas, 1994).  Furthermore, searching for an exact match 
may not be appropriate.  Within any NLS motif arginine can be substituted for 
lysine and vice versa and the non-basic residue can be substituted for any amino 
acid (Boulikas, 1994; Hodel et al., 2001).  Therefore, our search parameters were 
expanded to include these permutations. 
When the motif RKRxKR was used (“x” defined as any amino acid), a total 
of 19 potential hits emerged from the Toxoplasma set of predicted proteins based 
on the TIGR Draft3 prediction algorithm.  Eight of the proteins had no homology 
to known proteins nor contained any known protein motifs.  Of the remaining 11, 
nine possessed domains or homology indicating a nuclear function and only two 
had domains or homology indicating a cytoplasmic function.  Thus, over 80% of 
the proteins containing the motif RKRxKR with additional motifs or homology 
appear to have a nuclear function providing further evidence that the motif 
RKRxKR is a nuclear localization signal.  The nine putative nuclear proteins are 
listed on Table II. 
As shown in Table II, 20.m03745 contains RKRKKR and possesses 
several RRM 1 (RNA recognition motif 1) domains indicating it may function as a 
nuclear RNA binding protein mostly likely involved in mRNA processing (Maris et 
al., 2005).  Protein 38.m01112 contains a region with homology to the catalytic  
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Table II: Predictive value of the TgGCN5 NLS in Apicomplexa 
 
Identifier Putative NLS Predicted Homology / Motifs 
Toxoplasma   
20.m03745 
38.m01112 
42.m03605 
44.m02721 
49.m03309 
50.m05631 
55.m05013 
80.m02168 
162.m00318 
RKRKKR 
RKRGKR 
RKRIKR 
RKRMKR 
RKRDKR 
RKRWKR 
RKRRKR 
RKRTKR 
RKRQKR 
RRM_1 repeats (RNA recognition) 
tRNA synthetase class II core domain 
auxin response element 
WD40 repeats 
MAD (mitotic checkpoint protein) 
thioredoxin 
peptidase_C50 
DNA polymerase X 
protein kinase 
Plasmodium   
PFC0425w 
PY07179 
PF10_0175 
PF10_0362 
RKRNKR 
KRKNKK 
RKKRKK 
KKKMKK 
PHD (zinc finger) 
histone deacetylase domain 
tRNA pseudouridylate synthase 
DNA polymerase B family 
Cryptosporidium   
CpEST_AA224688 
CpEST_AA253596 
RKRNKR 
KKKRRK 
histone H2B 
putative nucleolar protein 
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core domain of a tRNA synthetase.  While originally thought to be cytoplasmic, 
there is mounting evidence that tRNA synthetases are also present in the 
nucleus (Schimmel and Wang, 1999).  Interestingly, several studies have 
implicated an NLS composed of basic residues (arginine and lysine) in targeting 
tRNA synthetases to the nucleus (Mucha, 2002).  To date, none of the proposed 
NLS-like motifs present in other tRNA synthetases are exact matches to the motif 
in 38.m01112 (Mucha, 2002).  Nonetheless, the fact that the search yielded 
another protein that appears to enter the nucleus via a NLS composed of basic 
residues in other organisms provides further support that RKRxKR is an NLS 
motif.  The exact function of tRNA synthetases within the nucleus is still unknown 
(Mucha, 2002). 
Protein 42.m03605 not only contains an NLS like motif but also contains 
an auxin response factor (ARF) which modulates gene expression in response to 
the plant hormone auxin (Liscum and Reed, 2002).  No studies have been 
conducted to determine if Toxoplasma generates or responds to auxin.  The 
apicoplast present in the parasites is of plant ancestry and ARF proteins may be 
apart of its function. 
Proteins containing WD40 repeats like 44.m02721 form a large family of 
proteins found in all eukaryotes, and are named because the repeats usually end 
in a tryptophan-aspartic acid (W-D) dipeptide (Smith et al., 1999).  This family of 
nuclear proteins is implicated in a variety of functions including transcription 
regulation and cell cycle control (Smith et al., 1999). 
The MAD (mitotic arrest deficient) domain present in 49.m03309 suggests 
a function within the nucleus and the motif, RKRDKR may be its NLS.  Proteins 
with MAD domains function as mitotic checkpoint proteins in other eukaryotic 
organisms (Glotzer, 1996). 
The predicted protein 50.m05631 contains a thioredoxin domain.  Proteins 
possessing thioredoxin domains are important in protection against reactive 
oxygen species (Byrne and Welsh, 2005).  Although thioredoxin proteins are 
typically found in the cytoplasm, stress conditions have been shown to cause the 
proteins to translocate into the nucleus (Karimpour et al., 2002).  The mechanism 
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behind how these proteins are targeted to the nucleus is still unknown, but the 
motif KRDKR in 50.m05631 may be involved. 
Protein 55.m05013 contains a peptidase family C50 domain which is a 
type of cysteine peptidase of the separase family (Uhlmann, 2003).  The 
separases are caspase-like proteases present in the nucleus, and they play a 
central role in chromosome segregation (Uhlmann, 2003).  Interestingly, the NLS 
in protein 55m05013 is located within the peptidase motif (Figure 15).  Usually, 
NLSs are not found within other domains as demonstrated by other proteins in 
Figure 15.  However, an exception is DNA and RNA binding proteins in which 
there is often overlap between the binding domain and the NLS (LaCasse and 
Lefebvre, 1995).  Although the mechanism for nuclear localization in other 
peptidase C50 family members has not been deduced, it is plausible given their 
function that the NLS is imbedded within the peptidase domain as is with other 
DNA binding proteins.  However, the hexapeptide RKRRKR in 55m05013 may 
simply be a functional part of the peptidase domain and does not function as an 
NLS. 
The protein 80.m02168 is undoubtedly a DNA polymerase and contains 
the motif, RKRTKR, which may contribute to its nuclear compartmentalization.  
The protein kinase 162.m00318 contains an NLS-like motif suggesting that the 
target of its phosphorylation may be within the parasite nucleus. 
Figure 15 shows schematic representations of TgGCN5 and the nine 
Toxoplasma proteins listed in Table II.  The NLS has been depicted as a black 
vertical line and the domains indicating nuclear function are in gray boxes.  The 
image was generated to determine if there was a trend in the position of NLSs 
within Toxoplasma proteins.  Figure 15 demonstrates that the putative NLS-like 
domains can be found anywhere within a protein.  Six of the proteins have the 
NLS present in the first half of the protein with three of them being with in the first 
5% of the protein.  The other three proteins have the NLS in the C-terminal half 
with 2 of them located within the last 10% of the protein.  Thus, there does not 
seem to be a clear consensus on the location of this particular NLS.  These nine 
proteins are no doubt a very small fraction of all the nuclear proteins present in  
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Figure 15: TgGCN5 and nine putative Toxoplasma nuclear proteins 
Schematic diagrams of TgGCN5 and the nine putative nuclear proteins in 
Toxoplasma from Table II comparing the location of the NLS within each protein.  
Each protein is depicted by a horizontal black line.  As indicated in the top right 
corner, 1cm is equal to 300 amino acids.  The NLS-like motif (RKRxKR) is 
depicted as a single vertical black line.  Other motifs indicating nuclear function 
present in the proteins are represented as gray boxes.  The motifs within each 
protein are labeled according to their function.  As is seen in other eukaryotes, 
the NLS in these Toxoplasma proteins can be located anywhere within the 
protein.  aa = amino acid, HAT = histone acetylase, A2 = Ada2 domain, Br = 
bromodomain, RRM1 = RNA recognition motif 1 repeats, tRS = tRNA synthetase, 
ARF = auxin response factor, WD40 = tryptophan-aspartic acid domain repeats, 
MAD = mitotic arrest deficient domain, TR = thioredoxin domain, DPX = DNA 
polymerase X, PK = protein kinase 
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Toxoplasma.  As more NLSs are identified, a trend may emerge indicating that 
NLSs with Toxoplasma proteins tend to be located in one particular area within a 
protein.  It should be noted that in other organisms there does not appear to be a 
general trend in the position of an NLS within other nuclear proteins (Dingwall 
and Laskey, 1991). 
The Toxoplasma proteins listed in Table II (page 100) contain domains 
implicating function within the nucleus which supports the hypothesis that the 
TgGCN5 NLS has value in predicting the localization of proteins.  Therefore, the 
eight Toxoplasma proteins with unknown function containing RKRxKR motifs 
should be targeted to the parasite nucleus.  However, two of the 19 proteins from 
the database search contained ribosomal motifs in addition to an NLS-like motif.  
Despite the presence of an NLS-like motif, the ribosomal domains suggest a 
cytoplasmic function, which demonstrates the limitation of database searches.  
The presence of an NLS-like domain within a protein does not guarantee it is a 
nuclear protein.  The presence of an NLS-like domain must be taken into context 
with other domains present in the protein.  Ultimately, localization studies must 
be performed to confirm if any of these hits are truly nuclear proteins. 
Table II also displays results from similar searches of the Plasmodium 
database with permutations of the TgGCN5 NLS.  For example, searching the P. 
falciparum annotated protein data set with RKRxKR revealed 14 hits, including 
the predicted nuclear protein PFC0425w which contains three PHD fingers.  PHD 
fingers are zinc finger-like motifs present in nuclear proteins that are involved in 
transcriptional regulation (Aasland et al., 1995). 
Searches with the less stringent criteria allowing for the basic residues to 
be either lysine or arginine (R/K)(R/K)(R/K)X(R/K)(R/K) revealed 1500 hits in the 
annotated protein data sets from P. falciparum.  Cursory analysis of some of 
these candidate nuclear proteins revealed a putative histone deacetylase 
(PY07179; KRKNKK), a nuclear protein tRNA pseudouridine synthase (PF10 
0175; RKKRKK), and a putative DNA B family polymerase with a zeta catalytic 
subunit (PF10_0362; KKKMKK). 
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Searches of the Cryptosporidium expressed sequence tag database in 
CrytptoDB for instances of (R/K)(R/K)(R/K)X(R/K)(R/K) were also successful in 
identifying nuclear proteins; among the nine hits were histone H2B 
(CpEST_AA224688; RKRRKR) and a putative nucleolar protein 
(CpEST_AA253596; KKKLRK). 
The fact that a Toxoplasma NLS is able to identify nuclear proteins in 
other apicomplexans indicates that the Plasmodium and Cryptosporidium may 
also utilize a similar NLS to target nuclear proteins to the nucleus. 
 
II. Identifying Proteins Interacting with the N-terminus of TgGCN5 
Two groups of proteins proposed to be interacting with the N-terminus of 
TgGCN5 are those involved in nuclear trafficking and those forming HAT 
complexes analogous to the yeast SAGA and ADA complexes. 
The previous section presented data that the hexapeptide RKRVKR in the 
N-terminus of TgGCN5 is required for nuclear localization.  In other organisms, 
proteins containing NLSs composed of basic residues are transported into the 
nucleus through an interaction with the nuclear trafficking protein, importin α 
(Gorlich et al., 1994; Figure 7, page 47).  Therefore, it is likely that the NLS within 
the N-terminus of TgGCN5 interacts with importin α.  However, an importin α 
homologue in Toxoplasma has not been identified. 
 
A. Cloning and characterization of an importin α homologue in Toxoplasma 
The Toxoplasma database (Release 2.1; http://toxodb.org) was screened 
for sequences encoding possible importin α homologues using the BLAST 
algorithm and text queries.  The genomic database entry Tgg_994532 in Release 
3.0 (52.m00001 in version 4.0) exhibited a high degree of similarity to importin α 
proteins from other species.  Primers designed to the genomic sequence data 
were employed to obtain the full length cDNA for Toxoplasma importin α 
(TgIMPα, AY267540).  Based on the results of the cDNA sequence, we have 
deduced that the ~9.5-kb TgIMPα genomic locus is comprised of 11 exons and 
10 introns. 
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TgIMPα possesses an open reading frame of 1638 nucleotides with a 
consensus start ATG (Kozak, 1991) that is preceded 156 nucleotides upstream 
by an in frame stop codon.  The deduced 545 amino acid sequence has a 
calculated molecular mass of ~60kD and shows unequivocal similarity to importin 
α orthologues present in other eukaryotic organisms, especially the fellow 
apicomplexan parasite P. falciparum (Mohammed et al., 2003; Figure 16A).  
TgIMPα contains the well conserved importin β binding (IBB) domain and 
armadillo (ARM) repeats found in all other importin α proteins known to date 
(Herold et al., 1998; Figure 16A).  The autoinhibitory motif (KRR) observed in 
other importin α proteins is present in the importin β binding (IBB) domain, but 
the corresponding sequence in TgIMPα is more akin to the one in plants (KKR).  
The Toxoplasma IMPα also possesses a CAS (cellular apoptosis susceptibility) 
binding site within its C terminus required to recycle importin α back to the 
cytoplasm (Kobe, 1999). 
Phylogenic analysis of apicomplexan importin α proteins (Figure 16B) 
illustrates that they are more similar to those found in plants, a characteristic that 
has been noted in other apicomplexan proteins (Huang et al., 2004). 
 
B. Interaction of TgIMPα with TgGCN5 though the NLS 
Co-immunoprecipitation studies were performed to assess whether 
TgGCN5 physically interacts with TgIMPα and, furthermore, whether such an 
interaction occurred by virtue of the NLS, RKRVKR. 
Recombinant HA-tagged TgIMPα and full-length cMyc tagged TgGCN5 
were generated using a commercially available in vitro translation system 
(Promega; Chapter 2, Section IV-C, page 74).  The in vitro translation system 
incorporates radiolabeled methionine into the synthesized proteins.  The two 
proteins were purified from the translation reaction using commercially available 
anti-HA and anti-cMyc affinity resins (Clontech).  The immunoprecipitated 
proteins were resolved by SDS-PAGE gel and visualized by autoradiography.  
Figure 17 shows the purification of each protein generated by the in vitro 
translation system in detectable quantities and effectively purified from the  
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Figure 16: Toxoplasma importin α (TgIMPα) 
A – protein sequences of importin α proteins from various species were aligned 
using the AlignX module in Vector NTI Advance 9.0.  Tg, Toxoplasma 
(AY267540); Pf, P. falciparum (AAO85774); At, Arabidopsis thaliana (Q96321); 
Sc, Saccharomyces cerevisiae (Q02821); Hs, Homo sapiens (P52294).  Black 
inversed letters indicate identical residues in all species, gray inversed letters are 
functionally conserved residues, and gray highlighted letters are identical or 
functionally conserved residues in more than 50% of the species examined; ↓ 
denotes residues not conserved in Toxoplasma; * denotes conservation in 
apicomplexans only, and ¥ denotes elements conserved between apicomplexans 
and A. thaliana.  IBB, importin β binding domain; ARM, armadillo repeats 1–8.  
The boxed region within the importin β binding domain is the autoinhibitory 
sequence, and the boxed region within armadillo repeat 8 is the CAS binding 
domain involved in nuclear export.  B – phylogenic analysis obtain from the 
AlignX module in Vector NTI Advance 9.0 of importin α orthologues from 
representative species with the calculated distance values in parentheses (Bhatti 
and Sullivan, 2005). 
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Figure 17: Successful in vitro translation and purification of TgGCN5 and 
TgIMPα 
Autoradiography results from the purification of TgGCN5 (129kD) and TgIMPα 
(60kD) using both anti-cMyc (lane 1) and anti-HA (lane 2) affinity resins.  
TgGCN5 and TgIMPα were generated using in vitro translation (Promega 
#L4610) and gel was exposed to High Sensitive Blue photographic film (RPS 
Imaging #33-0810).  Molecular weights are displayed in kilodaltons (kD). 
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reaction without significant degradation.  As a negative control, Figure 17 shows 
that TgGCN5 cannot be isolated with anti-HA affinity resin and TgIMPα cannot be 
purified with anti-cMyc affinity resin.  This negative control was necessary to rule 
out potential cross reactivity between the recombinant tags and affinity resins.  
Therefore, if TgIMPα and TgGCN5 co-immunoprecipitate, it cannot be argued 
that it is due to non-specific interaction between the proteins and the affinity 
resin. 
Once protein production was verified, a small amount of the translation 
reaction containing TgIMPα was mixed with a small amount of the reaction 
containing TgGCN5.  The mixture was then split between the anti-HA and anti-
cMyc resin.  The anti-cMyc affinity resin will pull down TgGCN5 by virtue of its 
cMyc epitope tag.  If TgIMPα interacts with TgGCN5 then it will be pulled down 
with the TgGCN5 resulting in two bands when resolved via SDS-PAGE and 
visualized by autoradiography.  The reverse would happen with the anti-HA resin.  
TgIMPα would be immunoprecipitated by its HA-tag and if the two proteins 
interacted, TgGCN5 would be co-precipitated.  Again, two protein bands would 
be visualized by autoradiography.  However, if the two proteins do not interact, 
only single bands would be present corresponding to the immunoprecipitated 
protein by virtue of the recombinant tag (i.e. HA or cMyc). 
Figure 18 contains the results of TgGCN5 and TgIMPα co-
immunoprecipitation experiments using cMyc and HA affinity resins.  
Unfortunately, the co-immunoprecipitation efficiency was very low.  The band 
intensity in lane 1 is very strong for the protein containing the recombinant tag.  
There is a faint band in lane 1 in both co-immunoprecipitations corresponding to 
a potential co-precipitated protein.  However, it is not nearly intense enough to 
state these two proteins interact with one another.  Either something is interfering 
with the interaction or TgGCN5 and TgIMPα do not strongly interact with each 
other.  Lane 2 contains proteins not bound by the affinity resin and demonstrates 
that both proteins were produced in sufficient quantities in the in vitro translation 
system to allow for good purification.  Therefore, it cannot be argued that protein 
production was insufficient. 
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Figure 18: TgGCN5 and TgIMPα co-immunoprecipitations with cMyc and 
HA affinity resins 
The above figure is a representative of three replicate experiments.  TgGCN5 
(129kD) and TgIMPα (60kD) were expressed using in vitro translation and 
subsequently mixed together.  Co-immunoprecipitations were performed with 
anti-cMyc and anti-HA affinity resin.  Following resolution using SDS-PAGE, gel 
was exposed to High Sensitive Blue photographic film (RPS Imaging #33-0810).  
Lane 1 contains the proteins eluted off the affinity resin and lane 2 contains 
proteins from the in vitro translation reaction that did not bind to the affinity resin.  
Molecular weights are displayed in kilodaltons (kD). 
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The possibility that TgGCN5 and TgIMPα do not strongly interact was not 
initially surprising.  Biophsyical experiments have shown that the interaction 
between importin α and an NLS is extremely weak (Catimel et al., 2001).  The 
weak interaction is due to the importin β binding domain, which possesses an 
autoinhibitory function (Kobe, 1999).  When importin α is bound by importin β 
through the importin β binding domain, the autoinhibition is attenuated allowing 
importin α to strongly interact with an NLS (Goldfarb et al., 2004).  While this 
model is the general excepted method of NLS binding by importin α, there are 
exceptions.  In plants, it has been shown that importin α is capable of binding an 
NLS and transporting a protein to the nucleus without importin β (Hubner et al., 
1999).  Because apicomplexans have a propensity to possess plant like functions 
(Huang et al., 2004), it still seemed plausible that TgIMPα could bind to TgGCN5 
without requiring an importin β protein.  As noted in the previous section, 
phylogenic analysis of TgIMPα illustrated that it was more closely related to plant 
importin α proteins (Figure 16B, page 108).  Therefore, the possibility that 
something was interfering with the interaction or with the co-immunoprecipitation 
needed to be ruled out. 
The cMyc and HA epitope tags fused to TgGCN5 and TgIMPα that are 
utilized for co-immunoprecipitation are located at the N-terminus of both proteins.  
Thus, the epitiope tags are proximal to where the two proteins may be interacting 
and therefore masked during an interaction.  If the epitopes were masked during 
the interaction, it would prevent them from being purified by the affinity resin.  In 
order to determine if this was occurring, the epitope tags would have to be 
moved to the C-terminal end, or a different method of purification needed to be 
employed.  Others working in the Sullivan Lab had generated a polyclonal 
TgGCN5 antiserum against the C-terminus of TgGCN5 (Chapter 2, Section IV-B, 
page 71).  Since the TgGCN5 NLS lies within the N-terminal extension, a C-
terminal antibody should bind to an area of the protein not involved in a potential 
TgGCN5-TgIMPα interaction.  Therefore, it would be an excellent tool to 
determine if TgGCN5 and TgIMPα actually interact.  As shown in Figure 19, Lane 
1 shows the antiserum effectively purifies TgGCN5 from the in vitro translation  
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Figure 19: Immunoprecipitation with TgGCN5 antiserum 
An autoradiogram of immunoprecipitation reactions preformed with the TgGCN5 
antiserum.  Following resolution using SDS-PAGE, gel was exposed to High 
Sensitive Blue photographic film (RPS Imaging #33-0810).  Lane 1 is 
immunoprecipitation of full-length TgGCN5 and Lane 2 is of TgIMPα.  Lane 3 is 
the flow through or unbound proteins from the TgIMPα immunoprecipitation with 
the TgGCN5 antiserum.  Molecular masses are displayed in kilodaltons (kD). 
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reaction mixture but does not cross react with TgIMPα (Lane 2).  Lane 3 in Figure 
19 is a small sample of the unbound fraction from Lane 2 indicating that TgIMPα 
was synthesized by in vitro translation in sufficient quantities. 
After evaluating the TgGCN5 antiserum, TgGCN5 and TgIMPα proteins 
were generated and mixed together.  Co-immunoprecipitation was performed 
using the TgGCN5 antiserum.  The immunoprecipitated proteins were resolved 
by SDS-PAGE gel and visualized by autoradiography.  If TgGCN5 interacts with 
TgIMPα, the antiserum will pull down TgIMPα through its interaction with 
TgGCN5.  When resolved on a gel, two bands will be present, one from TgGCN5 
and the other corresponding to TgIMPα.  If the two proteins do not interact, then 
the antiserum will only pull down TgGCN5 resulting in a single band on the gel.  
Lane 1 in Figure 20-B is the result of mixing full-length TgGCN5 with TgIMPα.  
Two bands are present indicating the two proteins interact in vitro. 
Once it had been established that TgGCN5 and TgIMPα interacted with 
each other, a truncated version of TgGCN5 starting just downstream of the 
RKRVKR NLS (Δ99TgGCN5; Figure 20-A) was expressed in the in vitro 
translation system and mixed with TgIMPα.  Lane 2 in Figure 20-B shows only 
one band corresponding to the size of this truncated TgGCN5 (118kD).  The 
single band indicates that without the first 99 residues, TgGCN5 no longer 
interacts with TgIMPα.  The single band runs slightly lower than full-length 
TgGCN5 indicating a lower molecular weight congruent with it being the 
truncated form. 
To definitively show that the NLS is the interaction point between TgGCN5 
and TgIMPα, a deletion mutant was generated removing the RKRVKR 
hexapeptide (ΔNLSTgGCN5).  It was replaced with a restriction enzyme site to 
facilitate construction of the expression construct which encodes the two amino 
acids alanine and serine (Chapter 2, Section II-D page 67).  Thus, the 
hexapeptide RKRVKR was replaced with an alanine and serine dipeptide.  
Following in vitro translation, ΔNLSTgGCN5 was mixed with TgIMPα.  Lane 3 of 
Figure 20-B shows the results of co-immunoprecipitation with only one band  
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Figure 20: TgGCN5 interacts with TgIMPα via the NLS RKRVKR 
A – Schematic diagrams drawn to scale depicting the different co-
immunoprecipitations that were performed to demonstrate that TgGCN5 interacts 
with TgIMIPα via the NLS RKRVKR.  Each diagram corresponds to a lane in the 
gel below (C = cMyc epitope tag, NLS = nuclear localization signal, ADA2 = Ada2 
binding domain, br = bromodomain, H = HA epitope tag, IBB = importin β binding 
domain, ARM = armadillo superhelical repeats).  B – Autoradiogram of 
immunoprecipitation reactions using High Sensitive Blue photographic film (RPS 
Imaging #33-0810).  Lane 1, full-length TgGCN5 + HA-TgIMPα; lane 2, 
Δ99TgGCN5 + HA-TgIMPα; lane 3, ΔNLSTgGCN5 + HA-TgIMPα; lane 4, HA-
TgIMPα.  Lanes 1-3 were immunoprecipitated with TgGCN5 antiserum and lane 
4 was precipitated with anti-HA affinity resin.  The top arrow points to the forms of 
TgGCN5 used (~118 - 130kD), and the bottom arrow points to HA-TgIMPα 
(~60kD).  Molecular masses are displayed in kilodaltons (kD). 
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present, corresponding to the size of ΔNLSTgGCN5 (128kD).  The lack of 
TgIMPα in this lane confirms that TgIMPα interacts with TgGCN5 at the NLS 
elucidated in the previous section.  Lane 4 in Figure 20-B is an anti-HA 
immunoprecipitation of the TgIMPα translation reaction used in the co-
immunoprecipitations in the previous lanes.  The immunoprecipitation provides 
evidence of adequate TgIMPα protein production. 
 
C. Identification of proteins interacting with TgGCN5 to form HAT complexes 
It is plausible that the N-terminus of TgGCN5 also interacts with parasite 
proteins to form complexes analogous to yeast SAGA and ADA.  Given the 
divergent nature of the N-terminal extension of TgGCN5, it may also interact with 
novel, parasite-specific components.  Several methods were considered in trying 
to identify proteins interacting with the N-terminus of TgGCN5. 
Yeast two-hybrid could be employed using the N-terminus as a bait 
protein to screen a cDNA library.  However, yeast two-hybrid has several 
limitations.  First, yeast two-hybrid screens notoriously generate false positives.  
Second, not all Toxoplasma proteins are going to be expressed properly in yeast 
because of codon bias, improper folding, and post-translational modification.  
The expression of certain Toxoplasma proteins may also be lethal to yeast. 
Another option would be to co-immunoprecipitate protein complexes from 
wild-type parasite lysate.  Our lab has developed an antiserum directed at the C-
terminal end of TgGCN5 with the potential to immunoprecipitate TgGCN5 
containing complexes.  However, attempts to purify native HAT complexes using 
endogenously expressed protein in other organisms have been largely 
unsuccessful because HAT proteins are not expressed at high levels. 
One of the more promising methods for purifying complexes is to over-
express one of the complex members fused to an epitope tag.  The N-terminal 
extension portion of TgGCN5 could be over-expressed in the parasites fused to a 
FLAG tag.  Using affinity resin, anti-FLAG co-immunoprecipitations could be 
performed on parasite nuclear extract.  The proteins would be eluted from the 
affinity resin and resolved via SDS-PAGE.  Bands present in the gel would be 
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excised and sent for sequencing analysis.  Unfortunately, multiple attempts at 
trying to stably express just the N-terminal extension of TgGCN5 in Toxoplasma 
were unsuccessful.  It appears that expression of only the N-terminus of TgGCN5 
is deleterious to the parasite.  If the N-terminus interacts with proteins in the 
parasite, expression of the N-terminus could have acted as a dominant negative.  
The recombinant N-terminal extension may have sequestered proteins away 
from fully functional complexes causing a depletion of HAT complexes resulting 
in dysregulation of histone acetylation and parasite death.   
An alternate strategy was developed using the viable transgenic parasites 
expressing recombinant full length TgGCN5 and TgGCN5 lacking the N-terminal 
extension (ΔNTTgGCN5) fused to a FLAG tag.  As shown in a previous section, 
both of these proteins can be stably expressed in the parasites.  FLAG co-
immunoprecipitations could be performed on these two parasites lines.  Proteins 
that are present in purifications using full length TgGCN5 and absent in 
purifications with ΔNTTgGCN5 would be considered to be interacting with the N-
terminus of TgGCN5. 
To isolate TgGCN5 containing complexes from these two transgenic 
parasite lines, a collaboration was established with Dr. Mohamed-Ali Hakimi’s 
laboratory at the French National Centre for Scientific Research in Grenoble, 
France.  His laboratory has developed a successful method to purify histone 
deacetylase complex members from the parasites using anti-FLAG co-
immunoprecipitation.  However, Dr. Hakimi’s protocol requires enormous 
amounts of parasite lysate; approximately 100 T-150cm2 cell culture flasks.  The 
research facility at Grenoble has a large centralized tissue culture facility allowing 
for the growth and cultivation of large numbers of parasites.  In addition, 
laboratories at the research center have free access to a protein sequencing 
facility.  Therefore, the two transgenic parasite lines over-expressing 
FLAGTgGCN5 and FLAGΔNTTgGCN5 were sent to Hakimi’s laboratory for a 
preliminary attempt to co-immunoprecipitate interacting proteins.  Unfortunately, 
the protein sequencing facility in Grenoble does not release the results of its 
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protein sequencing data and thus we are unable to confirm or make our own 
interpretations of the protein sequencing data. 
Large quantities of both of our parasite lines were cultivated by Dr. 
Hakimi’s laboratory.  Co-immunoprecipitations with anti FLAG affinity resin was 
performed on parasite lysate from the transgenic parasites using the same 
protocol that had been successful in purifying members of histone deacetylation 
complexes (Saksouk et al., 2005; Chapter 2, Section IV-H, page 85).  Once the 
purification was complete, elutions containing TgGCN5 were pooled, TCA 
precipitated, and resolved by SDS-PAGE. 
Figure 21 contains two gels (A and B) loaded with two different sets of 
pooled elutions from the affinity purification of nuclear cell extract from parasites 
over-expressing full-length FLAGTgGCN5.  Gel A contains proteins present in the 
first few elutions off the purification column.  The gel does not contain significant 
amounts of TgGCN5, but has very intense bands of low molecular weight that 
correspond to the size of histone proteins.  The four bands labeled with arrows A, 
B, C, and D were excised and sent for sequencing analysis.  The results of the 
sequencing confirmed that they are histone proteins.  Band D is the core histone 
H4.  The remaining bands are not the typical core histones, but rather variant 
histones H3.3, H2A.1, and H2AF/Z.  No known histones variants exist for histone 
H4.  The existence of histone variants has been previously established in 
Toxoplasma (Sullivan et al., 2006).  As mentioned in the introduction, histone 
variants differ from core histones in several ways.  The main difference is that 
variant histones are associated with restructuring transcriptionally active 
chromatin (Kamakaka and Biggins, 2005).  Finding variant histones interacting 
with TgGCN5 agrees with the predicted role for TgGCN5 being involved in 
remodeling chromatin. 
Gel B in Figure 21 represents a second pool of fractions that contained 
large amounts of TgGCN5.  The numbered rectangles correspond to locations in 
the gel that were excised and sent for sequencying analysis by nanocapillary 
liquid chromatography coupled with tandem mass spectrometry.  The sequencing  
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Figure 21: Chromatographic purification and identification of proteins 
interacting with FLAGTgGCN5 
Gel A and Gel B contain different sets of pooled elutions resolved by SDS-
PAGE (4% - 12%) and visualized by colloidal blue staining.  Molecular weight 
markers in kilodaltons (kD) are indicated on the left.  In Gel A, the arrows point to 
four low molecular weight bands that were excised and sent for sequencing 
analysis.  The results of the sequencing are listed below the gel.  In Gel B, the 
white rectangles represent the location and size of the excised bands sent for 
sequencing.  Each rectangle has a number that corresponds to the sequencing 
results listed below in the gel.  Two numbers next to a rectangle indicates both 
proteins were identified in the same excised gel slice.  Data preseted in this 
figure was generated by Dr. Mohamed-Ali Hakimi’s laboratory at the French 
National Centre for Scientific Research in Grenoble, France. 
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data was used to determine the identity of the proteins present within the gel 
slice.  A total of 7 gel slices were sequenced.  The numbers refer to the protein 
identity listed below the gel.  In some of the gel slices, more than one protein was 
present.  In cases where sequencing analysis detected two proteins, two 
numbers were placed next to the rectangle to denote the identity of two distinct 
proteins. 
The band labeled “2” corresponds to the size of FLAGTgGCN5 (~130kD).  
Sequencing data for band 1 suggests that this is also FLAGTgGCN5, but it is 
running about 30kD too large.  It is likely that this is a post-translationally 
modified version of TgGCN5 causing it to migrate slower.  There is evidence that 
GCN5 can be phosphorylated (Barlev, 1998) and the related HAT PCAF can be 
transacetylated (Herrera, 1997).  These same modifications may occur to 
TgGCN5. 
The gel slice of the band observed at about 100kD yielded sequence data 
consistent with two different Ada2 proteins (proteins 3 and 4 in Figure 21).  It has 
been shown that humans and plants possess more than one homologue of Ada2 
(Stockinger et al., 2001; Barlev et al., 2003), but to date all unicellular organisms 
such as yeast only express one Ada2 protein.  Searches of ToxoDB have 
revealed the presence of two Ada2 proteins (TgAda2-A and TgAda2-B), which 
our lab has subsequently cloned (Bhatti et al., 2006).  Consistent with our 
preliminary data, protein 3 agrees with the predicted size for TgAda2-A (~102kD), 
but protein 4 is much smaller than the predicted size of 238kD for TgAda2-B.  It 
is possible that protein 4 is an alternative splice variant of TgAda2-B or a 
proteolytically processed form resulting in a smaller protein.  Alternatively, it 
could be a degradation product.  Splice variants are known to exist for Ada2 
proteins but their functional importance is still unknown (Kusch et al., 2003). 
Protein 9 possesses homology to heat shock protein 70 (hsp70), which 
has been shown to be involved in bradyzoite to tachyzoite conversion in 
Toxoplasma (Weiss et al., 1998; Silva et al., 1998).  The Hsp70 family contains a 
number of highly-related protein isoforms ranging in size from 66kD to 78kD 
(Tavaria et al., 1996).  Protein 9 is migrating too low to fit within this size range 
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and therefore is either a unique shorter hsp70 member or breakdown from a 
larger hsp70 member.  Nonetheless, the presence of hsp70 interacting with 
TgGCN5 is a strong possibility despite the lack of full intact protein.  
Transcriptional studies have shown that histone acetylation can significantly 
enhance both the basal and the inducible expression of hsp70 gene in 
Drosophila (Chen et al., 2002).  It is plausible that a TgGCN5 containing complex 
is involved in remodeling and regulating hsp70 expression.  A similar 
phenomenon may occur in Toxoplasma.  A TgGCN5 containing complex may be 
activated under stress conditions resulting in the upregulation of hsp70 
expression and ultimately leading to bradyzoite differentiation.  Following the 
increase in hsp70 expression, the hsp70 protein may interact with TgGCN5 
containing complexes to further direct their activity to other stress responsive 
promoters or it may act as a negative feed back, repressing the activity of the 
TgGCN5 containing complex once TgGCN5 differentiation is complete. 
Proteins 7 and 10 have homology to previously described heat shock 
proteins 90 and 60 in Toxoplasma (Weiss and Kim, 2000).  These two heat 
shock proteins have also been linked to bradyzoite differentiation (Echeverria et 
al, 2005; Toursel et al., 2000).  If this is a true interaction, it links TgGCN5 to 
stress-induced pathways and possibly bradyzoite differentiation.  It should be 
noted that heat shock proteins are among the most abundant proteins in 
eukaryotic cells (Schlesinger, 1990) and are often contaminants in co-
immunoprecipitations.  Co-immunoprecipitations with in vitro translated heat 
shock proteins and full length TgGCN5 can be utilized to verify if these 
interactions are real. 
Protein 8 was identified as a homologue of yeast cdc48 (cell division 
control) which is a member of the type II AAA proteins (ATPase associated with a 
variety of activities; Neuwald et al., 1999).  As the class name suggests, cdc48 
has been implicated in many cellular functions including cell cycle regulation, 
stress response, transcriptional regulation, and protein degradation.  All of these 
activities seem to revolve around its involvement in the ubiquitin-proteosome 
system (Hershko and Ciechanover, 1998).  A link between acetylation and 
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ubiquitination pathways was established when cdc48 was shown to interact with 
a histone deacetylase (HDAC) complex in mice (Seigneurin-berny et al., 2001).  
Additionally, the yeast deubiquitinating enzyme, Ubp8 is a component of SAGA 
and mediates the removal of ubiquitin from histone H2B (Daniel et al., 2004).  
The deubiquitination of H2B by SAGA coincides with its acetylation of histone H3 
at lysines 9 and 14 (Daniel et al., 2004).  Therefore, ubiquitination may direct the 
function of GCN5 containing complexes.  A similar process might exist in 
Toxoplasma between TgGCN5 containing complexes and ubiquitination.  Thus, 
cdc48 may be involved in ubiquitinating histones while a TgGCN5 containing 
complex is responsible for removing the ubiquitin modification and acetylating 
histones.  However, cdc48 is highly abundant in cells (great than 1% of total 
protein) making it a potential contaminant in co-immunoprecipitations (Wang et 
al., 2004).  Therefore, this potential interaction must be confirmed in additional 
experiments such as co-immunoprecipitation of purified recombinant proteins.   
The two remaining proteins, 5 and 6, do not have homology to any known 
proteins nor do they possess any recognizable motifs.  These two proteins may 
be parasite-specific components of a TgGCN5 acetylase complex.  However, 
these two proteins are migrating between 100 to 150kD, which is much higher 
than their predicted molecular weights according to the Toxoplasma database 
(ToxoDB; ~61kD for protein 5 and ~71kD for protein 6).  Another band 
corresponding to protein 5 migrated to approximately 55kD which is close to its 
predicted molecular weight.  The larger version of proteins 5 and 6 may be 
alternative splice variants.  Further characterization of the ORF (open reading 
frame) encoding these two proteins is needed to clarify the discrepancy in sizes 
of these parasite proteins. 
 
D. Identification of proteins interacting with ΔNTTgGCN5 to form HAT complexes 
Similar purifications of whole cell lysate from parasites over-expressing 
FLAGΔNTTgGCN5 were analyzed (Figure 22).  Despite using the same purification 
protocol, the final elutions following purification of FLAGΔNTTgGCN5 whole cell 
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Figure 22: Chromatographic purification of proteins that may interact with 
FLAGΔNTTgGCN5 
Elutions were pooled, TCA precipitated, resolved by SDS-PAGE (4% - 12%), and 
visualized by colloidal blue staining.  Molecular weight markers in kilodaltons (kD) 
are indicated on the left.  Gel slices were made corresponding to the location of 
the numbers on the gel and were sent for protein sequencing.  Proteins identified 
by mass spectrometry sequencing are indicated on the right.  Data presented in 
this image was generated by Dr. Mohamed-Ali Hakimi’s laboratory at the French 
National Centre for Scientific Research in Grenoble, France. 
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extract were not as pure as the elutions following purification of full length 
TgGCN5 nuclear cell extract.  The three most intense bands were excised from 
the gel and sent for sequencing.  All three bands appear to contain 
FLAGΔNTTgGCN5.  The estimated size of FLAGΔNTTgGCN5 is 54kD, which 
corresponds to the size of band 3.  The slower migrating TgGCN5 found in bands 
1 and 2 may be posttranslationally modified. 
Also found in large abundance in the first gel slice is an unknown 
predicted protein (TgGlmHMM_3281) containing a leucine zipper domain.  
Leucine zipper domains are commonly found in gene regulatory proteins 
(Robinson and Lopes, 2000).  However, it is running smaller than the 140 
kilodaltons predicted in the ToxoDB.  The protein present as this size may be 
degradation product or it could be a protein prediction error. 
Heat shock protein 70 is also present in band one.  As mentioned earlier, 
this protein is associated with stress pathways potentially linking TgGCN5 to 
bradyzoite conversion.  All three predicted hsp70 proteins appear to be different 
and are not overlapping entries.  Thus, the possibility exists for multiple hsp70 
proteins in Toxoplasma.  TgGlmHMM_2161 is predicted to be approximately 
133kD, but this may be an error in the prediction algorithm used by the 
Toxoplasma database. 
The third gel slice contains several bands in addition to TgGCN5.  
However, the only protein migrating at its predicted size is TgGlmHMM_1548, an 
hsp60 homologue.  The same homologue was found in the co-
immunoprecipitation with full length TgGCN5.  TgGlmHMMM_1999 is a protein of 
unknown function and possesses no known motifs but is predicted to be 43kD.  It 
is possible that this protein is a parasite-specific component of an acetylase 
complex.  Predicted heat shock protein 70 and catalase are present but both of 
these proteins are running smaller than predicted size (72kD for hsp70 and 88kD 
for catalase), indicating these may be breakdown products or potential splice 
variants.  The hsp70 protein overlaps with the TgTwinScan_7546 entry found in 
band one and therefore maybe a splice variant from the same genomic loci.  
Splice variants for heat shock proteins are known to exist in mammals, but their 
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function in stress remediation is still unknown (Yamada et al., 1999).  To date, 
the possibility of splice variants of the heat shock proteins 60, 70 and 90 that are 
involved in bradyzoite conversion has not been addressed in Toxoplasma. 
Catalase is an enzyme involved in oxidative stress remediation 
responsible for catalyzing the conversion of hydrogen peroxide into water and 
oxygen (Chelikani et al., 2004).  A homologue has been characterized in 
Toxoplasma and it appears to serve a protective function against macrophage 
reactive oxygen specie formation (Murray and Cohn, 1979; Murray et al., 1980) 
and maybe involved in parasite virulence (Ding et al., 2004).  A potential 
interaction between GCN5 and catalase provides another link between HATs and 
stress remediation in the parasite.  However, catalyse is an abundant 
cytoplasmic protein in Toxoplasma (Ding et al., 2004) and therefore it could be a 
contaminant in the purification of FLAGΔNTTgGCN5. 
 
III. Characterization of the enzymatic activity of TgGCN5 
All GCN5 homologues and the closely related HAT PCAF preferentially 
acetylate histone H3 at lysine 14.  To a lesser degree, GCN5 and PCAF can also 
acetylate lysines 9 and 18 on histone H3 in vitro (Grant, 2001).  Given the high 
homology of the catalytic domain of TgGCN5 to other GCN5 proteins (Sullivan 
and Smith, 2000), it was expected to also preferentially acetylate histone H3 at 
lysine 14.  Therefore, recombinant TgGCN5 was obtained and in vitro HAT 
assays were performed to determine its acetylation pattern on core histones. 
The N-terminal extension in mammalian GCN5 proteins is not required for 
the acetylation of free histones (Xu et al., 1998).  As the N-terminal extension of 
TgGCN5 is divergent from mammalian homologues, it is important to investigate 
this function for the N-terminal extension in TgGCN5.  If the N-terminus of 
TgGCN5 is required for the acetylation of free histones, it would provide evidence 
that the N-terminus has a parasite-specific function not present in its mammalian 
counterparts. 
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A. Development of a positive control for in vitro HAT assays 
Before the enzymatic activity of TgGCN5 could be assessed, a positive 
control needed to be created for the in vitro HAT assay.  The catalytic activity of 
the Saccharomyces cerevisiae GCN5 homologue (ScGCN5) has been rigorously 
studied and well characterized using published in vitro assays (Sternglanz and 
Schindelin, 1999).  Therefore it seemed excellently suited to be used as a 
positive control for our purposes.  Recombinant protein is commercially available 
but it is extremely expensive.  Thus, it was decided to generate our own 
recombinant yeast GCN5 protein using a bacterial cell line. 
As outlined in Chapter 2 (Section IV-D, page 75), ScGCN5 was expressed 
using a BL21-CodonPlus® E. coli strain (Stratagene) in frame with an N-terminal 
6X histidine fusion tag to allow for purification using nickel-NTA resin.  The 
CodonPlus bacterial strains have been designed to solve the problem of codon 
bias which can limit efficient expression of heterologous proteins in bacteria. 
Codon bias refers to the observation that there is a bias in the genome of 
an organism for one or two codons for almost all degenerate codon families 
(Makrides, 1996).  The codon bias is different between organisms, reflected in 
the abundance of their cognate tRNAs.  Therefore, heterologous genes enriched 
with codons that are rarely used by E. coli may not be efficiently expressed 
(Gustafsson et al., 2004).  Forced high-level expression of heterologous proteins 
can deplete the pool of rare tRNAs and stall translation.  BL21-CodonPlus® 
strains are engineered to contain extra copies of genes that encode the tRNAs 
that most frequently limit translation of heterologous proteins in E. coli 
(Stratagene, 2002).  Increased availability of these rare tRNAs allows for high-
level expression of recombinant genes in BL21-CodonPlus® cells that are poorly 
expressed in conventional BL21 strains (Stratagene, 2002). 
There are two different BL21-CodonPlus® stains, RIL and RP.  
CodonPlus-RIL® cells contain extra copies of the argU, ileY, and lueW tRNA 
genes (Stratagene, 2002).  These genes encode tRNAs that recognize the 
arginine codons AGA and AGG, the isoleucine codon AUA, and the leucine 
codon CUA, respectively.  The CodonPlus-RIL® strains express extra tRNAs that 
129 
most frequently restrict translation of heterologous proteins from genes that are 
AT-rich (Stratagene, 2002).  BL21-CodonPlus-RP® cells contain extra copies of 
the argU and proL genes (Stratagene, 2002).  These genes encode tRNAs that 
recognize the arginine codons AGA and AGG and the proline codon CCC, 
respectively.  The BL21-CodonPlus-RP® strains are enriched with tRNAs that 
most frequently restrict translation of heterologous proteins of organisms that 
have GC-rich genomes (Stratagene, 2002).  For the expression of yeast GCN5, 
the BL21-CodonPlus-RIL® strain was used because the yeast GCN5 gene has 
an AT ratio of 62% suggesting that the BL21-CodonPlus-RIL® strain would be 
best suited for optimal protein expression. 
The CodonPlus® strains have been engineered using the lac operon for 
IPTG (isopropyl β-D-1-thiogalactopyranoside) induced protein expression.  
Protein induction was carried out as outlined in Chapter 2 (Section IV-D, page 
75).  Figure 23-A shows SDS-PAGE analysis of a small scale pilot induction of a 
BL21-CodonPlus-RIL bacterial clone expressing ScGCN5.  The first two lanes 
are from the uninduced (UN) bacteria to serve as a negative control.  The first 
lane contains the soluble (S) fraction and the second lane contains the pellet (P) 
or insoluble fraction from the bacterial cells just prior to protein induction.  The 
last two lanes are after three hours of protein induction (IN) at 37°C.  Again, the 
first lane contains the soluble (S) fraction and the second lane is the pellet (P) or 
insoluble fraction.  When compared to the uninduced sample, there is a band at 
approximately 55 kilodaltons in the induced sample that is ScGCN5.  The 
calculated size of ScGCN5 is 48kD, but ScGCN5 has been shown to migrate 
slightly higher than its calculated size during SDS-PAGE analysis (Candau et al., 
1997). 
The induced protein appears to be in sufficient quantities in the soluble 
fraction to be processed for purification.  Recombinant protein within the soluble 
fraction is desirable because it is more likely to possess enzymatic function 
(Makrides, 1996).  Protein in the pellet or insoluble fraction is contained within 
inclusion bodies and is less likely to be enzymatically active due to improper 
folding (Makrides, 1996). 
130 
  
131 
 
 
 
 
 
 
 
 
Figure 23: Protein induction and purification of ScGCN5 
A – SDS-PAGE of a pilot induction of ScGCN5 in BL21-CodonPlus-RIL stained 
with Simply Blue (Invitrogen) colloidal stain.  The first two lanes are from 
uninduced (UN) bacteria cells just prior to protein induction.  The last two lanes 
are after three hours of protein induction (IN) at 37°C.  (S = soluble fraction; P = 
pellet or insoluble fraction).  The band present at 55kD presumed to be ScGCN5 
is denoted by an arrow.  B – SDS-PAGE of washes and subsequent elutions 
from the purification of a large scale induction of ScGCN5 stained with Simply 
Blue.  Following incubation with bacterial lysate, the nickel-NTA resin was 
washed twice (W1 and W2) with 20mM imidazole.  Recombinant protein was 
eluted from the resin using increasing concentrations of imidazole: E1 and E2 = 
100mM imidazole, E3 and E4 = 200mM imidazole, and E5, E6, and E7 = 
300mM. 
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Once expression of soluble protein had been confirmed, a large scale 
induction was performed and the ScGCN5 protein was purified by virtue of the 
6X histidine tag using nickel-NTA resin (Qiagen) as outlined in Chapter 2 
(Section IV-D, page 75).  Figure 23-B shows the results of the nickel purification.  
Elutions E2 through E6 contain significant portions of ScGCN5 in reasonable 
purity.  Therefore, these five elutions were pooled and concentrated using an 
Amicon Ultra-4 Centrifugal Filter Device (Fisher #UFC801008).  The protein 
concentration of the pooled elutions was determined using a standard Bradford 
assay. 
Figure 24-A shows an SDS-PAGE analysis of ~1.0μg of ScGCN5 protein 
and a Western blot stained with an anti-histidine antibody confirming the 
production of a histidine tagged protein.  The SDS-PAGE and Western blot show 
several additional bands that are not full-length ScGCN5.  The bands are either 
contaminating bacterial proteins that co-purified with the ScGCN5 during nickel 
resin purification or possibly ScGCN5 degradation products that were generated 
during purification.  A commercially available His-Tag Protease Inhibitor Cocktail 
(Sigma #P8849) was added to all solutions used during purification to minimize 
degradation.  Alternatively, the lower weight bands could also be truncation 
products from incomplete translation of the recombinant protein.  As the 6X 
histidine tag is located at the N-terminus, truncation products would co-purify with 
full length protein. 
The presence of contaminating bacterial proteins does not pose a serious 
concern for the use of ScGCN5 in the in vitro HAT assay for our purposes.  
Bacteria do not possess histones, so it is highly unlikely that the contaminating 
bacterial proteins will adversely affect the enzymatic activity of ScGCN5 in the 
HAT assay.  To date, no bacterial proteins have been discovered that are 
capable of acetylating histones (Roth et al., 2001).  The lack of histone modifying 
enzymes in bacteria is one of the advantages of expressing HAT proteins in 
bacteria.  Any contaminating bacterial proteins that co-purify with the 
recombinant protein should not cause aberrant acetylation in the HAT assay. 
133 
  
 
 
 
 
Figure 24: Recombinant ScGCN5 possesses HAT activity 
A – Lane 1 is an SDS-PAGE of ~1.0μg of ScGCN5 stained with Simply Blue (SB, 
Invitrogen) colloidal stain.  Lane 2 is a Western of 500ng of TgGCN5 stained with 
a monoclonal anti-histidine antibody (α-his, Clontech #PT3359-2) at a dilution of 
1:5000 and the secondary antibody was goat derived anti-mouse (Amersham 
#NA931) used at 1:5000.  Detection was performed using Amersham ECL 
reagent (#RPN2209) with High Sensitive Blue photographic film (RPS Imaging 
#33-0810).  B – Autoradiograph of in vitro HAT assay with ~1.0μg of ScGCN5 
and core histones exposed to High Sensitive Blue photographic film (RPS 
Imaging #33-0810).  Markers are displayed on left in kilodaltons (kD). 
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It is doubtful that the truncated proteins and/or degradation products will 
interfere with full length enzymatically active ScGCN5 in the HAT assay.  The 
truncated proteins and degradation products probably do not possess enzymatic 
function.  However, the presence of truncated protein, degradation products, and 
contaminating bacterial proteins prevents accurate determination of the 
concentration of full length ScGCN5.  The amount of full length ScGCN5 protein 
present in the pooled elutions is an unknown percentage of the total protein 
concentration determined by Bradford assay.  Therefore, the actual amount of full 
length ScGCN5 protein used in our HAT assays is unknown.  Fortunately, our 
experiments do not require the exact amount of active HAT protein used in the 
HAT assay to be known. 
After obtaining recombinant ScGCN5 in sufficient quantity, the 
functionality was assessed in an in vitro HAT assay.  The mostly commonly used 
in vitro HAT assay reported in the literature measures HAT activity using tritiated 
acetyl CoA and core histones (Brownell et al., 1996).  A protein that possesses 
HAT activity will transfer the tritiated acetyl group from the acetyl CoA to the core 
histones present in solution.  The reaction is then resolved by SDS-PAGE and 
processed for autoradiography.  Histones modified with the radioactive tritiated 
acetyl group will form bands when the gel is exposed to film. 
Figure 24-B contains the autoradiograph of a HAT assay with ~1.0μg of 
ScGCN5 (lane 1) demonstrating that the recombinant ScGCN5 possesses HAT 
activity in our in vitro HAT assay based the assay published by Brownell et al. 
(1996).  As a negative control (lane 2), a HAT assay was performed containing 
only histones and tritiated acetyl CoA.  Clearly, the HAT activity of the 
recombinant ScGCN5 far exceeds the minor activity within the negative control.  
The small activity present in the negative control suggests that these histones 
are being acetylated.  Background activity has been a constant problem in HAT 
assays in other labs (Cote, J; unpublished observations).  The histones used in 
the HAT assay are commercially available histones (Upstate) purified from 
chicken erythrocytes.  It is plausible that they are contaminated with minor 
amounts of chicken HATs which generate minor background activity in the assay. 
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Regardless of the cause of the background activity, ScGCN5 possesses 
activity much higher than the activity in the negative control.  Thus, we have 
successfully reproduced the published in vitro HAT assay with a functionally 
relevant positive control.  As predicted from the literature, ScGCN5 shows a 
strong preference for acetylating histone H3 and has minor transferase activity 
on histone H4 (Kuo et al., 1996).  ScGCN5 also appears to acetylate histone H1.  
Other GCN5 homologues have been shown to also acetylate histone H1 in vitro 
but not in vivo (Herrera et al., 1997). 
 
B. Impact of the TgGCN5 N-terminus on histone acetylation 
Once the in vitro HAT assay had been successfully tested and a working 
positive control had been generated, the next objective was to obtain pure 
recombinant TgGCN5 protein.  As a result of the success in expressing ScGCN5 
in BL21-CodonPlus cells, an attempt was made to also express TgGCN5 in 
bacteria fused to an N-terminal 6X histidine tag.  Unlike ScGCN5, TgGCN5 has a 
GC ratio of 60% making the RP strain of the BL21-CodonPlus cell line better 
suited for expression. 
TgGCN5 is over twice the size of ScGCN5, therefore the protein induction 
protocol was altered to maximize expression of soluble protein in the bacteria.  
Lowering the temperature of bacterial cultures during induction has been shown 
to facilitate increased expression of soluble protein (Shirano and Shibata, 1990).  
Therefore, the protein induction of TgGCN5 was performed at 15°C instead of 
37°C.  Lowering the temperature of induction slows the bacterial translation 
machinery allowing for more efficient translation (Makrides, 1996).  The 
drawback of using a lower temperature is a reduction in the total amount of 
protein expressed.  However, a greater fraction of the protein that is expressed 
will be in the soluble fraction and be more likely to possess enzymatic activity 
(Shirano and Shibata, 1990).  To compensate for the reduction in the rate of 
protein synthesis the duration of induction was extended from three hours to 
sixteen hours.  The induction protocol used for generating TgGCN5 is outlined in 
greater detail in Chapter 2 Section IV-D (page 75). 
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Figure 25-A shows an SDS-PAGE analysis of a pilot induction of a BL21-
CodonPlus-RP bacterial clone expressing TgGCN5.  As a negative control, the 
first two lanes are from uninduced (UN) bacteria.  The first lane contains the 
soluble (S) fraction and the second lane contains the pellet (P) or insoluble 
fraction from the bacterial cells just prior to induction.  The last two lanes are after 
sixteen hours of protein induction (IN) at 15°C.  The first lane contains the soluble 
(S) fraction and the second lane is the pellet (P) or insoluble fraction.  When 
compared to the uninduced sample, there is a very abundant band between 
105kD and 160kD which is congruent with the 130kD size of TgGCN5.  A 
sufficient amount of recombinant protein is present in the soluble fraction to be 
process for purification. 
After confirming adequate expression of soluble protein, a large scale 
induction was performed and TgGC5 was purified via the 6X histidine tag using 
nickel-NTA resin (Qiagen) as outlined in Chapter 2 Section IV-D (page 75).  
Figure 25-B shows the results of the nickel resin purification.  Elutions E1 through 
E7 contain significant portions of TgGCN5 in reasonable purity.  Therefore, all 
seven elutions were pooled and concentrated using an Amicon centrifugal filter 
concentrator (Millipore).  The protein concentration of the pooled elutions was 
determined using a standard Bradford assay. 
Figure 26-A shows SDS-PAGE analysis of 500ng of TgGCN5 protein and 
a Western blot stained with an anti-histidine antibody (Clontech) confirming the 
production of a histidine tagged protein.  The SDS-PAGE and Western blot show 
several additional bands that are not full-length ScGCN5.  The bands are either 
contaminating bacterial proteins that co-purified with the TgGCN5 during nickel 
resin purification or are truncated products from incomplete translation of the 
recombinant protein.  Despite the presence of additional proteins, the major 
protein present is full length TgGCN5. 
The enzymatic activity of the purified recombinant TgGCN5 was assessed 
in an in vitro HAT assay (Figure 26-B).  Lane 1 is the positive control performed 
with 1.0μg of ScGCN5 and Lane 2 is the HAT assay performed with 500ng of 
TgGCN5.  As a negative control (lane 3), a HAT assay was performed containing 
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Figure 25: Bacterial protein induction and purification of TgGCN5 
A – SDS-PAGE of a pilot induction of TgGCN5 in BL21-CodonPlus-RP stained 
with Simply Blue colloidal stain (Invitrogen).  The first two lanes are from 
uninduced (UN) bacteria cells just prior to protein induction.  The last two lanes 
are after an overnight protein induction (IN) at 15°C.  (S = soluble fraction; P = 
pellet or insoluble fraction).  The band present at 130kD presumed to be 
TgGCN5 is denoted by an arrow.  B – SDS-PAGE of washes and subsequent 
elutions from the purification of a large scale induction of TgGCN5 stained with 
Simply Blue.  Following incubation with bacterial lysate, the nickel-NTA resin was 
washed twice (W1 and W2) with 20mM imidazole.  Recombinant protein was 
eluted from the resin using increasing concentrations of imidazole: E1 and E2 = 
100mM imidazole, E3 and E4 = 200mM imidazole, and E5, E6, and E7 = 
300mM.  Markers are on left displayed in kilodaltons (kD). 
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Figure 26: Recombinant TgGCN5 produced in bacteria lacks HAT activity 
A – Lane 1 is an SDS-PAGE of 500ng of TgGCN5 stained with Simply Blue 
colloidal stain (SB, Invitrogen).  Lane 2 is a Western of 500ng of TgGCN5 stained 
with a monoclonal anti-histidine antibody (α-his, Clontech #PT3359-2) at a 
dilution of 1:5000 and the secondary antibody was goat derived anti-mouse 
(Amersham #NA931) used at 1:5000.  Detection was performed using 
Amersham ECL reagent (#RPN2209) with High Sensitive Blue photographic film 
(RPS Imaging #33-0810).  B – In vitro HAT assay with 1μg of ScGCN5 (Lane 1), 
500ng of TgGCN5 (Lane 2), and core histones alone as a negative control (Lane 
3) exposed to High Sensitive Blue photographic film (RPS Imaging #33-0810).  
Markers are on left displayed in kilodaltons (kD). 
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only histones and tritiated acetyl CoA.  Unfortunately, the recombinant TgGCN5 
produced in BL21-CodonPlus-RP strain does not appear to possess significant 
HAT activity above background.  The positive control (ScGCN5, Lane 1) shows 
intense HAT activity on core histones suggesting that no error was made in 
performing the HAT assay.  The HAT assay was repeated two more times but no 
HAT activity was detected.  Recombinant TgGCN5 was purified from two 
additional BL21-CodonPlus-RP bacterial clones but the recombinant protein from 
these different clones did not possess HAT activity in the in vitro assay, either. 
Several explanations are possible for the lack of activity of TgGCN5.  The 
most plausible is that the BL21-CodonPlus-RP strain is unable to produce 
enzymatically active protein.  Unlike eukaryotic organisms, bacteria lack the 
ability to perform many of the posttranslational modifications found in eukaryotic 
proteins and they have limited ability to facilitate extensive disulfide bond 
formation (Makrides, 1996).  Bacteria do not possess chaperone proteins that 
may be required to assist in folding proteins into their proper conformation.  
Protocols have been established to solve the problem of disulfide bond formation 
and proper protein folding increasing the likelihood of obtaining functionally active 
recombinant protein from bacteria.  Many of these protocols involve the use of 
different bacterial strains, additional fusion tags or co-expression of chaperone 
proteins (Derman et al., 1993; Cole, 1996; Terpe, 2003).  While it is possible that 
these methods may have been successful in producing enzymatically active 
TgGCN5 in bacteria, a large amount of time would have been spent optimizing 
protein expression conditions without any guarantee of success.  Therefore it 
seemed best to try alternative methods for obtaining recombinant protein. 
To obtain active TgGCN5 protein, several options were possible.  One 
method would be to purify TgGCN5 directly from parasite lysate.  A TgGCN5 
antiserum has been developed in our lab and it was used in previous 
experiments exploring the interaction between TgGCN5 with importin α.  It is 
theoretically possible to purify endogenous TgGCN5 from wild type parasite 
using the same TgGCN5 antiserum.  However, low level expression of 
endogenous TgGCN5 would limit our ability to obtain sufficient amounts of the 
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protein to use in an in vitro assay.  An alternative would be to express 
recombinant protein in a eukaryotic expression system such as yeast or 
baculovirus-insect cell systems (Schmidt and Hoffman, 2002).  Eukaryotic cells 
possess chaperon proteins and are capable of readily generating disulfide bonds 
offering a greater likelihood that the recombinant protein would possess 
enzymatic activity (Schmidt and Hoffman, 2002).  However, these expression 
systems require laborious setup and optimization for efficient expression of large 
quantities of protein.  A third possibility, that had the potential to offer abundant 
pure protein without significant setup time, was to express the TgGCN5 protein in 
Toxoplasma.  Others have had success in expressing and purifying recombinant 
proteins directly from transgenic parasites (Donald and Liberator, 2002).  The 
advantage of expressing recombinant protein in Toxoplasma is that it guaranteed 
the proper folding and posttranslational modifications required for full HAT 
activity.  Furthermore, the two parasite lines necessary for our experiments had 
already been generated as part of the TgGCN5 NLS mapping experiments: (1) 
full length TgGCN5 fused to a FLAG tag (FLAGTgGCN5) and (2) the truncated 
from lacking the N-terminal extension also fused to a FLAG tag 
(FLAGΔNTTgGCN5).  Recombinant protein from the parasites could be purified 
from parasite lysate via the N-terminal FLAG tag using commercially available 
anti-FLAG affinity resin. 
Commercially available anti-FLAG affinity resin (Sigma) was used to purify 
FLAGTgGCN5 and FLAGΔNTTgGCN5 from transgenic parasites (Chapter 2, 
Section IV-E, page 80).  The purified recombinant protein was eluted from the
affinity resin using competitive elution via a concentrated solution of 3XFLAG 
peptide (Sigma).  The elution peptide was removed by dialysis and a standard 
Bradford assay was used to determine the concentration of the recombinant 
protein.  Unfortunately, no protein was detectable by Bradford assay in eithe
the dialyzed elutions of 
 
r of 
as FLAGTgGCN5 or FLAGΔNTTgGCN5.  The purification w
repeated several more times with similar results.  The most likely causes of low 
protein yield were either inefficient affinity purification and/or sample loss during 
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dialysis.  To determine the efficiency of the affinity purification, a Western blot 
stained with anti-FLAG was performed on transgenic parasite lysate, the elution  
before dialysis and the affinity resin from which protein had been eluted (Figure 
27).  To analyze the resin by Western blot, the resin was boiled in SDS- 
PAGE loading buffer following the elution step.  The loading buffer was run on a 
gel and transferred to a Western blot.  As shown in Figure 27, Lane 2, there 
appears to be no FLAGTgGCN5 or FLAGΔNTTgGCN5 present in the elutions that is 
detectable by Western blotting.  However, in Figure 27, Lane 3 there is a strong 
band at the size expected for FLAGTgGCN5 (130kD) and a faint band at the size 
expected for FLAGΔNTTgGCN5 (52kD) protein bound to the resin.  Therefore, it 
appears that the affinity purified protein is not being efficiently eluted from the 
affinity resin.  An alternative method of elution using acidic glycine was 
attempted, but the elutions also failed to have detectable protein following 
dialysis.  Harsher conditions could have been employed to elute the protein such 
as high salt concentration, adding detergents, or using denaturants such as urea 
or guanidine to elute FLAGTgGCN5 and FLAGΔNTTgGCN5.  However, these 
elution conditions would have partially or completely denatured the HAT protein 
making it unusable for enzymatic analysis (Rutkowska and Skowron, 1999). 
The Western blot results in Figure 27 indicate that the anti-FLAG affinity 
resin appears to be purifying sufficient protein from the parasite lysate for 
enzymatic assays.  Therefore, an in vitro HAT assay was attempted without 
eluting the protein from the resin.  The resin with FLAGTgGCN5 or 
FLAGΔNTTgGCN5 still bound was added directly to the HAT assay.  Following 
purification, resin containing the bound FLAGTgGCN5 or FLAGΔNTTgGCN5 was 
split between Western blot analysis and the HAT assay.  One third of the resin 
was boiled in SDS-PAGE loading buffer and processed for Western blot analysis.  
The remaining two-thirds of resin was used in an in vitro HAT assay.  By dividing 
up the resin in this manner, a qualitative comparison can be made between the 
amount of protein obtained from affinity purification and the overall activity 
elicited in the HAT assay.
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Figure 27: Elution of TgGCN5 and ΔNTTgGCN5 from FLAG affinity resin 
A – Western blot assessing the efficiency of the anti-FLAG affinity purification 
and elution of FLAGTgGCN5.  Lane 1 = lysate from parasites overexpressing 
FLAGTgGCN5, Lane 2 = elution from anti-FLAG resin using 3X FLAG peptide, 
Lane 3 = Resin boiled in SDS loading buffer following elution with 3X peptide. 
B – Western blot assessing the efficiency of the anti-FLAG affinity purification 
and elution of FLAGΔNTTgGCN5.  Lane 1 = lysate from parasites overexpressing 
FLAGΔNTTgGCN5, Lane 2 = elution from anti-FLAG resin using 3X FLAG peptide, 
Lane 3 = Resin boiled in SDS loading buffer following elution with 3X peptide.  
For both Western blots, the primary antibody was polyclonal anti-FLAG (Sigma 
#F7425) used at 1:1000 and the secondary antibody was goat derived anti-rabbit 
(Amersham #NA934) used at 1:2500.  Detection was performed using 
Amersham ECL reagent (#RPN2209) with High Sensitive Blue photographic film 
(RPS Imaging #33-0810).  Markers are on left displayed in kilodaltons (kD) 
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As shown in Figure 28A, the affinity purification pulled down adequate 
amounts of FLAGTgGCN5 (Lane 1) and FLAGΔNTTgGCN5 (Lane 2) protein.  Lane 
3 in Figure 28A is of wild type lysate carried through anti-FLAG affinity 
purification to serve as a negative control in the HAT assy.  As expected, it 
contains no FLAG tagged proteins. 
in 
Both FLAGTgGCN5 and FLAGΔNTTgGCN5 while still bound to the affinity 
resin are enzymatically active and acetylate core histones (Figure 28B).  In figure 
28-B, Lane 1 is a HAT assay performed with ~1.0μg ScGCN5 to serve as a 
positive control.  Lane 4 is a negative control HAT assay performed with anti-
FLAG affinity resin from the purification of wild type lysate.  In addition to the 
recombinant HATs expressed in the parasites, Toxoplasma also expresses other 
HAT proteins (Sullivan and Hakimi, 2006).  The negative control demonstrates 
that the anti-FLAG affinity resin is not capable of purifying these endogenous 
Toxoplasma HATs through non-specific interactions.  The results shown in 
Figure 28-A and -B are representative of three duplicate experiments which all 
yielded similar results. 
As shown in Figure 28-B, both TgGCN5 and ΔNTTgGCN5 are able to 
acetylate free non-nucleosomal histones in solution.  As expected for a GCN5 
HAT, the preferred substrate of both proteins is histone H3 and to a lesser extent 
H4.  Full length TgGCN5 appears to be able to acetylate H1.  The truncated form 
of TgGCN5 also shows detectable activity on H1 as well.  The acetylation of H1 
and H4 by GCN5 are believed to occur in vitro but not in vivo (Herrera et al., 
1997). 
The HAT assay results also suggest that full length TgGCN5 has higher 
activity than the truncated form.  Although there appears to be more 
ΔNTTgGCN5 present in the Western blot versus full length TgGCN5, 
ΔNTTgGCN5 appears to have much weaker activity than TgGCN5 in the HAT 
assay.  It is possible that the N-terminal extension stabilizes full length prote
and provides stronger catalytic activity.  However, the FLAG tag in both 
recombinant proteins is fused to the amino-terminal end.  In FLAGΔNTTgGCN5, 
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this places the catalytic domain in close proximity to the affinity resin, possibly 
impeding its activity.  Finding a 
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Figure 28: HAT activity of TgGCN5 and ΔNTTgGCN5 
A – Western blot of the anti-FLAG affinity purification.  Primary antibody 
(polyclonal anti-FLAG, Sigma #F7425) used at 1:1000 and secondary antibod
(goat derived anti-rabbit, Amersham #NA934) u
y 
sed at 1:2500.  Detection was 
perform  Blue 
T 
cyte 
  
.  
ed using Amersham ECL reagent (#RPN2209) with High Sensitive
photographic film (RPS Imaging #33-0810).  B – Autoradiogram with High 
Sensitive Blue photographic film (RPS Imaging #33-0810) of an in vitro HA
assay using 3H-Acetyl CoA (Amersham #TRK688) with chicken erythro
histones H1 (~30kD), H2A (~14kD) H2B (~15kD), H3 (~17kD), and H4 (~10kD).
LANES: 1 = ~1.0g of ScGCN5, 2 = over-expressing FLAGTgGCN5, 3 = over-
expressing FLAGΔNTTgGCN5, and 4 = wild-type lysate as a negative control
Markers are on left displayed in kilodaltons (kD). 
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method to effectively elute the proteins o  the affinity resin would give a better 
comparison.  Alternatively, the FLAG tag could be moved the C-terminus in both 
proteins and the activity reassessed.  Nevertheless, it is clear that both forms of 
TgGCN5 preferentially acetylate histone H3 in vitro. 
 
C. Determining the lysine(s) acetylated by TgGCN5  
The development of antibodies capable of recognizing specific 
modifications to histone proteins has made it possible to easily determine which 
lysine residues are targeted by HAT proteins using standard Western blot 
techniques (White et al., 1999).  Once it had been determined that TgGCN5 
preferentially acetylated histone H3, additional HAT assays were performed to 
identify which lysine(s) were being acetylated. 
Since Western analysis was employed to determine the residues that are 
acetylated by TgGCN5, radioactively labeled acetyl CoA was not required in the 
HAT assay.  Detection was obtained using chemiluminescence via a secondary 
antibody conjugated to horseradish peroxidase and exposing the blot to film.  
Therefore, the HAT assay protocol was altered, switching the radioactively 
labeled acetyl CoA with a similar solution of non-radioactive acetyl CoA (Sigma) 
dissolved in acidic sodium acetate.  In addition, the substrate was changed from 
core histones to commercially available recombinant histone H3, the preferred 
substrate for GCN5 proteins.  A detailed protocol of the non-radioactive HAT 
assay is in Chapter 2, Section IV-G (page 83). 
As in the previous HAT assays, anti-FLAG affinity purification was 
performed on parasites overexpressing FLAGTgGCN5 or FLAGΔNTTgGCN5.  
Affinity purification with anti-FLAG resin was also performed on wild type 
parasites to serve as a negative control for the HAT assay.  Following 
purification, the affinity resin was split between Western analysis (Figure 29-A) 
and HAT assay (Figure 29-B).  ScGCN5 continued to serve as a positive control 
in these HAT assays (Figure 29-B, Lane 1).  Following the HAT assay, the 
reactions were run on a gel and transferred to a PVDF membrane.  Acetylated 
lysines were detected by Western analysis using antibodies capable of detecting  
ff
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Figure 29: Specific lysine acetylation of TgGCN5 and ΔNTTgGCN5 
A – Western blot of the anti-FLAG affinity purification.  Primary antibody 
(polyclonal anti-FLAG, Sigma #F7425) used at 1:1000 and secondary antibody 
(goat derived anti-rabbit, Amersham #NA934) used at 1:2500.  Detection was
performed using Amersham ECL reagent (#RPN2209) with High Sensitive Blue 
photographic film (RPS Imaging #33-0810).  Markers are on left in kilodaltons 
(kD).  B – Western blots of in vitro HAT assay stained with different antibodies to 
specific acetylated (Ac) lysine residues.  Primary antibodies (α-AcH3(K9), 
Upstate #07-352; α-AcH3(K14), Upstate #07-353; α-AcH3(K9/K18), Upstate
593) were used at 1:1000 and secondary antibody (goat derived anti-rabbit; 
Amersham, #NA934), was used at 1:2500.  Detection was performed using 
Amersham ECL reagent (#RPN2209) with High Sensitive Blue photograp
(RPS Imaging #33-0810).  Markers are on left in kilodaltons (kD).  FL = full
length; ΔNT = lacking the N-terminus; Sc = Saccharomyces cerevisiae GCN
Tg = Toxoplasma GCN5; RH = wild type parasite lysate as a negative co
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specifi .  Given the activity 
of other GCN5 homologues (Kuo et al., 1996), antibodies recognizing acetylation 
on lysi ibody 
blot 
 
d 
e (Kuo et al., 1996), ScGCN5 strongly acetylates histone H3 on lysine 14 
(Figure
 
tivity on 
ow 
 
e 
 
e of acetylating lysine 14 
of histo rity, 
 
c acetylated lysine residues in histone H3 (Figure 29-B)
ne 14, lysine 9, and on lysine 9+18 were used.  The lysine 9+18 ant
was used because there is not a reliable antibody available for Western 
analysis that recognizes acetylation only on lysine 18 in H3. 
The first antibody used in the Western blot analysis recognizes acetylation
of lysine 14 on histone H3 (α-AcH3(K14); Upstate).  In agreement with publishe
literatur
 20B, middle panel).  Surprisingly, α-AcH3(K14) did not react with 
recombinant histone H3 incubated with TgGCN5 suggesting that TgGCN5 does 
not acetylate lysine 14.  Therefore, acetylation of lysines 9 and 18 were also 
examined.  As expected, ScGCN5 is able to acetylate lysines 9 and 18, but to a
lesser extent than lysine 14.  TgGCN5 does not appear to have any ac
lysine 9 in histone H3 (Figure 29-B, top panel).  However, histone H3 does sh
acetylation by TgGCN5 when probed for acetylation on lysines 9 and 18 (Figure
29-B, bottom panel).  Given the lack of TgGCN5 activity on lysine 9 alone, 
(Figure 29-B, top panel) this suggests that TgGCN5 specifically acetylates lysin
18.  ΔNTTgGCN5 shows the same acetylation pattern as full-length TgGCN5.  
Therefore it does not appear that the N-terminal extension is involved in 
determining the lysines that are acetylated.  There is a modest amount of 
background with anti-FLAG affinity purified RH (wild type) parasite lysate.  
However, the activity of TgGCN5 and ΔNTTgGCN5 is much higher than
background levels on lysine 18 in histone H3. 
To date, TgGCN5 is the first GCN5 HAT incapabl
ne H3 in vitro.  The bias for H3 lysine 18 is also an intriguing peculia
and begs the question if other HAT(s) are preset in Toxoplasma that can
acetylate the other lysine residues of H3 
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CHAPTER 4: DISCUSSION AND FUTURE STUDIES 
 
Phylum Apicomplexa is home to numerous intracellular protozoan 
parasites of tremendous medical and economical importance, including 
Plasmodium (malaria) and Cryptosporidium (cryptosporidiosis).  Toxoplas
gondii is another apicomplexan, capable of causing congenital birth defe
serious complications in immunocompromised patients (Black and Boothroyd, 
2000). 
Apicomplexan parasites typically have complex life cycles and interconvert 
between various stages.  The differentiation of Toxoplasma from its invasive form
(tachyzoite) into an encysted form (bradyzoite) is central to its pathology and 
transmission (Weiss and Kim, 2000).  Interfering with this process may lead to 
novel therapeutic strategies, but the processes orchestrating parasite 
differentiation 
ma 
cts and 
 
have not been completely resolved.  It is well established that 
stage-specific genes are present in Toxoplasma, indicating that transcriptional 
rol of differentiation (Singh et al., 2002).  
Furthe
e 
 
regulation participates in the cont
rmore, microarray analysis of differentiating tachyzoites has shown that 
several genes are expressed during the entire differentiation process and som
are expressed only at certain time points during differentiation suggesting a 
highly orchestrated and controlled event (Cleary et al., 2002).  There are 
currently no known transcription factors that are involved in governing the 
bradyzoite differentiation process.  Searches of apicomplexan genome 
databases indicate a lack of conventional transcription factors conserved in other 
species (Saksouk et al., 2005; Templeton et al., 2004). 
Tachyzoites develop into bradyzoites in vitro after being exposed to 
various stresses (e.g. pH, chemical, or heat shock; Soête et al., 1994), 
suggesting that stress response pathways may be involved in mediating signals 
to initiate differentiation.  Chromatin remodeling proteins in other eukaryotic 
organisms play a key role in gene expression, some of which are instrumental in
mediating stress responses (Huisinga and Pugh, 2004).  Thus, chromatin 
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remodeling proteins should be investigated in Toxoplasma as they may 
participate in the differentiation process. 
The GCN5 histone acetyltransferase (HAT) is involved in regulating 
genome, most of which are induced by stress 
(Huisin
e 
N5 
 
he 
 
e, the GCN5 
ry 
short 
es, 
extens ue 
sis 
N5 
approximately 10% of the yeast 
ga and Pugh, 2004).  An unusual GCN5 HAT has been cloned in 
Toxoplasma (Sullivan and Smith, 2000), but no work has been done to 
characterize the novel aspects of this unique HAT.  TgGCN5 contains a uniqu
N-terminal “extension” that bears no similarity to known proteins and is devoid of 
known protein motifs.  Elucidating the function of the N-terminus will facilitate our 
understanding of gene regulation in this parasite and other apicomplexans, and 
may shed new light on the bradyzoite differentiation process as well as other 
aspects of parasite biology.  For example, the N-terminal extension of TgGC
has been used a tool to explore the understudied area of nuclear trafficking in
Toxoplasma. 
 
I. The N-terminus and TgGCN5  
The TgGCN5 N-terminal extension is comprised of 820 amino acids.  T
large size of the N-terminal extension in TgGCN5 distinguishes it from GCN5
homologues found in other lower eukaryotic organisms.  For exampl
homologue expressed in the related alveolate Tetrahymena possesses a ve
small N-terminal extension of 69 residues.  Yeast GCN5 also possesses a 
N-terminal extension composed of 118 amino acids.  Although metazoan GCN5 
homologues contain longer N-terminal extensions of approximately 500 residu
they are still smaller than TgGCN5.  Furthermore, unlike the large N-terminal 
extensions present in metazoan GCN5 and the related HAT PCAF, the lengthy 
N-terminal extension present in TgGCN5 bears no similarity to the N-terminal 
ions found in other GCN5 homologues.  Our hypothesis is that this uniq
N-terminal extension is critical to the function of TgGCN5.  The goal of this the
was to ascertain functions for the novel N-terminus providing evidence that it is 
critical to the function of TgGCN5.  Based on what is known about other GC
proteins, three roles for the N-terminal domain of TgGCN5 that were investigated 
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in this thesis include nuclear localization, protein-protein interactions, and 
modulation of enzymatic function. 
 
A. Mapping the NLS of TgGCN 
Discussion: The data reported in this thesis demonstrates that the 
TgGCN5 N-terminal extension contains a nuclear localization signal (NLS) th
required for targeting TgGCN5 to the parasite nucleus.  Previous work in the 
Sullivan Lab had established that the N-terminal extension was essential for the 
nuclear translocation of TgGCN5.  Therefore, TgGCN5 made an excellent mode
to study how a GCN5 protein is transported into the nucleus.  Before our work 
elucidating the nuclear localization of TgGCN5, no NLS had been reported for 
any GCN5 homologue.  Furthermore, no NLS had ever been mapped in a 
Toxoplasma protein.  Additional studies had narrowed the region involved in 
nuclear localization to between amino acids 58 and 260. 
Stretches of 5-6 basic residues have been discovered to function a
nuclear targeting sequences in many nuclear proteins (Boulikas, 1994).  The 
mostly likely candidate for an NLS between amino acids 58 and 260 was the 
hexapeptide R
at is 
l 
on 
s 
KRVKR.  Truncations were made to the N-terminal extension 
isolatin
e and the hexapeptide 
was ab
y. 
g 
g this stretch of basic residues within the N-terminus.  Using 
immunocytochemistry, it was determined that the RKRVKR sequence was 
required for the nuclear localization of TgGCN5.  To demonstrate that the 
hexapeptide was a complete NLS, it was fused to the cytoplasmic protein, beta 
galactosidase.  The fusion protein of beta galactosidas
le to enter the parasite nucleus.  The ability for the hexapeptide to target a 
non-nuclear protein to the nucleus provides strong evidence that the hexapeptide 
is a complete NLS recognized by the parasite’s nuclear trafficking machiner
The sequence RKRVKR is the first NLS to be described in any GCN5 
protein.  Searches for the TgGCN5 NLS in other GCN5 proteins revealed no 
matches including metazoan GCN5 and PCAF homologues which possess lon
N-terminal extensions.  However, there are clusters of 4–5 basic residues 
present in the N-termini of metazoan GCN5 and PCAF homologues that are 
154 
potential candidates for an NLS.  The putative maize GCN5 NLS, RKRK, is
similar to the NLS isolated in TgGCN5 (Bha
 
t et al., 2003).  However, it is not 
terrupted by a non-basic residue.  The divergence between the maize and 
TgGCN CN5 
ite 
within 
 
CN5 
 
eptide RKRVKR is the first NLS that has ever been mapped for 
any Toxoplasma protein.  The RKRVKR sequence does fit one of the nine motifs 
st and is not 
commo
 
wever, 
in
5 NLS suggests that there may not be a conserved NLS between G
homologues.  Furthermore, yeast GCN5 (ScGCN5) does not possess any 
stretches of basic residues within its relatively short N-terminus.  The signal 
sequenced responsible for targeting yeast GCN5 to the nucleus is unknown, but 
it is doubtful that the N-terminal extension is involved.  There is a stretch of basic 
residues, RRKIR, within the Ada2 domain of ScGCN5 that is very similar to the 
NLS motif of TgGCN5 (Boulikas, 1994).  The hexapeptide RRKIR may be the 
putative NLS for ScGCN5.  Interestingly, the beginning four residues, RRKI are 
conserved in the Ada2 domain of TgGCN5.  However, these residues within 
TgGCN5 do not appear to be involved in targeting the protein to the paras
nucleus.  Furthermore, the stretch of basic residues RRKIR is not conserved 
the Ada2 domains of other GCN5 homologues.  Additional studies 
determining if this stretch is involved in targeted yeast GCN5 are warranted as it
may provide further evidence that there is not a conserved NLS among G
homologues. 
Small proteins less than 40kD are capable of passively diffusing through
the nuclear envelope (Pante and Kann, 2002).  The calculated size of yeast 
GCN5 is approximately 51kD.  The size of yeast GCN5 exceeds the threshold for 
passive diffusion through the nuclear envelope, and therefore requires a form of 
active transport in order to be present in the nucleus. 
The hexap
described by Boulikas, but this particular NLS motif is the rare
nly utilized by nuclear proteins (Boulikas, 1994).  The presence of a rare 
NLS motif suggests that Toxoplasma and perhaps other apicomplexans may 
utilize NLSs that differ slightly in composition from those utilized by yeast and
multicellular animals.  Differences in NLS composition may mean differences in 
nuclear trafficking pathways which could be exploited in drug design.  Ho
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additional NLS motifs will need to be elucidated in Toxoplasma and other 
apicomplexans to determine if this is true. 
 
Future Studies: While RKRVKR fits a recognized NLS motif pattern 
(Boulikas, 1999), it may not be the minimal requirement for targeting TgGCN5 
the parasite nucleus.  It is plausible that the three basic residues in fron
valine, RKR, could be the entire NLS.  Although most NLSs are composed of 4 
more basic residues, there are rare NLSs composed of only three basic residues 
(Boukilas, 1999).  Fusing only RKR to β-galactosidase would confirm whether or 
not three basic residues are enough to target a protein to the parasite nucleus.  
Alternatively, site-directed mutagenesis could be performed on the NLS present 
in TgGCN5 changing the basic residues to alanine.  The results would narrow the 
to 
t of the 
or 
NLS d he 
s 
n 
s-
  
e of 
e 
ium 
own to its minimal size and may indicate which residues within t
hexapeptide are the most important in targeting the HAT to the parasite nucleus. 
It would be interesting to ascertain if TgGCN5 is localized to the nucleu
when expressed in mammalian cells.  The purpose of such a study would be to 
determine if mammalian nuclear trafficking proteins could recognize the 
hexapeptide NLS and transport TgGCN5 into the nucleus.  Several transfectio
and expression methods for mammalian cells have been developed (Recilla
Targa, 2004).  If TgGCN5 is transported into the nucleus, it would argue that 
nuclear localization via the importin pathway is a highly conserved phenomenon.
However, if the TgGCN5 is not recognized by the nuclear transport machinery it 
would indicate that differences exist between mammalian and apicomplexan 
nuclear import.   
 
B. Apicomplexan database searches with the TgGCN5 NLS 
Discussion: Defining motifs such as an NLS has the potential to assist in 
the annotation efforts of apicomplexan genomics.  The NLS of TgGCN5 is on
the first fully mapped nuclear targeting sequences in an apicomplexan.  Th
online genomic databases for Toxoplasma, Plasmodium, and Cryptosporid
were searched for proteins containing identical and similar motifs.  If the 
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RKRVKR sequence was able to identify other proteins with a high probability of
possessing nuclear function based on homology or other domains prese
protein than it provided additional evidence t
 
nt in the 
hat the hexapeptide was a nuclear 
targeti
 
 indicate 
es may 
 
bases.  The 
lack of
 
 
ns 
ble homology to any known proteins nor contained any 
recogn
ng sequence and had the capability of identifying other nuclear proteins.  
The NLS could also aid in characterizing parasite proteins without any known 
function.  It is estimated that over 50% of the predicted proteins in the 
Toxoplasma and Plasmodium databases are parasite specific and possess no 
discernable homology to any known proteins (Li et al., 2003).  Proteins that have
no readily identifiable function but possess the sequence RKRVKR may
a function within the parasite nucleus.  Additionally, searching the databas
provide further insight into nuclear proteins that have already been characterized
suggesting a method for how these proteins are targeted to the parasite nucleus. 
Interestingly, searches of the predicted proteins present in the 
Toxoplasma genomic database revealed no exact matches to the TgGCN5 NLS 
sequence except for TgGCN5 itself.  Additionally, no proteins possessing the 
hexapeptide were found in the Plasmodium or Cryptosporidium data
 additional proteins possessing the exact same NLS suggests that the 
hexapeptide is a rare NLS not commonly used by apicomplexans.  However, 
searching for an exact match to the RKRVKR hexapeptide is not the most 
appropriate search.  Within an NLS motif, arginine can be substituted for lysine 
and vice versa and the non-basic residue can be substituted for any amino acid 
and nuclear targeting can still be achieved (Boulikas, 1994; Hodel et al., 2001).  
Therefore, the searches of the three apicomplexan databases were expanded to
include these permutations. 
The first variation was to search for the sequence RKRxKR where “x” can
be any amino acid.  A search of the Toxoplasma database of predicted protei
revealed a total of 19 potential hits.  Eight of the proteins were parasite-specific 
and had no discerna
izable protein motifs.  Of the remaining 11 proteins, nine contained 
additional domains or homology indicating a nuclear function and two had 
additional elements indicating a function within the cytoplasm.  Therefore, over 
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80% of the proteins containing additional motifs or homology appear to have a 
nuclear function indicating the motif RKRxKR has predictive function in 
identifying nuclear proteins in Toxoplasma. 
The nine proteins containing additional domains or homology implying a 
nuclear function included a RNA recognition protein, tRNA synthetase, a DNA 
polymerase, and several potential transcription factors.  The tRNA synthase 
(38.m01112, Table II, page 100) belongs to a group of proteins that function in 
both the cytoplasm and nucleus (Schimmel and Wang, 1999).  Several studies
have implicated an NLS enriched with basic residues in targeting tRNA 
synthetases to the nucleus (Mucha, 2002).  The NLS-like motif present in 
38.m01112, RKRGKR, does not match the proposed NLS m
 
otifs in other tRNA 
synthe N5 
tif to identify other nuclear proteins indicates 
that it possesses value in predicting the localization of proteins.  Therefore, the 
NLS ca function.  
otifs 
 
 
eus 
 
eins 
e 
 TgGCN5 NLS.  Searching the P. 
 10 
tases homologues (Mucha, 2002).  Nonetheless, the ability of the TgGC
NLS to identify other nuclear proteins including a tRNA synthetase that appears 
to enter the nucleus via an NLS composed of basic residues in other organisms 
provides additional evidence that RKRxKR is a nuclear targeting sequence and 
has the potential to assist in further characterizing known proteins. 
The ability of RKRxKR mo
n assist in deciphering the functions of proteins with unknown 
The eight Toxoplasma proteins with unknown function containing RKRxKR m
should be targeted to the parasite nucleus.  However, two of the 19 proteins from
the database search contained ribosomal motifs in addition to an NLS-like motif. 
The presence of a ribosomal domain indicates a function outside of the nucl
which illustrates the limitation of database searches.  The presence of an NLS
like-motif does not guarantee that the protein is nuclear and must be taken into 
context with other domains expressed in the protein.  Ultimately, localization 
studies will need to be performed to confirm the distribution of these 19 prot
within the parasite. 
Similar searches of the Plasmodium and Cryptosporidium databases wer
also performed looking for permutations of the
falciparum annotated protein data set with the RKRxKR motif returned over
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proteins.  One protein contained multiple zinc finger-like motifs suggesting it may 
be involved in transcriptional regulation and function within the nucleus (Aasland
et al., 1995).  A second search of the P. falciparum database was performed with 
less stringent parameters by allowing the five basic residues in the TgGC
to be either lysine or arginine and the non-basic va
 
N5 NLS 
line to be any amino acid.  
The se y 
 
 NLS 
t 
LS like-
oridium 
mic databases have been established.  Theileria 
parva, a tick-borne apicomplexan, is responsible for causing East Coast fever, a 
se of cattle in Africa (Graham et al., 2006).  
East C
r 
t 
(www.genedb.org/genedb/etenella/).  As new apicomplexan genomes are 
arch produced 1500 hits from the annotated protein data set.  Preliminar
analysis of some of these potential nuclear proteins included a putative histone 
deacetylase, a tRNA synthase, and a putative DNA polymerase subunit.  The
same criteria was also used to search the Cryptosporidium parvum expressed 
sequence tag database, which identified nine proteins with an NLS-like motif 
including the histone H2B and a putative nucleolar protein. 
The ability of permutations in the TgGCN5 NLS hexapeptide to identify 
nuclear proteins in other apicomplexans suggests that there may be shared
sequences between Toxoplasma, Plasmodium and Cryptosporidium that targe
nuclear proteins to their respective nuclei.  However, the ability of these N
motifs to target a protein to the nucleus in Plasmodium and Cryptosp
remains to be confirmed in vivo. 
 
Future Studies: Since the completion of this thesis, additional 
apicomplexan online geno
highly fatal lymphoproliferative disea
oast fever kills over 1 million cattle each year in sub-Saharan Africa, 
resulting in economic losses exceeding $200 million annually (Gardner et al., 
2005).  Results from sequencing efforts of the Theileria parvum genome are now 
available online (http://www.tigr.org/tdb/e2k1/tpa1/).  Eimeria tenella is anothe
apicomplexan that causes avian coccidiosis (Allen and Fetterer, 2002).  E. 
tenella is a constant threat to the poultry industry with an annual worldwide cos
estimated at about $800 million (Allen and Fetterer, 2002).  An online genomic 
database is also available for Eimeria tenella 
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s.  
localization 
studies  the 
 preventing 
localiz
C. Importin pathway in Toxoplasma 
mportin 
 
, 
port 
 early in eukaryotic evolution. 
ce and made available online, the TgGCN5 NLS will be an importan
to begin searching for nuclear proteins.  Searches with the RKRVKR se
and its appropriate permutations should be performed on these new database
Proteins that possessing sequences similar to RKRVKR NLS should be 
investigated further as potential nuclear proteins. 
While it has been demonstrated that RKRVKR NLS has the potential to 
assist in the identification of putative nuclear protein in silico, these results need 
to be confirmed in vivo.  Expression of recombinant proteins and 
 with putative nuclear proteins will need to be performed to determine
true potential of the TgGCN5 NLS to identify other nuclear proteins.  Expression 
systems and techniques are well established in Toxoplasma for this purpose 
(Soldati and Boothroyd, 1993).  Other members of the phylum Apicomplexa are 
not as readily amenable to genetic manipulation in the laboratory (Kim and 
Weiss, 2004).  Therefore, Toxoplasma could be utilized as a model system to 
determine the cellular localization of putative nuclear proteins from other 
apicomplexans.  Following heterologous expression in Toxoplasma, 
immunofluorescence assays could be employed to ascertain if the protein is 
targeted to the nucleus.  However, it is possible that the expression of certain 
heterologous apicomplexan proteins may be lethal in Toxoplasma
ation experiments. 
 
Discussion: Proteins that possess an NLS composed of basic residues are 
transported through the nuclear envelop by interacting with two proteins: i
α and importin β (Gorlich et al., 1995).  The role of importin α is to recognize and
bind to NLSs (Gorlich et al., 1994).  Importin α is a highly conserved protein 
present in virtually all eukaryotic organisms (Chook and Blobel, 2001).  In fact
the Giardia genomic database (www.mbl.edu/Giardia) contains an annotated 
entry of an importin α homologue indicating that the use of importin α to trans
proteins into the nucleus occurred
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Despite the extensive ongoing research in apicomplexans, nuclear 
trafficking is a greatly understudied area of parasite biology.  Although 
homologues of importin α and importin β have been identified in Plasmodium 
falciparum (Mohmmed et al., 2003), no functional studies have been performed 
on either of these nuclear trafficking proteins.  Furthermore, there are no reports
on the identification of any nuclear transport proteins in Toxoplasma.  Thus, the
newly mapped NLS in the N-terminal extension of TgGCN5 provided an ex
tool to studying the nuclear trafficking pathways in Toxoplasma. 
As the NLS of TgGCN5 is composed of highly basic residues, it was 
logical to theorize that Toxoplasma possessed a homologue of im
 
 
cellent 
portin α.  The 
Toxop h the 
f 
nt in 
 
. 
ow GCN5 and other 
proteins enter the parasite nucleus.  Discovering how to block chromatin 
ctors from entering the parasite nucleus 
may su  
he 
lasma protein database was screened using the BLAST algorithm wit
P. falciparum importin α sequence.  One search result revealed a high degree o
similarity to importin α.  Using the genomic database information, the gene was 
subsequently cloned.  The Toxoplasma homologue of importin α (TgIMPα) is 
composed of 545 amino acids and possesses two conserved domains prese
all known importin α proteins.  The importin β binding (IBB) domain is near the N-
terminus and is the region bound by importin β (Goldfarb, et al., 2004).  A long 
series of armadillo (ARM) repeats in the C-terminal half of the protein recognizes
and binds the basic NLS of nuclear proteins (Teh et al., 1999). 
In contrast to multicellular organisms, it appears that both Toxoplasma 
and P. falciparum possess only one importin α (Stewart and Rhodes, 1999)
 
Future Studies: It is important to continue elucidating h
remodeling proteins and transcription fa
bvert parasite differentiation and other processes essential for its survival. 
Novel elements found in the nuclear import pathway may be exploited in t
design of more selective therapeutic agents.  Additionally, the study of these 
pathways in protozoa provides a unique perspective on how these systems 
evolved in early eukaryotic cells. 
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The presence of an importin α homologue in Toxoplasma suggests that 
other components of the importin trafficking pathway should also be expressed 
by the parasite.  Bioinformatic searches using keywords or sequence data from 
other species reveals that Toxoplasma possesses homologues of other importin 
pathwa  
P. 
 
t 
 
onstrates the importance of continuing to 
charac
 an 
N5 
m.  
y components including: importin β, Ran, RCC1, CAS, and RanGAP1. 
Similar components of the importin pathway have been cloned previously in 
falciparum, including importin α, importin β (Mohammed et al., 2003), Ran 
(Dontfraid and Chakrabarti, 1994), and RCC1 (Ji et al., 1998).  These 
observations are consistent with the notion that the importin-mediated nuclear 
transport pathway is ancient in origin (Chook and Blobel, 2001). 
A screen of parasites that were treated with a non-specific mutagen 
revealed several clones defective in bradyzoite cyst formation in mice.  One of 
the mutations disrupted the genomic loci of the Toxoplasma homologue of RCC1
(Frankel et al., 2006).  RCC1 is a GTPase activating protein (GAP) involved in 
the importin trafficking pathway that activates the GTPase activity of Ran to 
hydrolyze GTP to GDP (Bischoff and Ponsting, 1991; see Figure 7, page 47).  I
has been hypothesized that the clone is defective in nuclear trafficking rendering 
the parasite unable form cysts making it susceptible to the host immune system 
(Frankel et al., 2006).  Additional studies have shown that the cyst formation is 
restored when recombinant Toxoplasma RCC1 is expressed in the defective
clone (Frankel et al., 2006).  The loss of RCC1 resulting in the defective to 
bradyzoite formation in mice dem
terize nuclear trafficking pathways in apicomplexans. 
 
D. Interaction of TgGCN5 with TgIMPα 
Discussion: Once it had been established that Toxoplasma possessed
importin α homologue, the next logical step was to determine if TgGC
interacted with TgIMPα and if that interaction occurred through the hexapeptide 
RKRVKR.  Both proteins were generated using an in vitro translation syste
The expression vectors used by the translation system incorporated an N-
terminal cMyc tag on TgGCN5 and an N-terminal hemagluttin (HA) tag on 
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TgIMPα.  Affinity resins directed to each tag were used in co-immunoprecipit
experiments to determine if the two proteins interacted.
ation 
  Unfortunately, the two 
protein  
s 
van 
f 
s 
N5 
 
 
tion 
immun gIMPα.  
s did not co-immunoprecipitate indicating that TgGCN5 and TgIMPα did
not interact. 
However, it was theorized that an interaction between the two protein
could mask the N-terminal fusion tags on both proteins and prevent the two 
interacting proteins from being co-immunoprecipitated.  Therefore, additional co-
immunoprecipitations were performed using an antiserum directed towards the 
C-terminal end of TgGCN5 that had been previously developed in the Sulli
Lab (Chapter 2, Section IV-B, page 71).  The antiserum targeted a region o
TgGCN5 that is away from the region involved in a potential interaction with 
TgIMPα alleviating the problem of masked fusion tags.  Co-immunoprecipitation 
experiments using the antiserum were able to pull down both proteins indicating 
they interacted with each other.  Control experiments were performed indicating 
that the antiserum is incapable of interacting with TgIMPα.  Therefore, the only 
way TgIMPα could have been isolated during the co-immunoprecipitation wa
through an interaction with TgGCN5.  The fact that the co-immunoprecipitation 
failed with the HA and cMyc affinity resins but was successful with the TgGC
antiserum supports the theory that the N-terminal tags were masked during an 
interaction between the two proteins.  Therefore, the concealment of the N-
terminal fusion tags provides a second line of evidence supporting an interaction
between TgGCN5 and TgIMPα. 
After it had been established that TgGCN5 and TgIMPα interacted with
each other, additional experiments were employed to determine if the NLS 
hexapeptide was involved in mediating the interaction.  A co-immunoprecipita
was performed using a truncated form of TgGCN5 lacking the first 99 amino 
acids (Δ99TgGCN5), which is just down stream from the NLS.  In co-
oprecipitation experiments, Δ99TgGCN5 was unable to pull down T
To further isolate the NLS as the element responsible for interacting with 
TgGCN5, a deletion mutant was generated (ΔNLSTgGCN5) removing the NLS 
and replacing it with an alanine-serine dipeptide.  ΔNLSTgGCN5 was also 
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incapable of pulling down TgIMPα indicating that the RKRVKR sequence is 
responsible for the mediating interaction with TgIMPα. 
It is important to note that the apicomplexan versions of importin α are 
more plant-like, which may have relevant functional and pharmacological 
implications.  In order for most proteins to be translocated into the nucleus, 
importin α must first be bound by importin β through an interaction with the IBB 
domain  
 may also possess the ability to translocate 
roteins to the nucleus without interacting with importin β.  Like all importin α 
homolo .  
ortin α 
in 
e IBB 
ne 
een in 
 
t TgGCN5 to the parasite nucleus.  
Therefore, it follows that TgIMPα is involved in trafficking TgGCN5 into the 
 (Kobe, 1999).  Once bound by importin β, importin α can interact with the
NLS of a nuclear protein.  However, importin α homologues in plants are able to 
translocate their cargo into the nucleus without being bound by importin β 
(Hubner et al., 1999).  TgIMPα
p
gues known to date, TgIMPα possess an IBB domain in its N-terminus
The IBB domain contains an autoinhibitory sequence which prevents imp
from binding an NLS (Kobe, 1999).  When the IBB domain is bound by import
β, the autoinhibiton is abolished and importin α is able to bind to an NLS.  The 
co-immunoprecipitation performed between TgIMPα and TgGCN5 used the 
entire native TgIMPα sequence which included the IBB domain.  Despite th
domain being present, TgIMPα was able to bind the TgGCN5 in vitro.  O
explanation is that TgIMPα does not require importin β to bind an NLS as s
plants.  Another explanation is the presence of an importin β protein in the 
translation system used to generate the TgIMPα and TgGCN5 proteins.  The in 
vitro translation system uses a cell fraction from rabbit reticulocytes, so it is 
possible that the cell fraction contains the rabbit homologue of importin β.  If 
present, the rabbit importin β may be facilitating the interaction between TgIMPα 
and TgGCN5.  Co-immunoprecipitation experiments performed with purified 
recombinant protein would provide a more accurate assessment of TgIMPα’s 
ability to bind TgGCN5 in the absence of importin β. 
In summary, the nuclear trafficking protein TgIMPα, interacts with 
TgGCN5 in vitro by binding the hexapeptide RKRVKR.  The sequence RKRVKR
has also been shown to be required to targe
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parasit tion, 
 
 
ites.  
5 was that TgIMPα did not require a prior 
interac
 
 
 
site 
s (Chapter 2, Section IV-E, 
page 8
5 
ate 
the 
e nucleus via an interaction with the hexapeptide RKRVKR.  In addi
the interaction of TgIMPα with TgGCN5 illustrates that the N-terminal extension 
participates in protein-protein interactions.  However, the interaction between 
TgIMPα and TgGCN5 has only been demonstrated through in vitro studies and
additional in vivo studies will need to be performed to confirm if TgIMPα is truly 
involved in trafficking TgGCN5 into the parasite nucleus.   
It is important to mention that these are the first studies elucidating how a
nuclear protein may be transported into the nucleus in apicomplexan paras
Furthermore, it is also the first study characterizing how a GCN5 protein is 
transported into the nucleus. 
 
Future Studies: An interesting finding in demonstrating the interaction 
between TgIMPα and TgGCN
tion with an importin β protein to alleviate the autoinhibition of the IBB 
domain.  It has been proposed that the cell lysate used in the in vitro translation 
system may contain a homologue of importin β that was facilitating the interaction
between TgIMPα and TgGCN5.  In order to remove potential artifact from
additional unknown proteins present during immunoprecipitation, pure 
recombinant proteins could be employed in future co-immunoprecipitation 
experiments.  TgIMPα could be expressed in Toxoplasma and purified by virtue
of an inframe fusion tag.  TgGCN5 would be purified from the transgenic para
line used to obtain protein for the in vitro HAT assay
0).  Purified recombinant TgGCN5 and TgIMPα could be mixed together 
and co-immunoprecipitated without the interference of other proteins.  If TgGCN
and TgIMPα interacted in the absence of any other proteins, it would provide 
fairly conclusive evidence that TgIMPα does not require importin β to bind an 
NLS indicating a sharp difference between Toxoplasma and other animal 
importin α homologues.  However, if the proteins do not interact, it would indic
that some element present in the in vitro translation system was facilitating 
interaction between TgGCN5 and TgIMPα. 
165 
The putative importin β homologue discovered in our bioinformatic 
searches of the Toxoplasma database could be cloned and overexpressed in t
parasites.  Following purification from parasite lysate, the Toxoplasma importin
homologue (TgIMPβ) would be added to co-immunoprecipitation experiments 
determining if it interacted with importin α through its IBB domain.  Additionall
performing co-immunoprecipitations comparing the ability of TgIMPα to pulll 
down TgGCN5 in the presence and absence of TgIMPβ would be the definiti
experiment to determine if TgIMPβ is required for TgIMPα to interact with 
TgGCN5.  If co-immunoprecipitations showed an increase in the amount of 
protein pulled down in the presence TgIMPβ, it would argue that TgIMPβ 
increases the strength of the interaction between TgIMPα and TgGCN5.  
Furthermore, it would indicate that TgIMPβ is probably required for TgIMPα to 
interact with an NLS in vivo. 
Once a stable transgenic parasite line overexpressing TgIMPα has b
generated, the thought of performing co-immunoprecipitations attempting to p
down TgGCN5 is tempting.  However, co-immunoprecipitations of TgIM
parasite lysate would pull down a multitude of nuclear proteins hindering 
detection of TgGCN5.  Furthermore, the interaction between TgGCN5 and 
TgIMPα is transient resulting in low yields of co-immunoprecipitated TgGCN5
making detection even more difficult.  The converse is also true.  Attempting t
perform co-immunoprecipitations using lysate from parasites overexpressing 
TgGCN5 would be plagued with similar limitations. 
he 
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Another important aspect in studying the nuclear localization of TgGCN5 
nt to transport the protein 
into the ol 
tact 
rs 
.  
tors (Adam and Gerace, 1991).  The 
advantage of this system is it allows for the selective addition of transport 
is determining if its interaction with TgIMPα is sufficie
 nucleus.  Treating living cells with digitonin permeabilizes the cholester
rich plasma membrane, but leaves the cholesterol poor nuclear membrane in
(Liu et al., 1999).  Digitonin permeabilization depletes the cytoplasm of facto
and proteins required for efficient nuclear import (Adam and Gerace, 1991)
Therefore, the import of nuclear substrates in digitonin-permeabilized cells 
requires the addition of purified transport fac
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protein
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et 
uclear 
ccurred.  A method has been reported for permeabilizing cells in 
suspen
 in 
assist in 
members of TgGCN5 HAT complexes 
s to determine which are involved in translocating TgGCN5 into the 
nucleus.  The only limitation is the ability to generate pure transport factors t
add back to the permeabilized cells.  If parasites overexpressing TgIMPα and 
TgIMPβ are successfully generated, they would provide an excellent source of
recombinant transport factors.  Once cells are permeabilized, the proteins of
interested are added to a HEPES-buffered acetate solution containing an ATP-
regenerating system (1mM ATP, 5mM creatine phosphate, 20U/ml creatine 
phosphokinase) to provide energy necessary to facilitate active transport (Liu 
al., 1999).  Immunofluorescent assays would be employed to determine if n
transport o
sion (Liu et al., 1999) that may work on freshly harvested extracellular 
tachyzoites.  If the permeabilization of parasites fails, the experiment may work
a mammalian cell line.  However, obtaining results using Toxoplasma parasites 
would be more meaningful as the nuclear pore complex may be divergent 
between parasite and mammal.  The basic experimental outline would be to 
assess the translocation of TgIMPα and TgGCN5 with and without the 
hexapeptide NLS and to determine if the addition of TgIMPβ is necessary to 
localize TgGCN5 to the nucleus.  If TgIMPα can transport TgGCN5 into the 
parasite nucleus without TgIMPβ it provides additional evidence that nuclear 
trafficking pathways in Toxoplasma are more similar to plants than animals.  
Establishing a digitonin permeabilization method in Toxoplasma will also 
characterizing the trafficking of other parasite nuclear proteins. 
 
E. Identifying 
Discussion: In addition to TgIMPα, we wanted to identify other proteins 
that could be interacting with TgGCN5.  GCN5 in other organisms does not 
function singly to remodel chromatin, but rather as a member of large multi-
subunit complexes (Roth et al., 2001).  The most likely candidate proteins 
interacting with TgGCN5 are those forming HAT complexes analogous to the 
SAGA and ADA complexes found in yeast. 
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Both the SAGA and ADA complexes possess GCN5 as their catalyt
(Grant et al., 1997).  The ADA complex is much smaller than SAGA, and is 
composed of three different proteins: Ada2, Ada3, and Ahc1 (Eberharter et
1999).  SAGA is a very large complex, approximately 1.8MD
ic core 
 al., 
a in size and has 
over 1
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not 
interacting with the N-terminal extension.  Dr. Mohamed-Ali Hakimi’s laboratory 
5 different subunits including four Ada proteins, several Spt and TAF 
proteins and Tra1 (Sterner and Berger, 2000).  In addition to proteins known to 
exist in the SAGA and ADA complexes, TgGCN5 may interact with parasite 
specific proteins not present in other GCN5 HAT complexes.  Novel proteins 
present in TgGCN5 complexes may interact with the unique N-terminus o
TgGCN5. 
To identify proteins interacting with the N-terminus, an attempt was mad
to overexpress the N-terminal extension of TgGCN5 in Toxoplasma fused t
FLAG tag.  Co-immunoprecipitations performed on parasite nuclear extract from
the transgenic parasites using FLAG affinity resin would identify interacting 
proteins.  However, attempts at trying to generate a transgenic parasite line 
expressing just the N-terminal extension of TgGCN5 were unsuccessful.  
Overexpression of only the N-terminus of TgGCN5 appears to be deleterious to
the parasite.  The deleterious nature of expressing the N-terminus of TgGCN5 
may be due to sequestering interacting proteins away from fully functiona
complexes causing a depletion of complex members resulting in a dysregula
of histone acetylation and parasite death.  Despite the failure of trying to 
overexpress the N-terminal extension of TgGCN5, it does provide preliminary
evidence that the N-terminal extension is involved in mediating protein 
interactions. 
A second option to identifying proteins interacting with TgGCN5 was to 
employ co-immunoprecipitation experiments using anti-FLAG affinity resin
parasites overexpressing recombinant full length TgGCN5 fused to FLAG tag
(FLAGTgGCN5) and TgGCN5 lacking the N-terminal extension also fused to a 
FLAG tag (FLAGΔNTTgGCN5).  Proteins isolated from FLAGTgGCN5 that are 
present in pull down assays from FLAGΔNTTgGCN5 would be judged as 
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at the French National Centre for Scientific Research has had success in 
purifying protein complexes from Toxoplasma.  Therefore, a collaboration was 
establi
e 
ve 
d 
 (Fan et al., 2004).  It is unknown why Toxoplasma would possess two 
Ada2 p
that at least two different HAT complexes containing 
TgGCN  
 
shed with Dr. Hakimi’s lab to biochemically purify proteins that may 
interact with full length FLAGTgGCN5 and FLAGΔNTTgGCN5. 
The co-immunoprecipitation from parasites overexpressing full length 
FLAGTgGCN5 revealed several interesting results.  The most interesting was th
identification of two different Ada2 homologues in Toxoplasma.  Ada2 is a well 
characterized protein known to associate with GCN5 in acetylation complexes 
(Eberharter et al., 1999).  Ada2 proteins associate with GCN5 acting as 
coactivators bridging the HAT complex to the acidic activation domains of DNA-
binding transcription factors and TATA-binding protein (Barlev et al., 1995).  It 
was unexpected to find two novel Ada2 homologues in an early branching 
eukaryotic cell like Toxoplasma.  While most metazoans and land plants ha
two Ada2s, our search results indicate that most protozoa, like yeast, have only 
one.  T. gondii appears to be an exception to this observation.  The related 
apicomplexan Plasmodium falciparum expresses a single Ada2 protein, terme
PfAda2
roteins when all other similar eukaryotes evidently only express one.  It is 
possible that one of the TgAda2 homologues operates independently of 
TgGCN5.  Drosophila has two Ada2 homologues, but only one (dAda2b) is 
incorporated into the SAGA complex (Kusch et al., 2003).  Data argues that 
dAda2a may have novel roles in transcription that are independent of GCN5 
(Kusch et al., 2003; Muratoglu et al., 2003).  Two different Ada2 proteins 
generates the possibility 
5 exist in Toxoplasma.  The different complexes may have independent
roles in regulating chromatin structure.  The apicomplexan Ada2 proteins 
PfAda2, TgAda2-A,  TgAda2-B are much longer than the Ada2 homologues 
present in other species, containing large regions flanking the Ada2 domain that
have no similarity to other protein sequences or known motifs (Bhatti et al., 
2006).  The function of these unique domains remains to be ascertained.  The 
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presence of unique domains suggests that apicomplexan Ada2 proteins may 
possess parasite specific functions not seen in other Ada2 proteins. 
In addition to the two Ada2 proteins, the full length FLAGTgGCN5 also 
pulled down four histone proteins: H3.3, H2A.1, H2AF/Z, and H4.  The hist
proteins H3.3, H2A.1, and H2A F/Z, are not the canonical core histones, but 
variant histones.  Histone variants are expressed in eukaryotic cells, and can
replace the four canonical histones that comprise the nucleosome (Henikoff e
al., 2004).  The existence of histone variants for histones H3 and H2A has b
previously reported in Toxoplasma and Plasmodium (Sullivan, 2003; Su
al., 2006; Miao et al., 2006).  Variant histones are associated with restructuring 
transcriptionally active chromatin (Kamakaka and Biggins, 2005).  Finding varia
histones interacting with TgGCN5 agrees with the TgGCN5’s predicted rol
remodeling chromatin.  The mechanisms involved in incorporating histone 
variants into the genome are poorly understood (Pusarla and Bhargava, 2005
is theoretically possible the HATs participate in depositing variant histones into
areas of the genome where active transcription is taking place (Kusch et a
2004). 
As the N-terminus is parasite-specific, proteins interacting with this region 
may also be unique to the parasite.  Parasite-specific proteins present in 
acetylation complexes may provide novel drug targets to combat apicomplexan
disease.  Two candidates, TgTwinScan_2624 and TgTigrScan_8186, were 
present in the co-immunoprecipitation of full length 
one 
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llivan et 
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uitful as 
 
FLAGTgGCN5.  However, 
further experiments are required to determine if these two proteins interact with
N-terminus of TgGCN5. 
The co-immunoprecipitations of FLAGΔNTTgGCN5 were not as fr
full length TgGCN5.  In hindsight, the experimental design may have been limited 
because FLAGΔNTTgGCN5 is cytoplasmic (Chapter 3, Figure 11, page 91).  As 
FLAGΔNTTgGCN5 is not localized to the nucleus, a proper comparative analysis 
between the two co-immunoprecipitations cannot be adequately performed.  It is
possible that HAT complexes may be completely or partially assembled in the 
cytoplasm before being transported into the nucleus.  Once assembled, an 
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interaction between one of the complex members (e.g. TgGCN5) and nuclear 
trafficking proteins would result in transport through the nuclear pore into the 
nucleus.  The nuclear pore complex has a rather large diameter pore capabl
translocating macromolecules and protein complexes exceeding 1.0MDa 
(Fahrenkrog and Aebi, 2003).  A “piggy back mechanism” has the advantage 
enabling the cell to provide equimolar concentrations of each subunit to the 
nucleus (Steidl et al., 2004).  Such a mechanism has been observed for the 
translocation of a heterotrimeric CCAAT-binding complex to the nucleus of 
Aspergillus nidulans.  A single subunit (HapB) within in the complex is 
responsible for nuclear localization of the entire complex (Steidl et al., 2004).
plausible that HAT complexes in Toxoplasma are assembled in the cytoplasm, 
with TgGCN5 serving as the critical member responsible for directing the 
complex into the nucleus.  Therefore, co-immunoprecipitations performed on 
parasites overexpressing 
e of 
of 
  It is 
ct rather than nuclear extract was used in the co-
immun xtract 
e 
ving 
ed 
 
and Hsp 70.  Full length FLAGTgGCN5 also revealed potential interactions with 
Hsp60  
t al., 
FLAGΔNTTgGCN5 may still provide a way to identify 
complex members.  However, because FLAGΔNTTgGCN5 is not present in the 
nucleus, whole cell extra
oprecipitations experiments.  The disadvantage of using whole cell e
versus nuclear extract is the large amount of background proteins present in th
lysate.  The large amount of background proteins resulted in difficulty resol
the elutions following co-immunoprecipitations with FLAGΔNTTgGCN5 parasite 
lystate.  Furthermore, the high amount of background proteins may have mask
potential complex members from being identified.  Thus, the interpretation of the
results from the FLAGΔNTTgGCN5 co-immunoprecipitation is limited by artifact 
caused by signification background proteins and lack of proper localization. 
Despite the limitations mentioned, co-immunoprecipitation with 
FLAGΔNTTgGCN5 indicated an interaction with the heat shock proteins Hsp60 
 and Hsp 70 as well as Hsp90.  Bradyzoite differentiation in Toxoplasma
can be generated in vitro under thermal and pH stress conditions (Soête e
1994).  The three heat shock proteins, Hsp60, Hsp 70, and Hsp90, have been 
shown to be involved in the transition between the two different parasite stages 
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(Weiss et al., 1998; Weiss and Kim, 2000).  In other organisms, GCN5 is 
involved in stress remediation.  GCN5 has been linked to activating stress 
respon
 
in response to stressful stimuli in Toxoplasma.  Therefore, 
TgGCN
 
5-containing 
 
, 2000).  Hsp70 and hsp90 have been shown 
to aid i
HAT 
plexes 
N5.  As outlined in the 
introdu
 the 
se pathways during amino acid and phosphate starvation in yeast 
(Georgakopoulos and Thireos, 1992; Gregory et al., 1998).  In Arabidopsis, 
GCN5 appears to be involved in the activation of stress response proteins during
exposure to low ambient temperatures (Stockinger et al., 2001).  Evidence of an 
interaction between heat shock proteins and TgGCN5 indicates that TgGCN5 
may also be involved 
5 may be involved in the bradyzoite differentiation process.  The 
mechanisms involved in recruiting GCN5-containing complexes to remodel areas 
of the chromatin during stress are poorly understood.  Heat shock proteins which
are expressed in higher levels during stress events (Schlesinger, 1990) may 
participate in directing the chromatin remodeling activity of TgGCN5-containing 
complexes leading to the upregulation and expression of genes involved in 
bradyzoite conversion.  The same process may occur with GCN
complexes in other organisms during stressful stimuli. 
Another reason for the interaction between heat shock proteins and 
TgGCN5 may be their involvement in the assembly of HAT complexes.  Heat
shock proteins function as chaperones in the construction of large protein 
complexes (Kimmins and MacRae
n the assembly of steroid receptors (Kimmins and MacRae, 2000) and 
Hsp 90 is involved in the initial formation of the kinetochore complex (Bansal et 
al., 2004).  Heat shock proteins may play a similar role in the assembly of 
complexes in Toxoplasma.  It is theoretically possible that TgGCN5 com
change composition under bradyzoite conditions.  Heat shock proteins may 
facilitate the change in composition TgGCN5 preceding bradyzoite conversion. 
 
Future Studies: Bioinformatics could aid significantly in the pursuit of 
identifying potential proteins interacting with TgGC
ction, many of the proteins present in GCN5-containing complexes have 
been identified in other species.  Table III is the result of a BLAST search of
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Tknown members of yeast S
Interestingly, the database contains no homologues for the members of 
th omp Ada1 da 2.  T T 
search did confirm the presence of two Ada2 proteins in Toxoplasma.  The lack 
of additional ADA complex members hat eith plasma does not 
posse ADA comp n ana plex co ivergent me bers 
not present in yeast. 
 of the cha zed S e yeas
complex appear to present in Toxop oplasm ancient euka yote 
and its GCN5-containing complexes may be more streamlined lacking many of 
the proteins in yeast or metazoans. , addi T compone ts 
lack s t homolog  detec LAST  The only pr eins 
for which putative homologues could d were Taf60, and a1.  
These proteins were not isolated in the full length TgGCN5 co-
immunopreciptiation.  The Taf90, Taf60, and Tra1 proteins may have been in too 
low ce to b d in th opr dditio  
siz tive Tra xoplas 3383  to be
kilod hich exe resolu  of the ed to resolv  the 
co-immunoprecipitated proteins. 
In fact, the sizes of the putative SAGA subunit homologues in Toxoplasma 
are larger than their yeast counterpar Toxoplasma 
homologues for Tra1, Ada2-B, and G er tw  of the
corres ng homolo he la  com mbers in 
Toxo suggests they have functions beyond their yeast counterparts.  The 
additional function may compensate for the limited number of complex members.  
As these HAT complexes ma
such  and Ada  have  into th r subunits p esent 
If additional complex members exist, they are either novel members not 
seen in other GCN5 containing complexes, or they are too divergent to be  
oxoplasma database predicted proteins based on the Draft3 algorithm with 
AGA and ADA complexes. 
e yeast ADA c lex (Ahc1, , Ada3, or A 5) besides Ada he BLAS
 suggests t er Toxo
ss an lex or a logous com ntains d m
None racteri pt or SGF prot ins found in the t SAGA 
lasma.  Tox a is an r
 Alternatively tional HA n
ufficien y to be ted by the B search. ot
 be identifie  Taf90, Tr
 in abundan e isolate e co-immun ecipitation.  A nally, the
e of the puta  1 in To ma, 59.m0 , is predicted  909 
altons, w eds the tion capacity  gels us e
ts.  As shown in Table IV, the 
CN5 are ov ice the size ir 
pondi gues.  T rge size of the plex me
plasma 
evolved, the larger Toxoplas  subunit homologues 
 as Tra1 2-B may  fragmented e smalle r
in yeast, each with their own specialized function. 
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Table III: Results of BLAST search of Toxoplasma database for ADA and 
SAGA complex members 
 
Protein Name B t Potential Hits Identity Score 
Co
Found 
mplex last Wi h 
Ahc1 ADA Y NONE  OR023C 
Ada1 SAGA YPL254W NONE  
35.m00936 - A <1e-100 
Ada2 Both 3
55.m04988 - B 4.1e-67 
AAA3439 .1 
Ada3 Both YDR176W NONE  
Ada5/Spt20 SAGA AAB07900 NONE  
Spt 3 NONE  SAGA YDR392W 
Spt 7 NONE  SAGA YBR081C 
Spt8 SAGA 0 C NONE  YLR 55
Taf5/Taf90 SAGA YBR198C 641.m01468 1.7e-13 
Taf6/Taf 60 A  1.8e-6 S GA YGL112C 86.m00838 
Taf9/17 SAGA Y NONE  MR236W 
Taf1 f25 SAGA YDR167W NONE  0/Ta
Taf1 f68 SA  Y 1 W NONE  2/Ta GA DR 45  
Tra1 SAGA AF076974 59.m03383 3.6e-66 
Sin4 SAGA A 4 NONE  AA3504 .1 
SGF11 SAGA YPL047W NONE  
SGF29 SAGA NONE  YCL010C 
SGF73 SAGA YGL066W NONE   
list of complex members adapted from R ., 20
 
oth et al 01 
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Table IV: Size comparison 
Protein Name S. cereviIdentifi
of Toxoplasma and Saccharomyces cerevisiae SAGA complex
siae 
er 
Estimated 
Size (kD) 
Toxoplasma 
Identifier 
Estimated 
Size (kD) 
P
Diff
 members 
ercent 
erence 
GCN5 YGR252W 51.1 AAF29981 126.8 248.1% 
35.m00936 (A) 109.9 108.3% 
Ada2 AAA34393.1 101.5 
55.m04988 (B) 248.9 245.2% 
Taf5/Taf90 YBR198C 57.9 641.m01468 89.3 154.2% 
Taf6/Taf 60 YGL112C 88.9 86.m00838 117.9 132.6% 
Tra1 AF076974 433.2 59.m03383 909.0 209.8% 
kD = kilodaltons 
 
detecte nique 
T 
site 
5 
esis.  To better ascertain the involvement of the N-terminal extension 
in prot
rom 
sed to 
t in 
 
  The 
d with nuclear 
xtract from wild-type parasites.  The immobilized N-terminus would be bound by 
ct.  The N-terminus protein complexes would 
be elut  
d using bioinformatic techniques.  Therefore, a large screening tech
such as additional co-immunoprecipitations, a yeast two hybrid screen, or a GS
pull down assay could be employed to identify additional complex members.  
Assays pertinent to this thesis would focus on identifying complex members that 
interact with the unique N-terminus of TgGCN5. 
As mentioned in the discussion, the co-immunoprecipitations from para
overexpressing FLAGΔNTTgGCN5 had limited utility because FLAGΔNTTgGCN
does not localize to the parasite nucleus.  FLAGΔNTTgGCN5 is cytoplasmic, 
hence it prevented the use of nuclear extract resulting in a higher amount of 
background proteins and subsequent poor resolution of elutions using gel 
electrophor
ein-protein interactions, a different protein could be expressed in the 
parasites.  For example, fusing the TgGCN5 NLS sequence, RKRVKR, to 
FLAGΔNTTgGCN5 should localize it to the parasite nucleus.  A protein that is 
targeted to the nucleus would allow for the use of nuclear extract in co-
immunoprecipitations, lowering the amount of background interference f
cytoplasmic proteins.  Co-immunoprecipitations with FLAGΔNTTgGCN5 fu
the TgGCN5 NLS would provide a better comparison to FLAGTgGCN5 in 
identifying proteins associating with the N-terminal extension of TgGCN5.  In 
addition, elutions from additional co-immunoprecipitation experiments could be 
resolved using 2D gel electrophoresis to provide better resolution and assis
identifying more potential interacting proteins. 
Other biochemical approaches that could be used include a GST pull 
down assay.  The N-terminal extension of TgGCN5 would be expressed in
bacteria or yeast fused to glutathione S-transferase (GST) tag.  The recombinant 
N-terminus is purified, concentrated, and immobilized on a glutathione resin.
glutathione resin containing the N-terminus would be incubate
e
various proteins present in the extra
ed off the GST affinity resin and resolved using 2D gel electrophoresis. 
Spots present on the 2D gel could be excised and sent for sequencing analysis. 
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A yeast two-hybrid screen is currently being performed using the N-
terminus as bait to screen a tachyzoite cDNA library for potentially interacting 
proteins.  The advantage of yeast-two-hybrid is a large number of proteins 
be rapidly screened searching for potential complex members.  However, yeas
two hybrid screens are often limited by the potential for false positives.  
Furthermore, some parasite proteins may be toxic to yeast and expressed in 
either low at levels or not at all.  Depending on how the library is gene
proteins expressed in low abundance might not be adequately represented i
such a screen.  Nevertheless, a yeast two hybrid screen has the potential to 
provide a start
can 
t 
rated, 
n 
ing point from which to begin elucidating additional complex 
memb
x.  
, 
 stress caused by mitochondrial 
dysfun
te 
 
ers. 
There are variants of the yeast SAGA complex that have been identified 
and appear to be more involved in stress remediation than the SAGA comple
A variant of the SAGA complex, termed SALSA (SAGA altered, Spt8 absent) 
lacks the Spt8 subunit (Sterner et al., 2002).  The SALSA complex has been 
reported to be more actively involved in the upreglation of histidine and 
tryptophan biosynthetic pathways during amino acid starvation over the 
traditional SAGA complex (Sterner et al., 2002).  The SLIK (SAGA-like) complex 
is another SAGA variant that also lacks Spt8, contains an altered form of Spt7
and potentially includes a number of additional components not found in SAGA 
(Pray-Grant et al., 2002).  The SLIK complex appears to be involved in the 
expression of certain nuclear genes during
ction (Pray-Grant et al., 2002).  The HAT complexes in Toxoplasma may 
also alter their compositions during stress (i.e. bradyzoite differentiation).  
Therefore, it would be important to include bradyzoite nuclear extract in the GST 
pull down assays or a bradyzoite cDNA library in a yeast two hybrid screen 
searching for potential GCN5-containing complex members. 
 
F. Histone acetylation by TgGCN5 
Discussion: All GCN5 homologues known to date selectively acetyla
histone H3 in nucleosomal substrates in vivo (Ruiz-Garcia et al., 1997).  Histone
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H3 possesses several conserved lysine residues that can be acetylated, and 
GCN5 preferentially acetylates lysine 14 (Kuo et al., 1996).  Recombinant 
also weakly acetylates lysine 8 and lysine 16 of histone H4 in vitro but it is 
doubtful GCN5 mediates modifications of histone H4 in vivo once it has been 
incorpo
GCN5 
rated into the SAGA complex (Grant et al., 1999).  The unique N-terminal 
extens atic 
 and 
on the 
ability e not 
 
 
 the 
assess the enzymatic activity of TgGCN5, a positive control and in vitro 
HAT a
N5 
N-
HAT 
 
or 
 H1 but 
ion of TgGCN5 raised the possibility that it may influence the enzym
activity of TgGCN5, making it different from previous study of GCN5 
homologues.  However, the catalytic domain of TgGCN5 is well conserved, 
sharing approximately ~60% with the yeast GCN5 catalytic domain (Sullivan and 
Smith, 2000). 
The relatively long N-terminal extensions present in mouse and human 
GCN5 and PCAF are involved in substrate recognition.  When the N-terminus is 
deleted in mouse and human GCN5 and PCAF, the ability to recognize
acetylate nucleosomal histones is lost (Xu et al., 1998).  However, deletion of the 
mouse and human GCN5 and PCAF N-terminal extension has no effect 
of these GCN5 enzymes to recognize and acetylate histones that ar
incorporated into nucleosomes.  Even though the N-terminal extensions are not 
homologous, the unusual N-terminal domain of TgGCN5 may also have a role in
regulating substrate specificity and/or acetylase function.  It was of interest to
determine if the long and divergent N-terminus of TgGCN5 was required for
acetylation of non-nucleosomal histones in solution and the specific histone and 
lysine residue(s) acetylated by TgGCN5. 
To 
ssay were developed based on previously described assays in the 
literature (Brownell et al., 1996).  Recombinant Saccharomyces cerevisiae GC
(ScGCN5) was express in E. coli bacteria and purified by virtue of an in-frame 
terminal 6X histidine fusion tag.  ScGCN5 was used in an in vitro radioactive 
assay measuring HAT activity using tritiated acetyl CoA and core histones.  In
our in vitro assay, ScGCN5 showed a strong acetylation of histone H3 and min
activity on histone H4, consistent with activities reported previously in the 
literature (Kuo et al., 1996).  ScGCN5 also appears to acetylate histone
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additional studies indicated that GCN5 homologues do not acetylate H1 in vivo
(Herrera et al., 1997).  Thus, we successfully recreated the in vitro assay 
published in the literature and generated an in-house positive control allowing for 
 
the an  
 
onds, 
ins that may be required to 
assist 
d 
 
 
s from 
re, in vitro HAT assays were performed with 
alysis of TgGCN5 and any additional Toxoplasma HATs identified in the
future. 
Since enzymatically active ScGCN5 was able to be expressed and
purified from bacteria, an attempt was made to express TgGCN5 in bacteria.  
Despite our best efforts, we were unable to elicit significant acetylase activity in 
our HAT assay from recombinant TgGCN5 produced in bacteria.  The most likely 
explanation for the lack of activity is the inability of bacteria to perform the 
necessary posttranslational modifications required by TgGCN5 to generate full 
acetylase activity.  Bacteria have a limited capacity to generate disulfide b
which restricts their ability to generate functional eukaryotic proteins.  
Additionally, bacterial do not possess chaperone prote
in folding TgGCN5 into its proper conformation (Makrides, 1996). 
Multiple methods are available for improving the odds of obtaining 
functional protein from bacteria (Derman et al., 1993; Cole, 1996; Terpe, 2003).  
Alternatively, eukaryotic expression systems such as yeast and baculovirus are 
capable of generating active recombinant eukaryotic proteins (Schmidt and 
Hoffman, 2002).  Any one of these methods could have been successful in 
producing enzymatically active TgGCN5, but a significant amount of time woul
have been spent optimizing expression conditions without any guarantee of 
success. 
To obtain active TgGCN5 with minimal time devoted to optimizing protein
expression, we purified protein from the transgenic parasites overexpressing 
FLAGTgGCN5 and FLAGΔNTTgGCN5.  The advantage of obtaining recombinant
protein from Toxoplasma is that it was very likely to have proper folding and 
posttranslational modifications required for HAT activity.  Using commercially 
available anti-FLAG affinity resin, the recombinant proteins were purified from 
parasite lysate.  However, difficulty arose when trying to elute the protein
the affinity resin.  Therefo
179 
FLAGTg
itro.  
rential acetylation 
f histone H3 is not surprising.  Loss of the N-terminal extension does not appear 
to affe
mal 
 
as 
nt HAT protein present in the ΔNTTgGCN5 HAT assay versus the full 
ngth reaction (Figure 28-A, page 146).  The N-terminal extension may stabilize 
 is evidence that human 
PCAF  
ll lower 
n 
still bo
ytic 
lly 
GCN5 or FLAGΔNTTgGCN5 still bound to the affinity resin.  Fortunately, 
both proteins retained enzymatic activity and acetylated core histones while still 
bound to the affinity resin 
Both TgGCN5 and ΔNTTgGCN5 are able to acetylate free histones in 
solution suggesting that the N-terminal extension is dispensable for the 
acetylation of non-nucleosomal histones.  As expected for a GCN5 HAT, 
TgGCN5 preferentially acetylates histone H3 and to a lesser extent H4 in v
Given the homology of the TgGCN5 catalytic domain, the prefe
o
ct the histones that are acetylated by TgGCN5 suggesting that the N-
terminal extension does not play a role in the recognition with non-nucleoso
histones.  The dispensability of the N-terminal extensions in TgGCN5 for 
acetylation of non-nucleosomal histones parallels observations of the N-terminal
extensions present in metazoan GCN5 homologues. 
At first glance, the HAT assay results indicate that full length TgGCN5 h
a stronger acetylation activity than the truncated form (Figure 28-B, page 146).  
Furthermore, the Western blot performed in parallel suggests that there is more 
recombina
le
TgGCN5 generating stronger catalytic activity.  There
appears to transacetylate its own N-terminus, potentially stabilizing the
enzyme (Herrera, 1997).  The TgGCN5 N-terminal extension may undergo 
similar transacetylation.  Loss of the N-terminal extension and subsequent 
modification would result in a less stable form of TgGCN5 and an overa
activity.  However, it may also be an artifact caused by using recombinant protei
und to the affinity resin.  The FLAG tag in both recombinant proteins is 
present on the amino-terminal end.  Therefore, the FLAG tag places the catal
domain of FLAGΔNTTgGCN5 in close proximity to the affinity resin, potentia
impeding its HAT activity.  Finding a method to effectively elute the proteins off 
the affinity resin or moving the FLAG tag to the C-terminus would give a 
meaningful comparison. 
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As with ScGCN5, TgGCN5 appears to be able to acetylate H1.  Unlike 
other eukaryotic organisms, apicomplexan parasites do not appear to possess a 
histone H1 homologue (Sullivan et al., 2006).  It is possible that the H1 ortholo-
gue present in apicomplexa is too divergent to detect.  A histone H1 knockout 
Tetrahymena, a protist related to Toxoplasma, grows normally, indicating that H
may not be necessary in protozoa (Shen et al., 1995).  Nonetheless, the abilit
acetylate histone H1 in vitro is conserved in TgGCN5 despite the fact that 
Toxoplasma does not express a canonical histone H1 protein. 
 
in 
1 
y to 
 and 
e the in vivo substrate of 
GCN5
 
le 
ibodies specific to 
 
Future Studies: The N-terminus does not appear to play a role in the 
acetylation of non-nucleosomal histones.  It still remains possible for the N-
terminus of TgGCN5 to be involved in the recognition of nucleosomal histones.  
As mentioned previously, the long N-terminal extensions present in human
mouse GCN5 are required for the recognition and acetylation of nucleosomal 
histones.  Therefore future studies should assess the enzymatic activity of full 
length TgGCN5 and ΔNTTgGCN5 on nucleosomal substrates.  Measuring 
activity on nucleosomal histones is desirable as these ar
 proteins. 
 
G. Determining the lysine(s) acetylated by TgGCN5 
Discussion: Once it had been established that TgGCN5 preferentially 
acetylated histone H3, we wanted to identify which of the conserved lysine 
residues were acetylated by TgGCN5 and if the unique N-terminal extension
influenced which residues were acetylated.  To date, all known GCN5 
homologues preferentially acetylate lysine 14 in histone H3 (Kuo et al., 1996).   
To determine the acetylation target of TgGCN5, in vitro HAT assays were 
performed with TgGCN5 and FLAGΔNTTgGCN5 using commercially availab
recombinant histone H3 instead of core histones.  The HAT assays were 
subsequently transferred to a Western blot and stained with ant
acetylated lysine residues.  Given the acetylation patterns of previously studied 
GCN5 homologues (Kuo et al., 1996), antibodies detecting acetylation on lysine
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14 were initially used.  As predicted, the recombinant ScGCN5 (positive control) 
generated in bacteria strongly acetylated histone H3 on lysine 14.  However, both 
gGCN5 and FLAGΔNTTgGCN5 failed to show significant acetylation of lysine 14 
in histo
AT 
o 
 
eference 
nked 
8 
rase 1; Daujat et al., 
2002).
 
T
ne H3.  The lack of acetylation by TgGCN5 on lysine 14 of histone H3 
was a very surprising and unprecedented result.  TgGCN5 represents the first 
GCN5 protein that does not acetylate lysine 14.  However, our previous H
assays performed with core histones clearly indicate that TgGCN5 acetylates 
histone H3.  Therefore, acetylation of lysines 9 and 18 in histone H3 were als
examined. 
As expected, ScGCN5 showed strong acetylation on lysines 9 and 18, but 
TgGCN5 and FLAGΔNTTgGCN5 appeared to only acetylate lysine 18.  Of the 
three lysine residues examined, lysine 18 of histone H3 appears to be the only 
one acetylated by TgGCN5, which is highly unusual for a GCN5 protein.  
However, despite the unusual acetylation pattern, removal of the N-terminus did 
not have any effect on which lysines were acetylated.  Therefore, the N-terminal 
extension does not appear to play a role in dictating which lysine residues are
acetylated by TgGCN5 in non-nucleosomal histone H3. 
Selective acetylation of lysine 18 has not been reported for any other 
GCN5 HAT.  As seen with ScGCN5, it was expected that TgGCN5 would be 
capable of acetylating lysine resides 9, 14, and 18, but with a stronger pr
for lysine 14.  In humans, acetylation of lysine 18 in histone H3 has been li
to subsequent methylation at arginine 17.  In humans, the acetylation of lysine 1
in vivo is catalyzed by the HAT CBP followed by arginine 17 methylation by 
CARM1 (cofactor-associated arginine [R] methyltransfe
  A CBP homologue is absent in Apicomplexa and is not present in other 
early eukaryotes (Sullivan et al., 2006).  It is plausible that TgGCN5 has adopted 
a CBP-like function in acetylating lysine 18 of histone H3 in Toxoplasma.  
Recently, a homologue of CARM1 has been cloned in Toxoplasma (TgCARM1) 
that methylates arginine 17 (Saksouk et al., 2005).  Chromatin 
immunoprecipitation (ChIP) experiments revealed a strong correlation between
lysine 18 acetylation and arginine 17 methylation suggesting that TgGCN5 and 
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TgCARM1 may work in concert to facilitate chromatin remodeling in Toxoplasma 
(Saksouk et al., 2005). 
 
Future Studies: The selective acetylation of lysine 18 and not 14 in histo
H3 by TgGCN5 was a most unexpected result.  The selective acetylation of o
one lysine seems to be highly unsual when compared to other HATs that 
possess the ability to acetylate multiple residues.  The Plasmodium homolog
of GCN5 (PfGCN5) has been demonstrated to acetylate lysines 9 and 14
histone H3 (Miao et al., 2006).  It is important to n
ne 
nly 
ue 
 of 
ote that the in vitro HAT assays 
with Pf
nd 
 
e 
sma 
tone H3 
or the recombinant Xenopus laevis histone H3 
used in
s 
er, 
5 on histone H3, its activity on histone 
H4 ma
d 
GCN5 were performed using recombinant Plasmodium histone H3 (PfH3; 
Miao et al., 2006).  The homology between the catalytic domain of PfGCN5 a
TgGCN5 is very high (~ 85%).  The high degree of homology suggests that the
acetylase activity of both proteins should be comparable.  The only differenc
between the PfGCN5 HAT assay and the assay used to assess TgGCN5 assay 
was the source of histones.  Therefore, it may be worthwhile to use Toxopla
histones in future enzymatic assays.  The four canonical core histones have 
been identified and characterized in Toxoplasma (Sullivan et al., 2006).  
Toxoplasma histone H3 differs very little from the chicken erythrocyte his
used in the radioactive assay 
 the non-radioactive assay (Sullivan et al., 2006).  Nevertheless, 
enzymatic assays should be performed to confirm that TgGCN5 does not 
acetylate endogenous histones differently.  The divergent N-terminal extension 
may interact with endogenous histones differently than heterologous histones 
resulting in a different enzymatic activity for TgGCN5. 
When core histones were used as substrates, TgGCN5 showed modest 
activity on histone H4.  The activity was dismissed as an in vitro artifact that ha
been seen in other GCN5 proteins that is not believed to occur in vivo.  Howev
given the selective acetylation of TgGCN
y not be artifact and should be investigated further.  Commercial 
antibodies recognizing residue specific acetylation of histone H4 are available 
and could be used to determine which lysines in histone H4 are being acetylate
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by TgGCN5.  However, the western blot approach is limited by the availability of 
antibodies to recognize specific histone modifications.  An alternative detec
method is to use MALDI/TOF (matrix-assisted laser desorption/ionization time-o
flight) and tandem mass spectrometry to identify the acetylation sites (Cocklin 
and Wang, 2003).  The advantage of using MALIDI/TOF is it allows for a full 
post-translational modification analysis on an entire histone protein assess
any place that TgGCN5 acetylates the protein.  It would be important to use 
recombinant histone proteins produces in bacteria to limit the amount of 
background acetylation present on the histones. 
It should be noted that two MYST homologues, TgMYST-A and –B, h
been cloned in Toxoplasma (Smith et al., 2005).  In other organisms, MYST 
HATs are the prote
tion 
f-
ing 
ave 
ins typically responsible for acetylating histone H4.  In vitro 
HAT a
ts that 
ible 
.  Future studies to assess this possibility will be 
ddressed in a latter section. 
mplexes are elucidated, their enzymatic activity 
should n profile 
 
 
, 
insight on the promoters that are remodeled through acetylation at lysine 18 in 
ssays with TgMYST -A demonstrate it strongly acetylates histone H4 
(Smith et al., 2005).  The presence of MYST HATs in Toxoplasma sugges
the parasite already possesses proteins capable of acetylating histone H4, 
reducing the likelihood that TgGCN5 acetylates histone H4 in vivo.  It is plaus
that TgGCN5’s primary function is to acetylate other transcription factors or 
proteins in the parasite
a
As TgGCN5-containing co
 be assessed as well.  TgGCN5 may have an expanded acetylatio
once it is incorporated into a complex.  Recombinant yeast GCN5 is capable of 
acetylating multiple lysine residues, but has a strong preference for lysine 14 in
histone H3 (Grant et al., 1999).  In vitro HAT with yeast ADA and SAGA
complexes indicated that the ADA complex acetylates both lysines 14 and 18
and SAGA acetylates to all four lysines in H3.  These results indicate that the 
association of yeast GCN5 with different proteins within HAT complexes may 
alter the substrate specificity of GCN5. 
The unusual acetylation specificity of TgGCN5 may have specific 
functions in the parasite.  Chromatin immunoprecipitation (ChIP) may yield some 
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histone H3.  The transgenic parasite line overexpressing FLAGTgGCN5 has been
used in 
 
preliminary ChIP assays showing TgGCN5 present at the SAG2A 
(surfac
d to 
 
 
ther GCN5 homologue (Bhatti et al., 2006).  Two GCN5 
homolo d 
al., 
 
wild ty
 
gGCN5 
e antigen 2-A) promoter (Saksouk et al., 2005).  SAG2A is a tachyzoite 
specific gene (Lekutis et al., 2001) suggesting that TgGCN5 may be involved 
regulating tachyzoite gene expression.  Additional ChIP assays are warrante
determine if TgGCN5 is associated with other tachyzoite promoters.  It is 
possible that TgGCN5 may be involved in the genetic switching that occurs 
during reactivation of bradyzoites back into tachyzoites.  Recrudescence of 
bradyzoites is the major cause of illness in humans with suppressed immune 
systems (Reiter-Owona et al., 2000).  The possibility that TgGCN5 may be 
involved in this process is exciting as it would represent the first factor associated
with this process. 
The fact that TgGCN5 does not acetylate histone H3 at lysine 14 suggests 
that either lysine 14 is not acetylated in Toxoplasma or another protein is 
responsible for the acetylation.  Searches of the Toxoplasma database revealed
the presence of ano
gues present in a lower eukaryote is unprecedented and will be discusse
in a following section. 
 
II. A TgGCN5 Deletional Mutant 
Experiments performed by others in the Sullivan Lab lead to the 
development of a stable deletional mutant of TgGCN5 (ΔTgGCN5; Bhatti et 
2006).  No observable phenotype difference is noted for the ΔTgGCN5 clone.  
When the expression of GCN5 is disrupted in yeast, there is no readily 
observable phenotype, either (Georgakopoulos and Thireos, 1992).  Further 
analysis revealed no appreciable difference in parasite growth rates between the
pe and ΔTgGCN5 (Bhatti et al., 2006).  In collaboration with Dr. David 
Sibley (Washington University, St. Louis, MO), mice were infected with 
ΔTgGCN5 to determine if loss of TgGCN5 impaired virulence in vivo.  Loss of
TgGCN5 did not have any effect on parasite virulence suggesting, that T
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does not play a significant role during the acute stage of infection (Bhatti et al., 
2006). 
While a viable knockout of TgGCN5 suggests the protein is not essential 
in tachyzoites, it offers the opportunity to identify genes that may be controlled by 
this HAT in the parasite.  Others in the Sullivan Lab have employed 2D gel 
analysis to assess the differential expression between wild-type and ΔTgGCN5 
parasites.  The 2D-gel analysis revealed several proteins down-regulated in the 
ΔTgGCN5 that are associated with host cell invasion including MIC4, MIC5, and 
MIC11 (Bhatti et al., 2006).  The MIC proteins are found within the micronemes, 
a secretory organelle apart of the apical complex that facilitates invasion of h
cells (Achbarou et al., 1991).  Despite the apparent reductions in the expression 
and secretion of these microneme proteins, any difference in parasite attachment
or invasion was undetectable (Bhatti et al., 2006).  It is possible that the obs
deficiencies on the 2D gel are not profound enough to alter the invasion process
or other invasion proteins are compensating for the reduced amounts of MIC4, 
MIC5, and MIC11. 
Interestingly, one of the enzymes that was upregulated in the ΔTgGCN
mutant was enolase I.  There are two paralogues of enolase in Toxoplasma that 
are stage specific (Singh et al., 2002).  Enolase 2 (ENO2) is expressed only in 
tachyzoites (Dzierszinski et al., 2001).  Enolase 1 (ENO1) is bradyzoite-spec
and possesses different enzyme kinetics that are believed to slow the metabolic 
rate of bradyzoites (Dzierszinski et al., 2001).  During the tachyzoite stage, 
enolase 1 expression is repressed (Kibe et al., 2005).  The increased levels of 
ENO1 suggest that TgGCN5 may play a role in maintaining the repression of the
ENO1 promoter during the tachyzoite stage.  The dysregulation of a brad
specific-gene provides evidence that TgGCN5 is linked to stage differentiation. 
Comprehensive microarrays for Toxoplasma are in the final stages of 
development.  When they are complete, it will be important to compare an
contrast mRNA expression between wild-type and the TgGCN5 knockout.  It 
ost 
 
erved 
 
5 
ific 
 
yzoite 
d 
would provide another tool to search for genes regulated by TgGCN5.  
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Microarray analysis would also determine if the differences detected by 2D gel 
results are reflected in the mRNA pool. 
There are three different strains of Toxoplasma (Howe and Sibley, 1995).  
 virulent strains because they are 
 al., 2002).  Types II and III 
grow m d 
 of 
e 
molecu
 
re 
nd Sibley, 1995).  Since 
the typ
r, 
he 
ess 
f TgGCN5 on the 
develo
The type I strains, like the RH strain, are termed
fast growing and uniformly lethal in mice (Sibley et
uch slower and mice often survive infection with these parasite lines an
remain chronically infected and seropositive (Sibley et al., 2002).  The majority
human toxoplasmosis cases are caused by a member of the type II strain (How
and Sibley, 1995).  Interestingly, the three lineages of T. gondii differ by only 1–
2% at the DNA sequence level (Su et al., 2002).  The ΔTgGCN5 clone was 
generated in the RH strain which belongs to the type I group and used in routine 
lar experiments because the fast growing nature of the parasite makes it 
more amenable to genetic manipulation (Bhatti et al., 2006).  However, the 
virulent, type I, RH strain of Toxoplasma, has largely lost its ability to convert to 
the bradyzoite cyst form (Dubey et al., 1999).  Therefore, it is not the ideal strain 
to assess the deletional effect of TgGCN5 on bradzyoite differentiation.  A more 
appropriate study would be to generate a deletional mutant in a type II strain
such as ME49 or Pru.  The type II strains are much slower growing and therefo
easier to differentiate into bradyzoites in vitro (Howe a
e II parasites are more commonly found human infections, making a 
TgGCN5 deletional mutant in these strains is more clinically relevant.  Howeve
generating a deletional mutant in a type II strain is much more challenging 
because of the slow growing nature of the parasites.  Nonetheless, a deletional 
mutant of TgGCN5 in a type II strain would allow for a better assessment of t
potential involvement of TgGCN5 in differentiation (Dubey et al., 1998).  
Additionally, a deletional mutant in a type II strain provides the ability to ass
bradyzoite differentiation in vivo using animal models and can also be fed to 
felines under laboratory conditions to assess the loss o
pment of micro- and macrogametes and oocysts (Dubey et al., 1970). 
Continued characterization of the ΔTgGCN5 strain will provide further 
information about role of TgGCN5 histone and protein acetylation in the parasite 
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and may provide a better understanding of bradyzoite differentiation and host ce
invasion. 
 
III. Additional HATs in Apicomplexan Parasites 
A. A second homologue of GCN5 in Toxoplasma 
From the studies conducted during this thesis, we have concluded that
TgGCN5 is unable to acetylate histone H3 at lysine 14.  In addition, w
ll 
 
hen the 
genom
 that 
g 
 
sence 
nd 
ATs in 
 the second homologue of 
GCN5 w 
cids, 
 
 
-B, 
GCN5 orthologue in Toxoplasma (Bhatti et al., 2006).  Furthermore, TgGCN5-B 
ic loci for TgGCN5 is disrupted, there is no observable phenotype even 
under stress conditions (Bhatti et al., 2006).  These two pieces of data argue
there must be another protein expressed in Toxoplasma capable of acetylatin
histone H3 at lysine 14 with the potential to compensate for the loss for TgGCN5.
Subsequent searches of the Toxoplasma database revealed the pre
of a second GCN5 homologue (Bhatti et al., 2006).  Mammals possess a seco
GCN5 family member, PCAF, but there are no reports of multiple GCN5 H
other animals or plants.  Our lab subsequently cloned
 (termed TgGCN5-B) and the TgGCN5 protein previously reported is no
referred to as TgGCN5-A.  Thus, Toxoplasma appears to be unique among 
invertebrates in harboring two independent GCN5 HATs, and the relevance to 
parasite physiology is subject to future investigation. 
The TgGCN5-B ORF encodes a predicted protein of 1032 amino a
which is 137 residues shorter than TgGCN5-A.  The HAT domains are nearly
identical, but the putative Ada2-binding domain and bromodomain are less 
conserved.  Most striking is the lack of homology in the N-terminal extensions of
both proteins.  Neither one of these N-terminal extensions has homology to 
protein sequences in other species, nor are any known protein motifs evident.  
Furthermore, the N-termini have no homology to each other.  The studies 
outlined in this thesis will serve as a template to begin investigating TgGCN5
particularly the role of its unique N-terminal extension. 
Preliminary enzymatic data produced in our lab indicates that TgGCN5-B 
acetylates histone H3 at the expected lysine 14, indicating it may be the true 
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is able to acetylate lysine residues 9 and 18 suggesting that it can compensate 
for the loss of TgGCN5-A explaining the lack of an observable phenotype in the 
TgGCN5-A knock out (Bhatti et al., 2006).  TgGCN5-A may be the result of a 
specific function in chromatin 
remod ine 18 
s 
e 
of 
ozygous null for 
murine PCAF (mPCAF) are developmentally normal without any distinct 
as been proposed that mGCN5 can 
functio
 likely 
 
fore, 
 similar 
gene duplication event that has evolved a highly 
eling in these parasites, as suggested by its proclivity to acetylate lys
of H3.  Finally, elucidating the proteins TgGCN5-B interacts with will provide 
additional insight into the overall function of this HAT in the parasite. 
Repeated attempts by our lab to disrupt the TgGCN5-B genomic loci have 
been unsuccessful.  The inability to knock out TgGCN5-B suggests that the 
protein is essential in tachyzoites.  Furthermore, it argues that TgGCN5-A i
unable to compensate for the loss of TgGCN5-B.  Given the completely different 
acetylation patterns between the two HATs, the inability for TgGCN5-A to 
compensate for the loss of TgGCN5-B is not surprising.  The similarities and 
differences between the two GCN5 proteins in Toxoplasma is akin to th
relationship between GCN5 and PCAF in mammals. 
When murine GCN5 (mGCN5) is deleted in mice, the embryos do not 
survive past day 10 post conception due to developmental defects (Xu et al., 
2000).  Thus a deletion of mGCN5 is lethal and the same appears to be true 
TgGCN5-B in Toxoplasma tachyzoites.  Mice that are hom
phenotype (Yamauchi et al., 2000).  It h
nally compensate for the loss of mPCAF (Yamauchi et al., 2000).  The 
deletional mutant of TgGCN5-A possess no phenotypic anomaly and it is
TgGCN5-B is able to compensate for the loss of TgGCN5-A.  The lethality of a
mGCN5 knockout suggests that mPCAF is unable to compensate for the loss 
mGCN5.  Given the inability to obtain a TgGCN5-B knockout, argues that 
TgGCN5-A is unable to compensate for the loss of TgGCN5-B.  There
TgGCN5-A may be analogous to mPCAF and TgGCN5-B is a functional 
equivalent to mGCN5.  However, the acetylation pattern of PCAF is highly
to GCN5 showing strong activity on lysine 14 of histone H3 with modest activity 
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on lysi N5-A 
extens  to 
gy to 
ontains the conserved domains present in other GCN5 
proteins: the catalytic HAT domain, Ada2 binding domain, and the bromodomain.  
 (Miao et al., 2006).  Plasmodium also 
posses
 
C. A M
-
ately 
T-A 
 vitro bradyzoite induction (Smith et al., 2005).  The decrease in 
expres
nes 9 and 18 (Schiltz et al., 1999).  Thus, the analogy between TgGC
and PCAF is not flawless. 
 
B. GCN5 homologue in Plasmodium falciparum 
A GCN5 homologue was also identified and cloned in Plasmodium 
falciparum (PfGCN5; Fan et al., 2004a).  PfGCN5 also contains a long N-terminal 
ion upstream from its catalytic domain, currently the longest one known
date (1126 amino acids).  The N-terminus in PfGCN5 possesses no homolo
any known protein and it is completely divergent from the N-termini in TgGCN5-A 
and -B.  PfGCN5 c
Enzymatic studies have shown that PfGCN5 acetylates histone H3 at lysines 9 
and 14 of Plasmodium histone H3 in vitro
ses a single Ada2 protein, (PfAda2; Fan et al., 2004b).  Unlike 
Toxoplasma, searches of the Plasmodium genome indicate that Plasmodium 
expresses only one Ada2 and GCN5 protein.  The lack of additional copies of 
Ada2 and GCN5 in Plasmodium suggests that the Toxoplasma has generated 
duplications of Ada2 and GCN5.  The purpose of these gene duplications in
Toxoplasma is unknown and warrants additional studies. 
 
YST homologue in Toxoplasma 
Two MYST HATs have been isolated in Toxoplasma termed TgMYST-A 
and -B (Smith et al., 2005).  The TgMYST-A genomic locus generates a 
transcript of approximately 3.5-kb that can encode two proteins of 411 or 471 
amino acids (Smith et al., 2005).  The longer protein has been termed TgMYST
A(L) and the shorter one TgMYST-A(S).  TgMYST-B mRNA is approxim
7.0kb and encodes a second MYST homologue (Smith et al., 2005).  
Interestingly, there is a decrease of in the expression of both forms of TgMYS
during in
sion suggests that both forms of TgMYST-A are predominantly expressed 
in tachyzoites. 
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Both the long and short forms of recombinant TgMYST-A acetylate 
histone H4 in vitro at lysines 5, 8, 12, and 16 (Smith et al., 2005).  Wh
family members show a bias towards acetylating H3, the MYST family of HATs 
display a preference for acetylating H4 (Utley and Cote, 2003).  The ability for 
TgMYST-A to acetylate all for residue in histone H4 suggests that TgMYS
may be an orthologue of Esa1/Tip60 since it can target every lysine in the H4 tail
Similar studies assessing the expression of TgMYST-B in tachyzoites 
versus bradyzoites and determining the acetylation pattern have yet to be 
completed.  It is conceivable that the second MYST may be expressed during
bradyzoite stage. 
 
IV. Additional Future Studies for TgGCN5-A 
A. Acetylation of non-histone substrates 
The unusual acetylation pattern of TgGCN5-A and the presence of
ile GCN5 
T-A 
. 
 the 
 a 
second  
 
r 
or p53 
ss 
).  The 
.  
is involved in stress remediation pathways through its FAT 
activity
tone 
 homologue capable of acetylating histone H3 at all the lysine residues
suggests that TgGCN5-A may involved in additional processes beyond chromatin 
remodeling.  It has been suggested that TgGCN5-A may represent a functional 
equivalent to mammalian PCAF.  In addition to acetylating histones, PCAF
possesses the ability to acetylate non-histone proteins.  Therefore, it is possible 
that TgGCN5-A may also acetylate non-histone proteins. 
The process of acetylating non-histone proteins is referred to as facto
acetyltransferase or FAT activity (Roth et al., 2001).  The cell cycle regulat
is one the of most widely study targets of the FAT activity of PCAF.  The 
acetylation of p53 by PCAF appears to be triggered in response to the stre
caused by DNA damage due to UV or ionizing radiation (Liu et al., 1999
acetylation of p53 by PCAF increases the affinity of p53 to bind DNA, 
augmenting its ability to upregulate stress response proteins (Liu et al., 1999)
Therefore, PCAF 
. 
PCAF also acetylates the chromatin associating protein HMG-17 (Herrera 
et al., 1999).  HMG (high mobility group) proteins are a group of non-his
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proteins which modulate the structure chromatin altering the accessibility of DNA 
(Bustin et al., 1995).  HMG-17 specifically binds to the 146 base pair 
nucleosomal core particle and modulates the chromatin structure of active genes 
(Bustin et al., 1995).  The acetylation of HMG-17 by PCAF reduces the affinity of 
HMG-17 for nucleosome cores.  Therefore, PCAF acetylation can affect 
chromatin structure through the acetylation of non-histone proteins.  The overall
affect of acetylating HMG-17 on gene transcription is still controversial.  The 
binding of HMG-17 to nucleosomes unfolds the higher-order chromatin fi
enhances the accessibility of various factors to the chromatin (Herrera et al., 
1999).  Acetylation appears to weaken the interaction of HMG-17 with DNA 
suggesting it may cause the chromatin to refold generating a repressive ef
transcription.  Alternatively, the acetylation of HMG-17 may have the same e
as the acetylation as histones, reducing the affinity for DNA and further opening 
chromatin allowing for an increase in transcription (Herrera et al., 1999). 
If TgGCN5-A possess FAT activity, it may also acetylated non-hist
proteins involved in stress remediation.  Therefore, it may ac
 
ber and 
fect to 
ffect 
one 
etylate DNA-binding 
transcr
ium 
gGCN5-A and recombinant non-histone substrates such as HMG would 
 acetylate non-histone 
substra
 substrates.  A 
ith 
iption factors that are involved in bradyzoite differentiation.  Searches of 
the Toxoplasma database indicate that the parasite does not containing a 
homologue of p53.  However, HMG proteins have been identified in Plasmod
and similar proteins may exist in Toxoplasma (Nambiar et al., 1997).  The 
presence of HMG proteins presents another level of chromatin remodeling 
present in apicomplexan parasites.  Apicomplexan HMG proteins may be 
acetylated by GCN5 proteins such as TgGCN5-A.  In vitro HAT assays with 
T
determine if TgGCN5-A possesses the ability to
tes.  If activity on non-histone substrates exists, HAT assays with 
FΔNTTgGCN5 would determine if the N-terminus is required to acetylate non-
histone proteins. 
A screen could be established to further identify non-histone
protocol has been established for monitoring acetylation by incubating cells w
with tritiated acetate (Zhang and Nelson, 1988).  The tritated acetate is 
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incorporated into the cellular acetyl CoA pool and is utilized by HATs to acetylat
proteins.  Both wild-type and the TgGCN5-A knock out parasites could be 
incubated in tritiated acetate.  Any proteins capable of being acetylated would b
marked with a radiolabeled acetyl group in the parasites.  The parasites would b
fractionated between nuclear and cytoplasmic fractions.  The nuclear fractio
would be resolved via 2D gel electrophoresis.  The gel would be processed fo
autoradiography and exposed to film.  Dots on the exposed film would indicate 
the presence of radioactive acetylation.  The knock out would provide a 
necessary comparison to establish which proteins were ac
e 
e 
e 
n 
r 
eylated by TgGCN5-A.  
Dots p
ed 
 
 MIC5, and 
MIC11
ential to be post-translationally 
g 
ed-
resent on film from wild type lysate that are missing on the film from the 
knock out would indicate a loss of aceyltation.  Proteins that appear to be 
differentially acetylated between wild-type and knock out would be sent for 
sequencing analysis.  Proteins that were acetylated could be eventually clon
and recombinant protein expressed.  The recombinant protein would be used as
substrate in an in vitro acetylation assay with TgGCN5-A to confirm that 
TgGCN5-A is responsible for the acetylation of the protein. 
The differential expression of proteins revealed in the 2D gel analysis of 
ΔTgGCN5-A may have been caused by decreased protein acetylation.  The 
decreased acetylation may have caused proteins such as MIC4,
 to migrate differently in the ΔTgGCN5-A 2D gel versus the wild type 2D 
gel.  Therefore, it would be interesting to see if the differences in the 2D gel 
analysis are paralleled in the acetyl Co-A labeling experiment.  No studies have 
been completed determining if the MIC (microneme) proteins are acetylated. 
 
B. Posttranslational modification of TgGCN5-A 
Like other proteins, GCN5 has the pot
modified.  The co-immunoprecipitations performed on parasites overexpressin
FLAGTgGCN5 and FLAGΔNTTgGCN5 through our collaboration with Dr. Moham
Ali Hakimi support this possibility.  The SDS-PAGE analysis of co-
immunprecipitations with both proteins produced multiple bands migrating at 
sizes larger than expected for FLAGTgGCN5 and FLAGΔNTTgGCN5 (Figures 21 
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and 22 on pages 121 and 126, respectively).  The slower migrating versions of 
FLAGTgGCN5 and FLAGΔNTTgGCN5 can be explained by the presence of post 
translational modifications that are retarding their migration through the gel.  A 
single  
AF can 
r 
kinase 
n is 
he 
g 
DNA repair is unknown however it may be to 
preven
-A 
N-
that are acetylated in 
phosphorylation can impede the SDS-PAGE migration of a protein by up
to 5 kilodaltons (Smith et al., 1989).  As more modifications are added, the 
retardation of migration becomes more pronounced.  There is evidence that 
GCN5 can be phosphorylated (Barlev et al, 1998) and the related HAT PC
be transacetylated (Herrera et al., 1997).  These same modifications may occu
to TgGCN5-A and may impact the activity of TgGCN5-A. 
Phosphorylation of human GCN5 (hGCN5) by the DNA-dependent 
Ku70 attenuates the HAT activity of hGCN5 (Barlev et al, 1998).  The kinase 
Ku70 interacts with the bromodomain of hGCN5 and through this interactio
believed to phosphorylate the amino terminus of recombinant hGCN5.  T
precise residues acetylated by Ku70 are still being resolved.  Using siRNA, the 
expression of Ku70 was knocked down in human cells resulting in an increased 
sensitivity to DNA damage caused by ionizing radiation suggesting the kinase 
has a role in DNA repair (Ayene et al., 2005).  The purpose of down regulatin
the HAT activity of GCN5 during 
t the remodeling of chromatin containing damaged DNA. 
Additionally, human PCAF appears to transacetylate its N-terminus, which 
is essential for it to be transported into the nucleus and may potentially stabilize 
the enzymatic function of the enzyme (Santos-Rosa et al., 2003; Herrera 1997).  
TgGCN5-A may be capable of similar transacetylation.  There are five lysines in 
the PCAF N-terminus that are acetylated; lysines 416, 428, 430, 441, and 442 
(Santos-Rosa et al., 2003).  Based on the alignment between TgGCN5-A and 
human PCAF using the Clustal W algorithm 
(http://www.ch.embnet.org/software/ClustalW.html), TgGCN5-A only possess 
one of these lysine residues, lysine 430, which corresponds to lysine 712 in 
TgGCN5-A.  The lack of conserved lysine residues suggests that TgGCN5
may not be transacetylated.  Human GCN5 does not appear to acetylate its 
terminus (Herrera et al., 1997).  Only two of the five lysines 
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human PCAF are conserved in human GCN5 (lysines 428 and 441).  However, 
es present in the N-terminal extension of TgGCN5-
A that 
ys 
al 
 
 determined that lysines in the N-terminus are being acetylated, site 
directed mutagenesis switching the lysine for arginine would provide information 
e of acetylating these residues.  Arginine is not susceptible to 
acetyla  
 
a in 
there are 25 other lysine resid
are potential acetylation sites. 
The acetylation mechanism of the N-terminus occurs via an interaction 
with a second PCAF protein (Santos-Rosa et al., 2003).  The in vitro HAT assa
used in this thesis could be modified using recombinant TgGCN5-A N-terminin
peptide as a substrate instead of histones.  Radioactive assays could be 
performed by comparing the acetylase activity of full length TgGCN5-A and a 
catalytically inactive mutant TgGCN5-A on the N-terminal peptide.  Following the 
in vitro assay, the proteins would be resolved via SDS-PAGE and the gel 
processed for autoradiography.  If a band corresponding to the size of the N-
terminal peptide developed on film after being exposed to the gel, it would 
indicate that the N-terminal extension is acetylated by TgGCN5-A.  The 
catalytically inactive mutant TgGCN5-A would serve as a negative control and 
should be unable to acetylate the N-terminal peptide.  In addition, non-radioactive
acetylation assays could be performed and the N-terminal peptide excised from 
the gel, and sent for MALDI/TOF analysis to determine which, if any, lysine 
residue(s) are being acetylated. 
If it is
about the importanc
tion but is positively charged like lysine and therefore should not generate
significant change it the conformation of TgGCN5-A when exchanged for lysine 
(Santos-Rosa et al., 2003).  Immunofluorescence assays performed on parasites 
expressing mutated TgGCN5-A with the lysine exchanged for arginine would 
determine if acetylation has an effect on nuclear localization as it does in human
PCAF.  The enzymatic function of recombinant protein purified from parasites 
expressing the same mutated versions of TgGCN5-A could be assessed vi
vitro HAT assays to determine if acetylation has any effect of the ability of 
TgGCG5-A to acetylate histone.  The enzymatic activity of human PCAF is 
increased when it is acetylated (Santos-Rosa et al., 2003). 
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 V. HAT and HDAC Inhibitors 
Histones were originally thought to be no more than simple scaffolding 
protein
me 
 
lar 
d 
sis 
g 
 
 
e 
003).  Trichostatin A (TSA), a well-known HDAC 
inhibito
l., 
 
s, providing a mechanism for compacting DNA into the nucleus.  However, 
in the past few decades it has become abundantly clear that histones can be 
posttranslationally modified altering the structure of chromatin.  The resulting 
changes in chromatin structure have profound impact on the expressed geno
resulting differentiation, activation of stress response pathways, apoptosis, and 
cell-cycle regulation.  Acetylation of histones is the most well studied modification
and is carried about by histone acetyltransferases (HATs) and histone deacetyl 
transferases (HDACs).  HATs and HDACs work cooperatively to provide the 
proper balance of histone and protein acetylation to maintain a functional cellu
state (Kurdistani and Grunstein, 2003).  Disruption in the balance of histone an
protein acetylation is deleterious to cells resulting in cell death or carcinogene
(Timmermann et al., 2001).  HAT and HDAC inhibitors hold the promise of bein
able to restore the acetylation balance and may be effective antitumor agents.  
Alternatively, HAT and HDAC inhibitors can be used to unbalance acetylation in
pathogenic organisms providing potential therapies for HIV and apicomplexan
infections. 
 
A. HDAC Inhibitors 
Interestingly, the involvement of histone modification in regulating global 
processes was originally discovered through screening compounds to aid in th
treatment of cancer (Kim et al., 2
r, was originally reported as a fungistatic antibiotic (Tsuji and Kobayashi, 
1978).  The treatment of a leukemia cell line with TSA resulted in differentiation 
and inhibition of the cell proliferation at very low concentrations (Yoshida et a
1987).  Additional analysis revealed that cells treated with TSA caused an 
accumulation of acetylated histones in a variety of mammalian cell lines.  
Furthermore, TSA strongly inhibits the activity of the partially purified histone
deacetylases in vitro. (Yoshida et al., 1990).  The same story is true for 
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depudecin which was isolated from a screening project for agents capable of 
reverting malignant carcinogenic cells to a normal phenotype and was later 
identified as targeting HDACs (Kim et al., 2003). 
The mechanism of HDAC inhibition leading to reversion of cancerous cells
is not entirely understood.  Direct alterations in the HDAC genes have not bee
demonstrated in human
 
n 
 cancers (Cress and Seto, 2000).  Typically HDACs are 
seen a g 
 
 proliferation (Vigushin and Coombes, 2004).  Thus, it would 
eem that inhibiting HDACs would push a cell further into carcinogensis, but 
opposite occurs with HDAC inhibitor exposure.  It has been 
theoriz
 of 
rman et al., 
 
 
autosomal dominant neurodegenerative 
disorde e 
ne 
tin 
s repressive proteins causing the deacetylation of histones restorin
chromatin into its condensed state.  Furthermore, cell cycle regulators such as 
Mad (mitotic arrest deficient) and the retinoblastoma (Rb) protein associate with
HDAC complexes to mediate transcriptional repression leading to differentiation 
and suppressing
s
paradoxically, the 
ed that the HDAC proteins act upstream of the dysregulated proteins 
allowing for histone hyperacetylation at promoters of cell regulatory proteins.  
The tumor suppressor protein p21 is a cyclin-dependent kinase (CDK) inhibitor 
which binds defective cell cycle regulators and inhibits their activity, leading to 
suppression of cell proliferation (Vigushin and Coombes, 2004).  Inhibition of 
HDACs results in hyperacetylated histones, markedly increasing transcription
p21.  In fact, treatment of colon cancer cells with HDAC inhibitors results in an 
upregulation of p21 expression and subsequent growth arrest (Timme
2001).  Given the impressive antitumor activity of HDAC, several inhibitors are
currently in phase I clinical trials for the treatment of the treatment of cancer  
(Vigushin and Coombes, 2002). 
The inhibition of HDACs may be beneficial to other disease states besides
cancer.  Huntington's disease (HD) is an 
r caused by a polyglutamine repeat expansion in the huntingtin gen
(Davies and Ramsden, 2001).  Recent studies have indicated transcriptional 
dysregulation as a mechanism of HD pathogenesis through disruption of histo
acetylation (Sadri-Vakili and Cha, 2006).  Several HATs including CBP and 
PCAF are depleted by the sequestration into the aggregates of mutant hunting
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resulting in a globally hypoacetylated state in a cell culture model (Butler a
Bates, 2006).  The inhibition of histone deacetylases is theorized to compensate 
for the reductions in HAT protein and restore the proper balance of acetylated 
histones in HD models (B
nd 
utler and Bates, 2006).  The use of HDAC inhibitors in 
HD an s (Sadri-
f 
bition 
 
isease, and systemic lupus erythematosus 
(Huang
ate 
e” 
 
 
betwee ash 
imal models has shown promise as potential therapeutic agent
Vakili and Cha, 2006). 
The inhibition of HDACs has also been linked to the repression o
proinflammatory cytokine production (Barnes et al., 2005).  Therefore, inhi
of HDACs may provide novel therapeutic treatments for inflammatory disease
such as asthma, inflammatory bowel d
, 2006). 
 
B. HAT inhibitors 
Aberrant lysine acetylation has also been implicated in carcinogenesis.  
As mentioned previously, the HAT protein p300/CBP has the ability to acetyl
non-histone proteins like p53 (Liu et al., 1999).  The acetylation of p53 augments 
its ability to bind DNA.  p53 is often referred to as the “guardian of the genom
and its importance is emphasized by the fact that 50% of all human cancers 
possess mutations in p53 (Balasubramanyam et al., 2004b).  Acetylation by 
p300/CBP and PCAF is key in activating p53 when DNA damage occurs (Liu et 
al., 1999).  Loss or a defect in the ability to acetylate p53 may lead to 
carcinogenesis.  A disruption in the p300 gene has been demonstrated to be 
common in colorectal and gastric cancer samples (Muraoka et al., 1996).  It is 
estimated that 80% of glioblastoma, the most aggressive form of primary brain 
tumors) cases have been associated with the loss of heterozygosity of the p300
gene (Balasubramanyam et al., 2004b). 
Chromosomal translocations resulting in the three different fusions
n p300/CBP and a MYST member are associated with leukemia (D
and Gilliland, 2001).  The three fusion proteins are MLL/CBP, MLL/p300 and 
MOZ/CBP and incorporate the well characterized transcriptional co-activators 
CBP/p300 to either the monocytic leukemia zinc finger (MOZ) gene or to MLL 
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(mixed linage leukemia; Timmerman et al., 2001).  The acetyltransferase 
domains of the MYST member and p300/CBP remain intact in the fusion protein
resulting in unregulated HAT activity and aberrant histone acetylation leadi
leukemia (Yang, 2004). 
Mutations in human CBP have also been associated with the 
developmental disorder, Rubinstein-Taybi syndrome (RTS; Timmerma
2001).  RTS occurs in 1/125,000 b
s 
ng to 
n et al., 
irths and is characterized by growth 
retarda
n 
 
of cellular 
us 
tional 
f 
ti-retroviral 
therap
 
tion and psychomotor developmental delay (Coupry et al., 2002).  
Interestingly, patients with RTS have a 5% increased incidence in childhood 
tumors (Miller and Rubinstein, 1995). 
Protein acetylation has also been implicated in the regulation of HIV-1 
gene transcription.  The histone deacetylase inhibitor trichostatin A (TSA) is a 
potent inducer of HIV-1 transcription in latently infected T-cell lines through 
hyperacetylation of histones (Sheridan et al., 1997).  Furthermore, the acetylatio
of histone H3 and H4 by HAT complexes stimulate HIV-1 transcription from 
preassembled nucleosomal templates (Steger et al., 1998).  The HIV viral protein
Tat (trans-activator protein) appears to highjack various acetyltransferases 
including Tip60, hGCN5 , p300/CBP and PCAF (Quivy and Van Lint, 2002).  Tat 
interacts with Tip60 (Tat-interactive protein) to hinder the expression 
genes which normally interfere with the replication and propagation of the vir
(Creaven et al., 1999).  p300/CBP, hGCN5, and PCAF appear to each acetylate 
Tat at specific lysine residues within the protein, stimulating the transcrip
activity of Tat (Col et al., 2001).  It has been suggested that the requirement o
histone and Tat acetylation in the replication of HIV defines HATs as new targets 
for HIV drug design (Quivy and Van Lint, 2002).  HAT inhibitors could maintain 
infected cells in the latent state and may augment highly active an
y (HAART) in controlling HIV infection (Quivy and Van Lint, 2002). 
Although significant progress has been made in the field of histone 
deacetylase inhibitors, there are only a few HAT inhibitors (Balasubramanyam et
al., 2003).  Two synthetic peptide-CoA conjugates have been generated that are 
specific inhibitors of PCAF and p300.  Lysyl CoA (Lys-CoA) specifically inhibits 
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p300 and PCAF is inhibited by H3-CoA-20 (Lau et al., 2000).  Interestingly, Lys-
CoA does not effectively inhibit PCAF and H3-CoA-20 only affects p300 at very 
high concentrations (Lau et al., 2000).  The difference between these two 
inhibitors demonstrates that different HATs can be selectively inhibited despite 
homology between their catalytic domains.  Unfortunatley, Lys-CoA is unable to 
permate cell membranes limiting its usefulness to only in vitro assays 
(Balasubramanyam et al., 2003). 
Newer HAT inhibitors that are permeable to cell membranes are being 
cashew
3).  A 
ve 
ment 
 
d of 
an 
 
6).  
ng HAT inhibitors to derive more 
selecti  
 
ndent 
derived from naturally occurring substances.  Anacardic acid is derived from 
 nut shell liquid, and has been shown to exhibit antitumor activity 
(Balasubramanyam et al., 2003).  Further in vitro analysis demonstrates that it 
inhibits the HAT activity of p300 and PCAF (Balasubramanyam et al., 200
p300 selective inhibitor curcumin (diferuloylmethane) is derived from the spice 
turmeric (Kang et al., 2005).  Curcumin is selective for p300 and does not ha
any effect on the activity of PCAF (Balasubramanyam et al., 2004b).  Treat
of HIV infected cells with curcumin significally repressed the multiplication of the
virus and inhibited the acetylation of HIV-Tat protein (Balasubramanyam et al., 
2004b).  Garcinol, a polyisoprenylated benzophenone derivative from the rin
Garcinia indica berries, is capable of inhibiting both p300 and PCAF 
(Balasubramanyam et al., 2004a).  Garcinol and curcumin displayed strong 
growth inhibitory effects and induction of apoptosis in human leukemia cells (P
et al., 2001).  Furthermore, curcumin also appears to selectively induce 
apoptosis in mouse and human cancer cell lines but has minimal effect upon
exposure to healthy primary mouse and human cell cultures (Jiang et al., 199
However, it is still unknown if the apoptotic effects of garcinol and curcumin are 
caused by acetylase inhibition or through different mechanisms. 
Work has been done using natural occurri
ve inhibitors as potential theraputics and tools to further characterize HAT
proteins.  Compound MC1626 (2-methyl-3-carbethoxyquinoline) is an analog of
anacardic acid (Ornaghi et al., 2005).  It is able to permeate cell membranes and 
treatment of yeast cells with MC1626 inhibits cell growth in a Gcn5p-depe
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way (Ornaghi et al., 2005).  Cell growth inhibition was significantly diminished in 
a null gcn5Δ and a HAT catalytic mutant strain (Ornaghi et al., 2005).  M
represents the first membrane permeable inhibitor of GCN5.  While MC1626 
have potential as a therapeutic compound, it may be an even more important a
molecular tool facilitating continued dissection of GCN5-mediated expr
chromatin remodeling.  It may also provide a starting point from which a
GCN5 inhibitors or activators can be derived. 
 
C. Apicomplexan HDAC and HAT inhibitors 
Compounds able to inhibit HDAC and HAT proteins eventually made i
way into the apicomplexan world led by the discovery of apicidin.  Apicidin is a 
fugal metabolite isolated from a Costa Rican fungus (Fusa
C1626 
may 
s 
ession and 
dditional 
ts 
rium spp.) and 
posses  
ealed 
 
been 
oal effect of apicidin 
illustra otential 
m 
 are 
ites 
ses a tetrapeptide structure (Darkin-Rattray et al., 1996).  When cultured
parasites were treated with apicidin, it inhibited the growth of drug-resistant 
human malaria, C. parvum, and Toxoplasma, demonstrating it as a broad 
spectrum antiprotozoal (Darkin-Rattray et al., 1996).  Further analysis rev
that apicidin inhibits the histone deacetylases in apicomplexan parasites (Singh
et al., 2002).  Unfortunately, apicidin has a narrow therapeutic window and 
inhibits human HDACs resulting in an anti-proliferative effect on human cells, 
limiting its clinical potential to treat apicomplexan diseases.  Attempts have 
made by Merck Research Laboratories at modifying the parent compound to 
increase the selectivity for parasite HDACs.  However, none of the related 
compounds were active against parasites in vivo (Tucker-Samaras, 2003).  
Nevertheless, the potent and broad spectrum antiprotoz
tes the importance of pursuing chromatin remodeling enzymes as p
therapeutic targets to combat apicomplexan diseases (Darkin-Rattray et al., 
1996). 
Disruption of HATs in other systems is often deleterious to the organis
(Timmerman et al., 2001).  HATs in Toxoplasma and other apicomplexans
involved in regulating gene expression.  In fact, progression of malarial paras
through different life cycle stages has been linked to changes in histone 
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acetylation (Miao et al., 2006).  Therefore, disrupting HAT and HDAC complexes 
could influence stage differentiation in apicomplexans.  Evidence exists 
suggesting that TgMYST-A and TgGCN5-A HATs are involved in regulating 
tachyzoite expression (Saksouk et al., 2005; Smith et al., 2005).  Inhibition of 
these proteins may lock the parasite in the tachzoite stage or prevent 
recrudescence from bradyzoites back into tachyzoites.  The inability to 
succes s 
 the 
remely 
 selective inhibitors are 
obtaina  1 still 
 HAT 
ivo 
).  Therefore, 
anacar
sfully generate a TgGCN5-B and TgMYST-A deletional mutants suggest
that these two chromatin remodelers are essential to the tachyzoite state of 
Toxoplasma (Bhatti et al., 2006; Smith et al., 2005).  Therefore, HAT inhibitors 
able to target these HATs may inhibit parasite growth.  A limiting step in
inhibition of HATs and HDACs in parasites is finding an inhibitor that is selective 
for parasites and has little to no effect on human tissues. 
A screening of several HAT inhibitors identified a candidate compound, 
Compound 1, with good parasite selectivity and broad-spectrum antiprotozoal 
effects (Tucker-Samaras, 2003).  Unfortunately, Compound 1 was ext
toxic in vivo but it provides evidence that parasite
ble (Tucker-Samaras, 2003).  The selective nature of Compound
makes it an excellent investigational tool for further characterizing parasite
proteins.  Compound 1 may also provide a starting point upon which to design 
further compounds that maintain its parasite selectivity but lower its in v
toxicity (Tucker-Samaras, 2003).  The in vivo toxicity of Comound 1 was very 
rapid suggesting that it was mediated by a mechanism other than HAT inhibition 
(Tucker-Samaras, 2003).  Additional studies indicate that Compound 1 targets 
one of the MYST acetyltransferases in apicomplexans. 
Future experiments testing the effect of anacardic acid, curcumin, 
garcinol, and compound MC1626 on parasite growth are warranted.  Toxoplasma 
does not possess a homologue of p300 (Nallani and Sullivan 2005
dic acid, curcumin, and garcinol may have no effect on the growth of 
Toxoplasma.  However, it has been suggested that TgGCN5-A may be a 
functional equivalent of PCAF.  The ability of garcinol and anacardic acid to 
inhibit its HAT activity would provide further evidence of a PCAF-like function.  
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However, all four of these compounds may possess activity against Toxoplasma
HATs.  As compound MC1626 has been demonstrated to inhibit yeast
 
 GCN5, it 
would be of particular interest to demonstrate its ability to inhibit parasite growth.  
If compound MC1626 is able to inhibit parasite growth, it is highly probable that it 
is targeting TgGCN5-B and not TgGCN5-A, because a knock out of TgGCN5-A 
is viable (Bhatti et al., 2006). 
In vitro HAT assays could also be employed to determine the targets of 
HAT inhibitors in Toxoplasma.  Different inhibitors may display selectivity against 
different HATs expressed in Toxoplasma.  Additionally, as new HAT inhibitors 
are discovered they should be tested against known and newly cloned 
apicomplexan HATs.  It is important to investigate compounds that are ineffective 
or weak inhibitors of mammalian HATs.  These inhibitors may selectively inhibit 
apicomplexan HATs.  Thus, when they are added to parasites in culture, they will 
injure the parasites but have no effect on the host cells.  Inhibitors with parasite 
selectively have the potential to be novel therapeutics in treatment of 
Toxoplasma and other apicomplexan infections. 
Novel inhibitors of apicomplexan HATs and HDACs may also be 
applicable to other disease caused by dysregulated histone acetylation.  
Although originally discovered to thwart apicomplexan disease, apicidin is now 
being investigated as a potential anticancer agent.  Treatment of v-ras-
transformed mouse fibroblasts with apicidin induced morphological alteration 
towards differentiation due to hyperacetylation of histone H4 (Kim et al., 2004).  
Furthermore, apicidin strongly inhibited angiogenesis of vascular endothelial cells 
(Kim et al., 2004).  Angiogensis is the formation of new vessels and is a key step 
in the spread of metastatic cancer and has been linked to histone acetylation 
(Kim et al., 2003).  Therefore, the anti-angiogenic and anti-oncogenic potential of 
apicidin may lead to its use as a new type of drug to treat cancer. 
Clearly, the continued characterization of Toxoplasma HATs and other 
chromatin remodeling proteins will aid in understanding parasite biology and the 
bradyzoite differentiation process.  Furthermore, it will assist in the development 
of development of HAT and HDAC inhibitors which have the therapeutic potential 
203 
to treat not only in apicomplexa  disorders including 
cancer, HIV infection, genetic diseases, and inflammatory conditions. 
n infections but many other
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C MARY 
  N-terminal extension of TgGCN5 is required for the nuclear 
9 
 ic protein to the 
n. 
 
s 
Pα). 
 teracts with TgIMPα via the RKRVKR NLS in vitro, 
 
HAPTER 5: SUM
 
The
localization of TgGCN5-A. 
The motif RKRVKR present in the N-terminus between r esidues 93 and 9
is required for TgGCN5-A nuclear localization. 
The motif RKRVKR is capable of targeting a cytoplasm
parasite nucleus. 
 RKRVKR is the first NLS to be described in any apicomplexa
The RKRVKR NLS is not present in any other known GCN5 proteins. 
 Permutations of RKRVKR have predictive value in bioinformatic searche
of apicomplexan sequence databases. 
 A homologue of importin α was identified and cloned in Toxoplasma 
(TgIM
TgGCN5-A in
demonstrating that the N-terminus can participate in protein-protein 
interactions. 
In collaboration with Dr. Mohamed-Ali Hakimi’s laboratory at the French 
National Centre for Scientific Research in Grenoble, France, proteins 
associating with TgGCN5-A were identified in co-immunoprecipitation 
experiment suggesting that HAT complexes exist in Toxoplasma. 
TgGCN5-A preferential ly acetylates histone H3 only at lysine 18 in vitro.  
The selective acetylation of lysine 18 in histone H3 has not been 
described for any other GCN5 homologue. 
Rem oval of the TgGCN5-A N-terminal extension does not affect the 
acetylation of free histones in vitro. 
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